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Abstract

1 OTT
Cloning of the inversion breakpoints in the agouti mutant strain a

has

implicated the E3 ligase Itch in the spontaneous inflammation that occurs in these mice.
1 RH
Anaylsis of a

mice suggests that the inflammatory disease is due to a dysregulated T

helper type-2 immune response. In order to verify the importance of Itch inactivation in
the spontaneous inflammation of a mice and to determine which cell type is
responsible for the pathology, the Itch gene has been targeted for conditional deletion in
mice using the Cre-loxP system.
The results presented in this thesis provide the first direct evidence that Itch
deficient CD4+ T cells are sufficient to cause spontaneous inflammation. The function of
CD4+CD25+ regulatory T cells was found to be intact in vitro. Instead, sensitivity to the
immunomodulatory cytokine TGF-(3 was reduced in Itch deficient CD4+ T cells.
Inadequacies in peripheral tolerance mechanisms were observed based on oral tolerance
studies.
Itch deficiency was found to directly contribute to the CD4+ bias towards T
helper type-2 (Th2) differentiation observed in a mice. Itch modulation of Th2
differentiation occurs in a Stat6 dependent pathway. Itch fl/fl CD4 Cre Stat 6 -/- CD4+ T
cells were found to be incapable of differentiating into Th2 cells in vitro. Itch fl/fl CD4
Cre Stat 6 -/- did not develop spontaneous inflammation disease, underscoring the
1 ST-T
importance of T h 2 differentiation in the pathology of a

mice.

Itch fl/fl CD4 Cre mice were found to accumulate memory phenotype CD8+ cells
in their secondary lymphoid organs. The inflammatory pathology of Itch fl/fl CD4 Cre

1

mice w a s not required for accumulation of Itch deficient memory-like C D 8 + cells. T h e
cause for this accumulation remains unclear, although an increase in homeostatic
proliferation of the memory-like cells is considered unlikely.
The findings of this thesis provide definitive support for several speculations
regarding the function of Itch. In addition, they provide novel venues of study for the
role of Itch in the immune system. Collectively, they argue that further study of this E3
ligase will be a fruitful endeavor for immunologists.

C h a p t e r 1: I n t r o d u c t i o n
1.A Tolerance in the immune system:
In a well-regulated immune system, immune reactions occur in response to
pathogenic antigens but not in response to self or harmless foreign antigens. This

acceptance of both self-antigens and antigens to which the immune system is constant

exposed (through inhalation or ingestion) is defined as tolerance. The study of tole

mechanisms is an integral field of immunology, and the manipulation of tolerance has

extensive clinical applications. Problems with tolerance are linked to a wide spectr
clinical pathologies, including allergies and autoimmune diseases. Furthermore, the

ability to tolerize or break tolerance to specific antigens has ramifications in bot
immunology and transplantation.

1.A.1 Deletion:
One of the key mechanisms for maintaining tolerance against self-antigens is

clonal deletion of self-reactive T cells, either in the thymus or in the periphery (
and Basten 1996). The importance of thymic deletion has been underscored by the
recent description of AIRE deficient mice (Anderson, Venanzi et al. 2002), which

develop a multi-organ autoimmune disease due to an inability to delete self-reactive

cells in the thymus. The existence of autoreactive T cells in the periphery of healt

individuals, however, indicates that clonal deletion does not completely account for
tolerance (Fowell and Mason 1993).

1.A.2 Ignorance:
Another straightforward mechanism for tolerance is immunological ignorance. In

this situation, immune cells cannot localize to the environment in which their antig

found (Zinkernagel, Ehl et al. 1997). The blood-brain barrier is a classic example of this
type of tolerance, as lymphocytes are not found in the central nervous system of

otherwise healthy individuals. Signaling pathways involved in T cell mobility may pl
key role in this mode of tolerance.

1.A.3 T cell anergy:
Sometimes T cells do encounter their cognate antigen but do not elicit an immune
response through proliferation or cytokine release (Schwartz 1996). This cellautonomous state of unresponsiveness is defined as anergy and can be induced when a

cell is stimulated by antigen in the absence of co-stimulation (Jenkins, Chen et al.
or in a specific immunomodulatory cytokine milieu (Groux, Bigler et al. 1996). The
molecular basis of anergy remains poorly defined, but heterkaryon studies involving

fusion of anergic and nonanergic T cells have made it clear that the anergic state i

maintained by the dominant action of one or more regulatory molecules, rather than t
simple absence of signaling components (Telander, Malvey et al. 1999).

l.A.3.1 Clonal anergy:
Anergy can be further subdivided into two potentially distinct experimental
groups: clonal anergy and in vivo anergy (Schwartz 2003). Clonal anergy arises in
antigen-experienced cells and occurs in response to partial stimulation without

appropriate co-stimulatory signals. It should be noted that clonal anergy can only b

induced in previously stimulated cells, with most studies of clonal anergy involving

cell lines. It has not been successfully described for naive T cells, making this for

anergy a purely in vitro model system for tolerance (Davis and Lipsky 1993; Schwartz
2003). Once cells become clonally anergic, they do not proliferate in response to

subsequent antigenic stimulation; however, their effector functions are not affected. This

form of anergy can be reversed by the addition of exogenous interleukin 2 (IL-2) (Es
Feldmann et al. 1988; Powell, Bruniquel et al. 2001).
The biochemical pathways involved in regulating clonal anergy have been worked
out in some detail. Treatment of T helper type 1 (Thl) cell lines with cyclosporine
inhibits clonal anergy, implying that the calcium/calmodulin/calcineurin pathway is

critical for anergy induction (Jenkins, Chen et al. 1990). Further proof that this pa

is important comes from studies in which treatment of T cells with the calcium ionop
ionomycin mimics clonal anergy (Jenkins, Pardoll et al. 1987). Critical differences

between clonal anergy and ionomycin-induced anergy exist, however, as the latter tak

longer time to induce, abolishes all cytokine production, and is stable for only fou
Biochemically, the selective activation of NFAT without AP-1 is critical for anergy

induction, as it leads to reduced IL-2 production as well as activation of a specifi
"anergy genes" (Macian, Garcia-Cozar et al. 2002). In addition, there is a loss of
mitogen activated protein kinase (MAPK) signal transduction in anergized cells

((DeSilva, Feeser et al. 1996; Fields, Gajewski et al. 1996; Li, Whaley et al. 1996).

l.A.3.2 In vivo anergy:
In contrast to the induction of clonal anergy in antigen experienced cells, in vivo
anergy is seen when naive T cells are stimulated with antigen in the absence of costimulatory molecules or in the presence of high levels of co-inhibitory molecules.
undergoing in vivo anergy proliferate and differentiate to varying degrees but then

proliferate upon second exposure to the antigen. Historically, in vivo anergy was fi

noted in 1989 with the injection of Mls-la splenic cells into Mls-lb mice (Rammensee

Kroschewski et al. 1989). Most T cells proliferated and died, but a small proportion

survived and did not proliferate in response to further stimulation with Msl-lb cell

potential caveat in this model and subsequent superantigen model systems was that th

surviving, non-proliferating cells may never have recognized the antigen. Jenkins an

colleagues addressed this issue by devising a model of anergy involving adoptive tra
of transgenic T cells into nonirradiated syngenic mice followed by intraperitoneal

injection of antigen (Pape, Merica et al. 1998). Cells that survived the initial prol

and collapse were viable for several months and remained unresponsive to further ant

stimulation for several weeks. This tolerance was not due to bystander suppressor ef

or a suppressor cytokine milieu, as mixed transgenic TCR transfers revealed that ane
was antigen specific (Pape, Merica et al. 1998).
Considering the different natures of clonal anergy and in vivo anergy, it is not
surprising that the biochemical events regulating these two types of anergy seem to
very different. Whereas clonally anergic cells show a block at the level of MAPK

signaling, changes in proximal tyrosine phosphorylation events and calcium mobilizat

upon antigen engagement have been described for in vivo anergy (Bhandoola, Cho et al
1993; Migita, Eguchi et al. 1995; Tanchot, Guillaume et al. 1998; Utting, Teh et al.
2000).

1.A.4 Regulatory T cells:
Activation and proliferation of T cells can be actively suppressed by a dominantly
acting subset of T cells known as regulatory T cells (Sakaguchi 2000; Shevach 2000;
Shevach 2002). These cells have generated considerable excitement because of their

dominant role in modulating immune responses, which has led to intriguing speculatio

for their potential roles in a u t o i m m u n e diseases, transplants, cancer, a n d infectious
diseases. There are currently at least three classes of T cells for which regulatory or
immunomodulatory functions have been described in detail, and the relationship between
these three remains unclear (Figure 1-1).

Thymus-denved
naturally occurring
C W C D Z S 1 Treg cells
(nTreg)
MHCNaive
peptide
CD4Tcell

CD25
Activated
CD4"_Tcell
0

APC

TCR

CD25

Activated
eflectot
Tcell
Autoimmunity
Transplantation
Tumor immLMiity
Infectious disease
Allergy

Peripherally induced CD4f Treg cells
(iTreg)
Including Tregl, Th3. CD4* CD25*

Figure 1-1. Regulatory T cell subtypes. Both naturally occurring (nTreg) and peripherally
induced (pTreg) have been implicated in downregulating i m m u n e responses (yellow box). T h e
lineage relationship between nTregs and pTregs is presently unclear. Figure taken from Piccirillo
et al., Trends in Immunology, 2004.

A.4.1 C D 4 + C D 2 5 + Regulatory T cells:
C D 4 + C D 2 5 + regulatory T cells, which make up 5-10% of peripheral T cells, are a
naturally occurring immunosuppressive T cell subpopulation (Sakaguchi, Sakaguchi et

1995). CD4+CD25+ cells behave like partially anergic cells in vitro, proliferating po
in response to TCR stimulation unless provided with exogenous IL-2 (Papiernik, de

Moraes et al. 1998; Takahashi, Kuniyasu et al. 1998). Depletion of these cells in viv
leads to multi-organ autoimmune disease characterized predominantly by gastritis,

thyroiditis, and oopheritis (Takahashi, Kuniyasu et al. 1998). It is of note that tho

more than one organ m a y be affected in a given mouse, this disease is always restricted to
organs, with no evidence for the development of systemic autoimmune disease or anti-

nuclear antibody formation (Takahashi, Kuniyasu et al. 1998; Shevach 2000). In additi
to their role in maintaining immune homeostasis, CD4+CD25+ cells have also been

implicated in acquired tolerance such as oral tolerance (Thorstenson and Khoruts 200
Zhang, Izikson et al. 2001; Hauet-Broere, Unger et al. 2003). In addition CD4+CD25+

regulatory T cells can inhibit T helper type 2 (Th2) mediated airway eosinophilia in
(Suto, Nakajima et al. 2001).
Characterization of CD4+CD25+ regulatory T cell is still in its infancy. Although

markers other than IL-2 receptor alpha chain (CD25) have been identified for regulat
T cells (CD103, galectin 1, Ly6, OX-40, CTLA-4 (CD158), 4-1BB, glucocorticoid

induced tumor necrosis factor receptor (GITR), TNFR2, TGF-(3 1, programmed cell death

1 (PDI), and neutropilin-1) , they are also expressed on activated CD4+ cells (Gavin,
Clarke et al. 2002; McHugh, Whitters et al. 2002; Bruder, Probst-Kepper et al. 2004).
functional role for CTLA-4 in regulatory T cell function has been described (Read,
Malmstrom et al. 2000), but the role of CTLA-4 in suppressor function remains

controversial. Classification of CD45RBlo cells as another, potentially overlapping,

group of naturally occurring regulatory T cells causes further confusion in the lite
although it has recently been shown that only the CD4+CD25+ fraction of CD45RBlo

have functional suppressive properties in vivo (Mottet, Uhlig et al. 2003). A critica

discovery was the recent finding that regulatory T cell development is controlled by
transcription factor Foxp3. Foxp3 is selectively expressed in CD4+CD25+ cells
(Fontenot, Gavin et al. 2003; Hori, Nomura et al. 2003) and over expression of Foxp3

non-suppressor cells leads to a suppressor phenotype both in vitro and in vivo (Hori,
Nomura et al. 2003).
The mechanisms by which CD4+CD25+ cells suppress immune responses are
still a subject of debate. Upon TCR mediated activation, CD4+CD25+ are capable of

suppressing proliferation of other T cells by inhibiting in vitro IL-2 production in

antigen non-specific manner, but require direct cell-cell contact with T cells to do
(Thornton and Shevach 1998; Thornton and Shevach 2000). Interluekin 4 (IL-4),

Interleukin 10 (IL-10), and Transforming Growth Factor |3 (TGF-(3) are not required f

this in vitro suppression (Takahashi, Kuniyasu et al. 1998; Thornton and Shevach 199
Piccirillo, Letterio et al. 2002). In vivo, the mechanism by which CD4+CD25+

regulatory T cells exert their effect is less clear. It seems unlikely that the dire
contact mediated suppression seen in vitro is the sole mechanism by which such a

relatively small percentage of CD4+CD25+ suppressor T cells can systemically regulat

the effects of all T cells, but data supporting other mechanisms are still contradic
unclear.

l.A.4.2 Trl Regulatory T cells:
A potentially distinct group of regulatory T cells,Trl cells, secrete IL-10 and
TGF-(3 and dampen immune responses via these immunomodulatory cytokines

(Roncarolo, Bacchetta et al. 2001). In contrast to CD4+CD25+ cells, which are natural

generated in the thymus, Trl cells are induced upon exposure to foreign or tissue sp
antigen in the periphery (Bluestone and Abbas 2003). Similar to CD4+CD25+

suppressor cells, Trl cells are capable of suppressing T cell proliferation in vitro
antigen non-specific manner; however, their effects are mediated primarily by IL-10

TGF-(3.

Both IL-10 and TGF-|3 are particularly important for regulating immune

responses to mucosal antigens (Jutel, Akdis et al. 2003).
The role of IL-10 in modulating immune responses is well established. IL-10
deficient mice develop chronic cholitis due to dysregulation of Thl mediated immune

responses (Kuhn, Lohler et al. 1993). Conversely, IL-10 transgenic mice fail to mount
proper Thl and Th2 responses (Rouleau, Cottrez et al. 1999). IL-10 dampens immune
responses via multiple mechanisms, including inhibition of antigen presentation by

antigen presenting cells (APCs) (Enk, Angeloni et al. 1993; Steinbrink, Wolfl et al.

Moore, de Waal Malefyt et al. 2001) and induction of T cell anergy (Groux, Bigler et
1996; Zeller, Panoskaltsis-Mortari et al. 1999).
A specific role for IL-10 in the function of regulatory T cells comes from several
lines of experimental evidence. The existence of IL-10 secreting T cells has been
associated with tolerance in SCID patients transplanted with HLA mis-matched

hematopoetic stem cells (Roncarolo, Yssel et al. 1988; Bacchetta, Bigler et al. 1994)
Induction of anergy to phopholipase A2, the major allergen of bee venom, in either

patients undergoing immunotherapy or in naturally tolerant beekeepers, correlates wi

an increase in IL-10 producing T cells (Akdis, Blesken et al. 1998). In addition, ant
stimulation of T cells in the presence of IL-10 leads to the generation of poorly

proliferating T cell clones that secrete high levels of IL-10, moderate levels of TGF

interferon gamma (IFN-y) and Interleukin 5 (IL-5), and no IL-2 or IL-4 (Groux, O'Garr

et al. 1997). These regulatory T cells, defined as Tr-1 cells, are capable of suppress
vitro. Suppression is predominantly mediated by IL-10 and TGF-(3 in an antigen nonspecific manner.
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In addition to their suppressive capabilities in vitro, Trl cells are capable of

modulating immune responses in vivo. Trl cells can inhibit Inflammatory Bowel Diseas
(IBD) in severe combined immunodeficiency (SCID) mice (Groux, O'Garra et al. 1997).

In contrast to the preventative role of CD25+ or CD45RBlo regulatory T cells, Trl ce
are capable of suppressing IBD associated inflammation even after the inflammatory
process has begun (Foussat, Cottrez et al. 2003). Trl cells have also been shown to
inhibit airway hyperreactivity (Stock, Akbari et al. 2004) as well as Th2 mediated

inflammation in an IL-10 dependent manner (Cottrez, Hurst et al. 2000). Taken togethe

these data suggest a role for IL-10 secreting Trl regulatory T cells in modulating i
responses.
The connection between suppression by CD4+CD25+ regulatory T cells and Trl

T cells is still unclear. Since CD4+CD25+ regulatory T cells have been shown to lead

the differentiation of T cells into Trl cells in vitro (Dieckmann, Bruett et al. 2002

possible that the function of regulatory T cells in vivo is mediated by their abilit
induce Trl cells (Figure 1-2):
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O

Figure 1-2. The lineage and functional
relationships between C D 4 + C D 2 5 +
naturally occurring regulatory T cells
and induced Tr-1 and Th3 regulatory T
cells.
Induced regulatory T cells
(striped cells) can develop either from
C D 4 + C D 2 5 + cells (blue stripes) or
C D 4 + C D 2 5 - cells (red stripes).
C D 4 + C D 2 5 + cells function to suppress
either by direct cell contact mediated
inhibition, or through the suppressive
cytokines secreted by induced
regulatory T cells. Figure taken from
Bluestone et al., Nature Reviews
Immunology, 2003.
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l.A.4.3 T h 3 regulatory T cells:
Another subset of induced suppressor cells is T helper type-3 (Th3) cells, which

secrete TGF-p, IL-10, and IL-4. Th3 cells can be induced by stimulation of T cells i
the presence of TGF-P in vitro (Zheng and McKeown-Longo 2002). Th3 cells are also
induced in gut associated lymphoid tissue (GALT) in models of oral and mucosal

tolerance (Chen, Kuchroo et al. 1994; Friedman and Weiner 1994; Neurath, Fuss et al.
1996; Weiner 1997; Weiner 2001). Th3 cells are capable of inhibiting Th2 immune

responses (Garside, Steel et al. 1995; Russo, Jancar et al. 1998) and have also been

shown to be important in models of colitis (Neurath, Fuss et al. 1996; Powrie, Carli

al. 1996) and tracheal eosinophilia (Haneda, Sano et al. 1997; Russo, Jancar et al. 1

TGF-p secretion was critical for the suppressive function of Th3 regulatory T cells
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colitis model, as blocking TGF-i3with antibodies blocked the regulatory cells'
suppressive capacity (Powrie, Carlino et al. 1996).
The TGF-(3 family is one of the most pleiotropic cytokine families known, with

members playing a role in development, epithelial cell growth and differentiation, a
carcinogenesis (Letterio and Roberts 1998). The three isoforms of TGF-(3 (TGF-(3 1,

TGF-(3 2, TGF-(3 3) are highly homologous and use the same serine-threonine kinase t

I and type II receptors to signal (Massague 1990). TGF-(3 1 is the predominant TGF-(3
isoform expressed in lymphoid organs, whereas TGF-(3 2 and TGF-(3 3 are highly
expressed in mesyncymal tissues and bone (Millan, Denhez et al. 1991). Early
embryonic lethality of TGF-(3 2 and TGF-(3 3 deficient mice has made studying their

in immune cell function difficult (Kaartinen, Voncken et al. 1995; Proetzel, Pawlows

al. 1995). About 60% of TGF-(3 1 deficient mice die in utero, but the remainder devel
a severe autoimmune phenotype that leads to their death by 4 weeks of age due to

cardiopulmonary infiltrations (Shull, Ormsby et al. 1992; Kulkarni, Ward et al. 1995
Yaswen, Kulkarni et al. 1996).
TGF-|3 plays a critical role in T cell function during an immune response. TGF-(3

deficient mice progressively develop a multi-organ autoimmune disease (Shull, Ormsby

et al. 1992; Kulkarni, Huh et al. 1993), and a similar disease phenotype is seen in m

expressing a dominant negative TGF-(3 receptor II subunit in T cells (Gorelik and Fl

2000). TGF-(3 inhibits proliferation, cytokine production, and cytotoxicity in T cell

(Letterio and Roberts 1998). In addition, TGF-(3 secreting regulatory T cells are cap
of regulating both Thl and Th2 mediated immune responses (Bridoux, Badou et al.
1997). Retroviral transduction of T cells with TGF-(3 induces IL-10 production,
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suggesting that part of TGF-p's role in modulating the immune response may be through
IL-10 (Kitani, Fuss et al. 2003).

l.A.4.4 TGF-P, IL-10, and CD4+CD25+ regulatory T cells:
The role of IL-10 or TGF-(3 in the suppressor function of C D 4 + C D 2 5 + regulatory

T cells is still unclear and is one reason for the distinction between regulatory su

Assays using cells deficient in TGF-(3 and IL-10 signaling have shown that TGF-(3 an
IL-10 are not necessary for the suppressive effects of CD4+CD25+ regulatory T cells
vitro (Piccirillo, Letterio et al. 2002). These results have been used to suggest that
C D 4 + C D 2 5 + regulatory T cells do not exert their effect through either of these cytokines;
however, it remains unclear if the mechanisms used by C D 4 + C D 2 5 + cells to suppress T
cell proliferation in vitro are the same as those used in vivo.
The role of IL-10 in mediating C D 4 + C D 2 5 + suppression in vivo may depend on
the context of the immune response.

IL-10 deficient C D 2 5 + cells are capable

suppressing the autoimmune disease that occurs in post-natal day 3-thymectomized mice
(Thornton and Shevach 1998).

In contrast, C D 2 5 + regulatory T cells prevent

inflammatory bowel disease in the SCID colitis model in an IL-10 dependent manner
(Asseman, Mauze et al. 1999). IL- 10-/- CD4+CD25+ T cells can suppress autoimmune
gastritis but not bacterial driven inflammatory bowel disease, suggesting that the type of
inflammatory response may also influence the role of IL-10 in the suppressive effects of
CD4+CD25+ regulatory T cells (Suri-Payer and Cantor 2001).
The role of TGF-,3 in CD4+CD25+ regulatory T cell function in vivo is equally
unclear. Studies using identical regiments of anti-TGF-(3 antibodies have provided

contradictory results in different in vivo models of suppressor function (Powrie, Ca
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et al. 1996; Read, Malmstrom et al. 2000; Piccirillo, Letterio et al. 2002; Nakamura,

Kitani et al. 2004). TGF-f3 is not required for suppression of autoimmune gastritis b
CD4+CD25+ regulatory T cells (Piccirillo, Letterio et al. 2002). In contrast, TGF-(3

required for CD4+CD45RBlo regulatory T cell suppression in the SCID model of colitis
(Powrie, Carlino et al. 1996). CD4+CD45RBlo cells do not represent a different
regulatory T cell subpopulation, as TGF-(3 is also required when CD4+CD45RBlo cells
are further purified into CD4+CD25+CD45RBlo cells (Read, Malmstrom et al. 2000).
CD4+ CD25+ regulatory T cell suppression of trinitrobenzene acid (TNBS) induced

colitis in SJL/J mice (Fuss, Boirivant et al. 2002) is also TGF-(3 dependent. Finall
TGF-(3 has been implicated in CD4+CD25+ suppression of CD8+ cytotoxic T cells in a

model of type-1 diabetes (Green, Gorelik et al. 2003). Thus, most existing data sugge
that CD4+CD25+ suppress via a TGF-(3 dependent mechanism in vivo, but
counterexamples exist which may imply a context dependent role for TGF-(3 as well.
The mechanism by which TGF-(3 exerts an effect on regulatory T cell functions is
even less clear. Surface bound TGF-(3 is upregulated in CD4+CD25+ suppressor cells

upon antigen stimulation (Nakamura, Kitani et al. 2001). The coordinate expression of

TGF-p and TGF-PRII on suppressor cells may explain their anergic phenotype, as TGF-J

negatively regulates IL-2 mediated proliferation (Kehrl, Wakefield et al. 1986). TGFhas also been shown to play a role in the generation (Park, Paik et al. 2004) and

expansion (Yamagiwa, Gray et al. 2001) of regulatory T cells. TGF-(3 may work in par

by inducing Foxp3 expression and regulatory T cell function of naive T cells (Chen a

Wahl 2003; Fantini, Becker et al. 2004) (Figure 1-2). In addition, TGF-(3 plays a cr
role in the suppressive capabilities of T helper cells that have been anergized and
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converted to suppressor cells by C D 2 5 + regulatory T cells (Jonuleit, Schmitt et al. 2002).
This mechanism may provide a means by which local suppression can be spread to a

more systemic level of tolerance. In summary, it is clear that the exact relationshi
between TGF-(3 and CD4+CD25+ suppressor cells requires further experiments.

1.B Atopic D i s e a s e s :
Mucosal immune responses are tightly regulated to allow activation of effector

mechanisms against pathogens but prevent cell mediated inflammatory responses to non
pathogenic external antigens. Misregulation of these immune responses may lead to
atopic diseases. Atopic diseases, including asthma and atopic dermatitis, are
multifactorial and complex pathologies that effect approximately 20% of the world's
population, according to the World Health Organization. These diseases share in

common high IgE levels (referred to as atopy) as well as infiltration of effector ce

the site of the allergic response. The types of effector cells present can be divers
ranging from T lymphocytes to eosinophils, monocytes/macrophages, and mast cells.
Both genetic predisposition and environmental factors influence the type and extent
the pathology (Cookson 1999).

1.B.1 The role of Th2 immune responses in atopic diseases:
C D 4 + helper T cells can differentiate into two well defined subsets called T
helper type 1 (Thl) cells and T helper type 2 (Th2) cells. Thl cells preferentially
the chemokine receptors CCR5, CXCR3, and CCR1 and produce inflammatory cytokines
such as interferon gamma (IFNy) and lymphotoxin alpha (LTa). Thl cells generally
mediate cellular immunity. Th2 cells express the chemokine receptors CCR3 and CCR4
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and produce cytokines such as interleukins 4,5,9,10, and 13 (IL-4,IL-5,IL-9,IL-10,IL-13).

These cytokines in turn regulate B cell proliferation and isotype switching (Rossi a
Zlotnik 2000; Dong and Flavell 2001). Th2 immune responses are critical for humoral

responses and for immune responses against extracellular parasites such as helminthe

(Heinzel, Sadick et al. 1989; Finkelman, Pearce et al. 1991). The distinction between
Thl and Th2 immune responses is not only significant during an immune response

against a pathogen, but is also important in immune system mediated pathologies. The
dominance of either helper cell type shapes the outcome of immunologically mediated
disease conditions, including autoimmune diseases and allergic responses (Abbas,
Murphy etal. 1996).
There exists a strong correlation between atopic diseases and Th2 differentiation

of T cells. The Th2 cytokine cluster is a susceptibility locus for atopic diseases (1

Kawashima, Noguchi et al. 1998; Forrest, Dunn et al. 1999). Coordination of the effec
cells in atopic diseases is controlled primarily by the cytokines secreted by Th2 T
(Abbas, Murphy et al. 1996; O'Garra 1998). Furthermore, over expression of Th2
cytokines by even threefold upon antigen encounter leads to spontaneous atopic

dermatitis and lung infiltrations similar to those seen in asthmatic patients (Lee a
Flavell 2004).

1.B.2 The Generation of Th2 effector T cells:
The signals that determine T helper cell differentiation and function are not yet

completely understood. It is currently thought that several potentially unrelated fa

contribute to a cell's lineage commitment choice. Experimental evidence suggests tha

Thl/Th2 differentiation is influenced by factors such as the strength of the TCR sig
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the-costimulatory ligand engaged, the cytokine environment, and cell cycle progression.
It is important to note that the phenotype of helper cells becomes increasingly stable over
time and independent of extrinsic factors such as cytokines (Huang, Hu-Li et al. 1997).

1.B.3 Instructive versus Selective signals for T helper differentiation:
There are currently t w o models for h o w

cyotkines m a y

affect T

helper

differentiation (Figure 1-3). The Instructive model states that cytokines directly lead to
epigenetic modifications of T helper specific loci, increasing the expression of either Thl
or Th2 specific genes. In contrast, the Selective model argues that Thl or Th2 skewing
cytokines favor the growth of T helper cells that stochastically express the respective
mRNA. In the case of Th2 differentiation, data exist to support both models (Farrar,
Ouyang et al. 2001; Zhu, Guo et al. 2002).
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Figure 1-3. Instructive versus selective models of T helper differentiation, a. Instructive model.
Cytokines provide instructive signals to naive cells to differentiate along given pathways, b.
Selective model. Cytokines support the outgrowth of T helper cells that stochastically
differentiate along a given pathway. Figure taken from Murphy et al. Nature Reviews
Immunology 2002.
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1.B.4 T h e role of Cytokines in T helper differentiation:
It is well established that cytokines play a dominant role in Thl versus Th2

differentiation under most experimental conditions. The importance of IL-12 and IL-4
the development of Thl and Th2 helper cells, respectively, has been established for
a decade (reviwed in (Abbas, Murphy et al. 1996)). The importance of cytokines has

been demonstrated in several ways. Addition of exogenous IFN-y and IL-12 leads to Th
differentiation (Gajewski and Fitch 1988; Manetti, Parronchi et al. 1993), whereas

exogenous IL-4 leads to Th2 differentiation. Conversly, mice deficient in IL-4 or IL
Ra have markedly diminished Th2 responses (Kopf, Le Gros et al. 1993; Noben-Trauth,

Shultz et al. 1997). The critical role of IL-2 in Th2 differentiation has been demons

in similar studies (Ben-Sasson, Le Gros et al. 1990; Le Gros, Ben-Sasson et al. 1990).

The role of cytokines in T helper differentiation has also been supported by studies

cytokine signaling pathways. For example, SOCS5, which binds the IL-4R and inhibits i
function, leads to Thl skewing (Seki, Hayashi et al. 2002).

1.B.5 Transcriptional regulation of Th1 versus Th2 differentiation:
T helper differentiation is influenced by cytokines through both autocrine and

paracrine mechanisms. The autocrine feedback loop is considered critical for T helpe

differentiation. As a consequence, the transcriptional regulation of signature cytok

within a differentiating cell plays an important role in determining its eventual fa

Recent work has shown that chromatin remodeling is necessary during the differentiat

of both Thl and Th2 cells (Agarwal and Rao 1998). In addition, specific transcription
factors have been shown to support either Thl or Th2 differentiation. Although Thl

differentiation is mediated primarily by the master regulator T-bet (Szabo, Sullivan

2002), multiple transcription factors are involved in Th2 differentiation (Figure 1-4
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l.B.5.1 N F A T :
The N F A T (nuclear factor of activated T cells) family of transcription factors is

involved in regulting T helper differentiation. NFATc and NFATp can both bind to the
IL-4 promoter NFAT sites (Timmerman, Healy et al. 1997). It is thought that the two
NFAT factors antagonize each other, as NFATp deficient mice have a dysregulated Th2
immune response whereas NFATc deficient mice have a dysregulated Thl immune
response (Hodge, Chun et al. 1996; Xanthoudakis, Viola et al. 1996).
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F i g u r e 1-4. Transcriptional regulation of T h 2 differentiation, a. P a t h w a y s for t h e induction of IL-4
expression. Signals through the T Cell Receptor (TCR) and through the IL-4 receptor are important
for the initial induction of GATA-3 and remodeling of the IL-4 locus. NFAT, AP1, and c-Maf are
critical for initial IL-4 transcription, b. Pathways for the induction of Th2 cytokines. Signals from the
TCR, co-stimulatory ligands, and additional ligands synergistically increase GATA-3 expression.
Figure taken from Murphy et al., Nature Reviews Immunology, 2002.
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l.B.5.2 J u n B a n d c-Maf:
T w o other transcription factors that influence Th2 differentiation include Jun B

and c-Maf. JunB positively regulates IL-4 gene expression by binding specifically to

AP-1 site in the promoter of IL-4 (Li, Tournier et al. 1999). It does this in combina
with c-Maf, a basic region/leucine zipper transcription factor that is specifically

upregulated in Th2 cells and also binds to a site in the proximal IL-4 promoter (Ho,

Hodge et al. 1996). In transgenic mice overexpressing c-Maf, there is an increased bi

towards Th2 differentiation(Ho, Lo et al. 1998). Analysis of c-Maf deficient mice has

demonstrated that c-Maf is critical for IL-4 production, as c-Maf deficient T cells

markedly deficient in IL-4 production (Kim, Ho et al. 1999). Similarly, overexpressio
of JunB in transgenic mice leads to Th2 differentiation of T cells even under Thl
polarizing conditions (Li, Tournier et al. 1999).

l.B.5.3 Stat6:
The transcription factor Stat6 is necessary and sufficient for IL-4's role in Th2

differentiation (Zhu, Guo et al. 2001). Stat6 is phosphorylated and activated in resp

to IL-4 and IL-13 (Kohler, Alliger et al. 1994), two major cytokines involved in Th2

differentiation. Although IL-4 transcription can occur in the absence of Stat6, IL-4

mediated signaling is completely abrogated (Kaplan, Wurster et al. 1999). As a result
cells from Stat 6 deficient mice are defective in differentiating into Th2 cells in
(Kaplan, Schindler et al. 1996). Stat6 deficient mice produce very reduced levels of

cytokines in response to infection with the nematode Nippostrongylus brazilinesis an

parasite worm Schistosoma mansonii (Takeda, Tanaka et al. 1996; Kaplan, Whitfield et
al. 1998). In addition, Stat6 deficient mice show a complete abrogation of antigen

induced airway hyperresponsiveness, which is driven by a Th2 T cell response (Akimot
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Numata et al. 1998; Kuperman, Schofield et al. 1998). Conversely, ectopic expression of
Stat6 in cells undergoing TH1 differentiation leads to the development of Th2 cells
the upregulation of GATA-3 and c-Maf, demonstrating that Stat6 regulates Th2

differentiation upstream of these two transcription factors (Kurata, Lee et al. 1999)

should be noted that in some model systems, Th2 differentiation can be induced in th
absence of Stat 6 (Ouyang, Lohning et al. 2000) and Th2 driven immune responses are

not significantly affected (Finkelman, Morris et al. 2000; Jankovic, Kullberg et al. 2

These results suggest that Stat6 independent pathways for Th2 differentiation may al

exist, though analysis of in vivo data is complicated by the fact that IL-4 producti

NK and NKT cells is Stat6 independent (Kaplan, Wurster et al. 1999; Stetson, Mohrs e
al. 2003).

l.B.5.4 GATA-3:
O f the transcription factors that influence Th2 differentiation, G A T A - 3 is perhaps

the most powerful. GATA-3 is rapidly induced in Th2 differentiating cells in a parti
IL-4 and Stat6 dependent manner (Ouyang, Ranganath et al. 1998; Ouyang, Lohning et
al. 2000), and it remains expressed in effector Th2 cells (Zheng and Flavell 1997).
Transgenic mice in which GATA-3 is overexpressed produce Th2 cytokines (IL-4, IL-5,

IL-6, IL-10) even under Thl polarizing conditions where no exogenous IL-4 is present
(Zhang, Cohn et al. 1997; Zheng and Flavell 1997). Antisense mediated reduction of

GATA-3 blocks Th2 cytokine production in Th2 clones and allergic airway inflammation
in vivo (Zheng and Flavell 1997; Finotto, De Sanctis et al. 2001). Expression of a

dominant negative GATA-3 also decreases Th2 mediated pulmonary allergic responses in
mice (Zhang, Yang et al. 1999). Furthermore, conditional deletion of GATA-3 leads to
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impaired Th2 differentiation in vitro, even in the presence of exogenous IL-4. In

addition, it abolishes Th2 immune responses in vivo (Zhu, Mm et al. 2004). Deletion o

GATA-3 in fully differentiated Th2 cells abolishes IL-5 and IL-13 production, althou
IL-4 production is only diminished (Zhu, Min et al. 2004).
Although GATA-3 is critically important for Th2 differentiation, it alone cannot
account for all aspects of Th2 differentiation. GATA-3 expressing T cells polarized

under Thl differentiation conditions, though they generate Th2 cytokines, do not exp

as well as conventional Th2 cells. This growth defect can be rescued by the expressi

of the Stat6-inducible gene growth factor inhibitor 1 (Gfi-1) (Zhu, Guo et al. 2002).

l.B.5.5 Stat5:
The Stat5 transcription factors regulate Th2 differentiation in a G A T A - 3
independent fashion. Four isoforms of Stat5 exist, encoded by two genes (Stat5a and

Stat5b) that each give rise to two isoforms based upon post-translational modificati
(Azam, Erdjument-Bromage et al. 1995; Azam, Lee et al. 1997). Stat5 proteins are

activated downstream of the IL-2R, IL-7R, IL-9R, and IL-15R and have been implicated

in IL-2 induced cell cycle progression (Hoey and Grusby 1999; Moriggl, Topham et al.

1999). Stat5a-deficient mice or cells in which Stat5 activity is blocked by treatment

cell permeable phospho-Stat5 peptide are defective in Th2 differentiation (Yamashita
Katsumata et al. 2000; Kagami, Nakajima et al. 2001). Furthermore, expression of a

constitutively active Stat5a protein removes the requirement for IL-2, IL-4, and Sta
Th2 differentiation (Zhu, Cote-Sierra et al. 2003). The constitutively active Stat5a
protein does not lead to enhanced GATA-3 expression. Rather, Stat5a and GATA-3
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collaborate in Th2 differentiation by "opening" the IL-4 gene locus at different regions
(Zhu, Cote-Sierra et al. 2003).

1.B.6 Cell cycle progression and T helper differentiation:
Cell cycle progression is critical for both Thl and Th2 differentiation.

Instructional signals for promoting Thl or Th2 differentiation can neither induce ef

cytokine expression in the absence of cell cycle progression nor alter the pattern o
division-dependent expression of effector cytokines, suggesting that epigenetic

modifications are critical for T helper differentiation. More cell divisions are req
Th2 differentiation than Thl differentiation (Bird, Brown et al. 1998).

1.B.7 Co-stimulatory ligands and Th1 versus Th2 differentiation:
The role of antigen presenting cells (APCs) in directing Thl versus Th2

differentiation is substantiated by numerous studies (reviewed by (Eisenbarth, Piggo
al. 2003; Kapsenberg 2003). APCs influence T helper differentiation through both
cytokines and cell surface expressed ligands. Though not all modes of influence are
yet determined, the role of co-stimulatory ligands is clear.
CD28 co-stimulation is particularly important for Th2 differentiation (Seder,
Germain et al. 1994; Schweitzer and Sharpe 1998). Stimulation of CD4+ T cells with

APCs in the presence of blocking antibodies against CD28 or stimulation with fibrobl
lacking CD28 leads to IFNy producing Thl cells but not IL-4 producing Th2 cells.
CTLA-4, a member of the CD28 family that acts as a negative regulator of T cell

activation, negatively regulates Th2 differentiation. As a consequence, CTLA-4 defic
DO 11.10 transgenic mice show increased Th2 differentiation upon stimulation

(Oosterwegel, Mandelbrot et al. 1999). Furthermore, Th2 differentiation in the absence
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of C T L A - 4 occurs in the absence of Stat6 signaling (Bour-Jordan, Grogan et al. 2003).

Stimulation with B7.1 or B7.2 leads to increased Thl or Th2 differentiation, respect

The differential roles of B7.1 and B7.2 in modulating T helper differentiation may b
explained by their selective recruitment of either CTLA-4 or CD28 to the immune
synapse (Kuchroo, Das et al. 1995; Pentcheva-Hoang, Egen et al. 2004). Another
member of the CD28 family, ICOS (Inducible CO-Stimulator) is highly expressed on

Th2 cells and seems to specifically regulate Th2 effector function. In contrast, ICO

inhibits differentiation of naive cells into either Thl or Th2 effector cells (Coyle

al. 2000). Another co-stimulatory ligand, OX40, participates in Thl cell differentiat
Mice deficient in OX40 have reduced numbers of CD4+ IFN-yproducing T cell in

response to viral infection (Kopf, Ruedl et al. 1999). DR6, a member of the TNF famil

of receptors, also modulates T helper differentiation, as DR6 deficient CD4+ T cells
show increased Th2 cytokine production (Liu, Na et al. 2001).
Co-stimulatory ligands can also indirectly affect a T cell's differentiation fate.
For example, expression of CD40L on a T cell leads to increased IL-12 expression in
APC to which it binds (Grewal and Flavell 1998). TRANCE/TRANCE-R ligation on
dendritic cells also leads to IL-12 expression in vitro and enhanced Thl mediated
IFNyresponses in vivo (Bachmann, Wong et al. 1999; Green and Flavell 1999).

Although not technically co-stimulatory signals, the LFA (leukocyte function-associa
antigen 1)-ICAM (intercellular adhesion molecule 1) binding biases T helper

differentiation in favor of Thl (Salomon and Bluestone 1998; Luksch, Winqvist et al.
1999; Camacho, Heath et al. 2001; Smits, de Jong et al. 2002).
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Recently, the Notch pathway has been implicated in regulating T helper
differentiation. In vitro stimulation with Delta ligand leads to increased Thl

differentiation (Maekawa, Tsukumo et al. 2003). Furthermore, dendritic cells that are

primed to stimulate Thl immune responses express the Delta ligand, whereas dendritic
cells, which are primed for Th2 immune responses, express Jagged (Amsen, Blander et

al. 2004). Finally, expression of the constitutively active intracellular domain of N

leads to increased Th2 differentiation, even in the absence of Stat6 (Amsen, Blander

2004). These data suggest that the Notch pathway can regulate T helper differentiatio
independently of cytokines.

1.B.8 TCR signaling and Th1 versus Th2 differentiation:
T cell activation is strictly controlled by signals emanating from the T Cell
Receptor (TCR) and co-stimulatory ligands. The biochemical pathways coupling TCR

engagement with downstream signaling events include a tyrosine kinase cascade, serin

threonine kinases, G proteins, and Ca2+ mobilization. In addition, actin polymerizati

and receptor turnover critically regulate the duration of an antigenic stimulus by a
the stability of the immune synapse.
The strength of the stimulation through the TCR has also been shown to modulate

the differentiation decision of helper T cells. T cells need prolonged stimulation (

hours) in order to differentiate into either Thl or Th2 cells in the absence of exog

cytokines (Iezzi, Scotet et al. 1999). Th2 differentiation seems to be favored at the

extremes of antigenic stimulation, with both low dose and low affinity ligand stimul

(Constant, Pfeiffer et al. 1995; Pfeiffer, Stein et al. 1995) as well as high antige
stimulation (Hosken, Shibuya et al. 1995) favoring Th2 differentiation. In addition
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require simultaneous stimulation through the T C R and cytokine receptor in order to

differentiate into Th2 cells, although Thl differentiation can occur if both signals
provided separately (Iezzi, Scotet et al. 1999).
Differences in signaling downstream of the TCR have been described for Thl

and Th2 cells, but these initial differences were noted between differentiated effec
and Th2 cells (Fitch, McKisic et al. 1993; Fallon, Smith et al. 1998; Balamuth,
Leitenberg et al. 2001). The pathways downstream of the TCR that are involved in T

helper cell differentiation are currently being elucidated. These pathways can eithe

involved in directly promoting T helper differentiation along a given pathway, or ca

influence differentiation by inhibiting differentiation along the alternate pathway.
example of the second, indirect mode of action is the Tek family member Itk, which

promotes Th2 differentiation by negatively regulating T-bet (Miller, Wilcox et al. 20
One of the most proximal events after TCR engagement that has been linked to

the differentiation process is ZAP-70 signaling. Inhibition of ZAP-70 signaling lead

bias towards Th2 differentiation (Tanaka, Bi et al. 2003). In Th2 differentiating T ce

this inhibition is mediated by the SWAP-70 like adaptor of T cells (SLAT) (Tanaka, B
al. 2003). Recently, a role for SAP (SLAM associated protein) in Th2 differentiation

been described. Stimulation of SAP deficient CD4+ T cells in vitro reveals reduced T
cytokine production (Czar, Kersh et al. 2001; Wu, Nguyen et al. 2001). SAP functions

an adaptor protein that recruits FynT to SLAM family receptors. The critical role of

phosphorylation of SLAM in Th2 differentiation has been established using Fyn-bindin
deficient SAP knock-in mice (Davidson, Shi et al. 2004). Furthermore, the downstream
pathways affected by SAP deficiency, including PKC-6 recruitment, Bel-10
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phosphorylation, IxB-a degradation, and nuclear accumulation of NF-kB 1 (Cannons, Y u

et al. 2004), may also be involved with Th2 differentiation. Consistent with this ide
the finding that mice containing a point mutation in the Carma protein, which acts
downstream of SAP and Fyn, also show a skewed Th2 bias (Jun, Wilson et al. 2003).
Further downstream of the TCR, JNK signaling has been linked to T helper

differentiation. Mice deficient for JNK1, JNK1 and JNK2, or the JNK activating kinase

MKK7 have exaggerated Th2 responses, although these T cells are capable of undergoin
Thl differentiation under Thl polarizing conditions (Dong, Yang et al. 1998; Dong,
Yang et al. 2000). Conversely, mice deficient in JNK2 show deficient Thl immune
responses (Yang, Conze et al. 1998). Moderate increases in the levels of nuclear Jun
and significant increases in nuclear NFATc were seen in anti-CD3 and anti-CD28
activated T cells from JNK1 deficient mice. The accumulation of NFATc is presumably
due to the absence of JNK1 mediated phosphorylation of NFATc, which is involved in
inhibiting calcineurin binding and hence NFATc translocation to the nucleus (Chow,
Dong et al. 2000).

1.C. CD8+ Memory T cells Maintenance and Generation:
During a primary infection, one critical aspect of the adaptive immune system is
the generation of immunological memory against the invading pathogen. The basis of
immunological memory lies in a specialized subgroup of cells called memory cells,

which have a number of characteristics that distinguish them from naive cells (Ahmed
and Gray 1996; Gray 2000). Memory cells survive longer compared to naive cells and

respond more rapidly to antigen in terms of entry into cell cycle and conversion int

cytokine secreting effector cells (Pihlgren, Dubois et al. 1996; Rogers, Dubey et al.
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2000). Because of the cytotoxic abilities of C D 8 + effector cells, memory C D 8 + cells are

critical mediators of immunity against a broad range of bacterial, viral, and protoz

intracellular pathogens during secondary infections. Understanding the generation an
maintenance of CD8+ memory cells is thus critical for further improvements in
vaccination against infectious agents.
Although small and quiescent like naive cells, CD8+ memory cells differ from
their naive CD8+ counterparts in several aspects. CD8+ memory cells constitutively

express genes that are involved in the effector functions of CD8+ cells, such as IFN
perforin, and granzyme B. Though the proteins are synthesized only upon antigen

encounter, the elevated mRNA levels of these genes allows for the synthesis of incre

amounts of proteins in a shorter amount of time (Bachmann, Barner et al. 1999; Veiga
Fernandes, Walter et al. 2000; Swanson, Murakami et al. 2002). Memory CD8+ cells

also express different surface proteins involved in cell adhesion and chemo taxis. T

molecules allow memory cells to extravasate into non-lymphoid tissue and mucosal sit

Finally, as secondary infections can occur years after the initial infection, memory
cells maintain themselves over an extended period of time through slow, homeostatic

proliferation (Homann, Teyton et al. 2001). Because of these fundamental differences,

differentiation of naive CD8+ cells into effector and/or memory cells involves struc

reorganization of the membrane and cytoskeleton, chromatin remodeling, expression of
new genes, and induction of cell division (Kaech, Hemby et al. 2002).

30

1.C.1 Central v e r s u s Effector M e m o r y C D 8 + T cells:
l.C.1.1 Phenotypic characterization:
All C D 8 + memory cells can be distinguished by their surface expression of
canonical memory cell markers such as CD44, CD122, Ly6C, CDlla, and CD132. In
addition, CD8+ memory cells do not express the activation markers CD25 and CD69
(Wherry, Teichgraber et al. 2003). Analysis of these cell surface markers allows for

identification of potential memory CD8+ cells in polyclonal populations in vivo, whe
the specific antigen to which a memory CD8+ cell was formed is unknown.
CD8+ memory cells can be further subdivided into central and effector memory

cells based on location and expression of specific cell surface markers (Sallusto, L
al. 1999). CD62Lhi CCR7+ cells are deemed central memory cells, as expression of

these ligands allows for their efficient homing to lymph nodes via interactions with
chemokines CCL19 and CCL21 (Forster, Schubel et al. 1999; Mori, Nakano et al. 2001).

Upon restimulation, these cells can proliferate and differentiate into effector cell
(Zinkernagel, Bachmann et al. 1996). Conversely, long-lived CD62Llo CCR7- cells

cannot home to lymph nodes but exist in the periphery and are termed effector memory
cells. Effector memory cells have been found in the bone marrow in response to LCMV

(Slifka, Whitmire et al. 1997), in the lung in response to intranasal influenza (Flyn
et al. 1998), respiratory viruses (Hogan, Usherwood et al. 2001) or Sendai virus

(Usherwood, Hogan et al. 1999), in the liver in response to oral Listeria monocytogen

infection (Pope, Kim et al. 2001), in gut mucosal tissue in response to vesicular sto

virus, vaccinia virus, and Listeria (Masopust, Jiang et al. 2001) and in the brain in

response to dengue virus (van der Most, Murali-Krishna et al. 2003). Both central and
effector memory populations are found in the blood and spleen.
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l.C.1.2 Functional characterization:
The distinct roles central and effector memory subsets in providing protective

immunity for the host are presently unclear (Masopust and Lefrancois 2003; Masopust,
Kaech et al. 2004). Contradictory data exist regarding the speed with which effector

memory and central memory cells acquire effector functions such as cytokine secretio

and cytotoxic activity. Experiments involving polyclonal stimulation of effector and

central memory cells have shown that effector memory responses are faster (Sallusto,

Lenig et al. 1999; Tussey, Speller et al. 2000; Masopust, Vezys et al. 2001); however,
experiments involving stimulation with cognate antigen have demonstrated equivalent
responses between the two subpopulations (Unsoeld, Krautwald et al. 2002; Wherry,

Teichgraber et al. 2003). In addition, central memory cells have a proliferative adva

over effector memory cells in response to antigenic stimulation, suggesting that cen
memory cells may provide better immunological protection over time (Wherry,
Teichgraber et al. 2003)

l.C.1.3 Generation of CD8+ Central and Effector Memory Cells:
The lineage relationship between central and effector memory is also presently
unclear. Two opposing models exist for the relationship between these two subtypes,
with experimental data existing to support both. In one model, central memory and
effector memory cells are two independent potential pathways for CD8+ memory cell

differentiation (Sallusto and Lanzavecchia 2001). Data consistent with this theory co

from in vitro studies showing that the cytokine environment can influence the phenot
generation of central or effector memory cells (Manjunath, Shankar et al. 2001).

Furthermore, the TCR repertoire in human central and effector memory cells is distin
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supporting the argument that these two subpopulations are distinct (Baron, Bouneaud et
al. 2003).
In sharp contrast, in vivo data from mice using both a viral and bacterial model of

infection suggest that there is a linear progression from effector memory cells to c
memory cells (Wherry, Teichgraber et al. 2003). Furthermore, the conversion rate of

effector memory cells to central memory is linked to the initial antigenic challenge
programmed during the initial antigen encounter. Low dose antigen exposure leads to

faster conversion rates from effector memory to central memory cells, whereas high d

antigen exposure leads to slower rates. Collectively, these findings provide a model

linear CD 8+ memory T cell differentiation from effector memory to central memory in
the case of acute infections.
The relationship between central and effector memory cells in the case of chronic

infections is also unclear. Recent experimental data has shown that persistent viral

antigen leads to the accumulation of distinct populations of memory cells or differe

stages of memory cells, depending on the viral infection (Champagne, Ogg et al. 2001

Appay, Dunbar et al. 2002). The lineage relationship between these different populati
has been difficult to ascertain in vivo.

1.C.2 Progressive versus Linear models for CD8+ Memory Cell
Generation:
The generation of memory cells from naive cells is a poorly understood process.

There are currently two models for how this differentiation occurs (Figure 1-5). The

progressive model of differentiation argues that a naive cell commits to either memo

cell formation or effector cell generation based on the strength of the TCR signal d
priming, with stronger signals leading to effector cells and weaker signals leading
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generation of m e m o r y cells (Sallusto and Lanzavecchia 2001). In contrast, the linear

differentiation model argues that memory cell precursors are a subset of effector c

survive the contraction phase of the memory cell response. There is data to support
these viewpoints.

a Divergent pathway of effector and memory T cells
fAq
I

o
Vfirorycell
b Linear development of effector and memory T cells
+Ag
..—.

o

—

—
E-'ectpj- ..d:
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Figure 1-5. Progressive and linear models for m e m o r y C D 8 + cell generation, a.
Progressive model. C D 8 + T cells c a n bypass the effector stage a n d directly
b e c o m e m e m o r y cells, b . Linear model. M e m o r y C D 8 + cells are direct
descendents of effector C D 8 + cells. Figure taken from K a e c h et al., Nature
Reviews Immunology, 2002.

T h e data in favor o f the linear progression m o d e l is three fold.

Experiments

utilizing Cre-mediated genetic marking of activated CD8+ cells have shown that memory
cells can arise from activated CD8+ cells (Jacob and Baltimore 1999; Opferman, Ober et
al. 1999). In addition, the signals that mediate naive CD8+ cell differentiation into
effector cells are also sufficient for CD8+ memory cell formation. Cells stimulated with
antigen for a brief period not only undergo programmed division and gain effector

function but also generate long-lived memory cells (Mercado, Vijh et al. 2000; Kaech
and Ahmed 2001). Finally, identification of CD8+ memory cell precursors during an
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immune response has shown that precursors upregulate expression of genes required for
effector functions (Kaech, Tan et al. 2003).
Data also exist that are more consistent with the progressive model of

differentiation, which states that CD8+ memory cell formation and CD8+ effector cell
generation are two independent pathways. It has been shown both in vitro and in vivo

that it is not necessary for CD8+ cells to pass through an effector phase for memory
generation (Lauvau, Vijh et al. 2001; Manjunath, Shankar et al. 2001). Furthermore,

CD8+ cell proliferation, which is critical for memory cell generation, can be uncoup

from gain of effector function (Hernandez, Aung et al. 2002). The discrepancies betwe

this data and the data in support of the linear differentiation model may be resolve
central and effector memory cell generation are considered separately.

1.C.3 The impact of Proliferation on CD8+ Memory Cell Development:
U p o n antigen encounter in lymphoid tissues, C D 8 + T cells undergo a

programmed proliferative response. This proliferation leads to a 10,000-100,000 -fol

increase in the number of antigen specific cells (Murali-Krishna, Altman et al. 1998

Blattman, Antia et al. 2002). The extent of proliferation is important because the si

the memory pool is directly correlated with the size of the effector-cell population
Hyland et al. 1994; Busch, Pilip et al. 1998). Memory cell numbers after antigen
encounter are always roughly 10% of cell numbers seen at the peak of the effector

response, regardless of whether the number of antigen specific cells recruited initi

only 1-2% of total CD8+ cells, as in the case for Listeria, or is over 50%, as is the
for LCMV (Busch, Pilip et al. 1998; Butz and Bevan 1998). Thus mechanisms that
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modify C D 8 + effector cell generation will invariably effect C D 8 + memory cell
generation as well.

1.C.4 The effect of Antigen Dose on CD8+ Memory cell Generation:
Both in vitro and in vivo data demonstrate that only a brief antigenic exposure (2-

24 hours) is required for commitment to 7-10 rounds of programmed division (Mercado,
Vijh et al. 2000; Kaech and Ahmed 2001; van Stipdonk, Lemmens et al. 2001; Wong and
Pamer 2001; van Stipdonk, Hardenberg et al. 2003). The daughter cells derived during

this proliferation need no further antigenic stimulation for proliferation to procee
Furthermore, weak signaling through the peptide-MHC complex, which does not induce
calcium fluxes or phosphorylation of MAPK, can none-the-less lead to proliferation
(Rosette, Werlen et al. 2001).
Although a proliferative response can occur in response to minimal antigen
exposure, the amount of antigen available plays a critical role in the extent of

proliferation in vivo. Infection of mice with recombinant vaccinia strains expressin
different levels of an ovalbumin epitope demonstrate that the magnitude of the CD8+

cell response varies with the levels of epitope presented (Wherry, Puorro et al. 1999

Similar results have been obtained by titrating peptide and peptide loaded dendritic
(Ludewig, Ehl et al. 1998; Kedl, Rees et al. 2000; Kaech and Ahmed 2001). These data

show that upon minimal antigen exposure, CD8+ cells proliferate 7-10 times, but that
both the recruitment of naive precursors and the rate of expansion of the recruited

can be increased by further antigen exposure, leading to an increase of the magnitud

the expansion (Badovinac, Porter et al. 2002). In this way, the strength of antigenic
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stimulation plays a role in the development of effector and memory C D 8 + cells upon
acute antigen exposure.
The role of antigen in CD8+ memory cell formation is more complicated in

persistent infections. Antigen dependent proliferation does not continue indefinitel
expansion ceases in the case of chronic persisting antigen (Badovinac, Porter et al.
Furthermore, persisting antigen can compromise CD8+ memory cell development
(Wherry, Teichgraber et al. 2003).

1.C.5 The role of co-stimulatory ligands in CD8+ memory cell
generation:
There are two ways in which co-stimulatory ligands can effect C D 8 + memory cell

generation. The first is by modulating the strength of the proliferative response. T

second is by providing signals necessary for CD8+ memory cell generation. Data exist
support a role for both of these pathways.
The strength of the T cell receptor (TCR) signal is determined not only by the

presence of antigen but also by the co-stimulatory signals present. Studying the rol

co-stimulatory ligands in CD8+ effector cell generation can be confounded by the fac

that CD4+ cells are at times necessary for CD8+ effector cell generation (Kaech, Whe

et al. 2002). Fortunately, some viral infections in mice induce CD8+ effector cells i

absence of CD4+ T cells. Studies performed with these viral infections in mice defic

in specific co-stimulatory ligands has shed light on which ligands are important for
robust CD8+ effector cell response. The co-stimulatory ligands CD40L and OX40 are

not critical for CD8+ effector cell function. (Kopf, Ruedl et al. 1999; Whitmire and
Ahmed 2000). The role of the co-stimulatory ligand CD28 seems to be virus dependent,

as generation of CD8+ effector cells in response to LCMV is not affected (Shahinian,
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Pfeffer et al. 1993) but responses to V S V (McAdam, Farkash et al. 2000), vaccinia
(Sigal, Reiser et al. 1998), and influenza (Wu and Liu 1994) are reduced. 4-1BBL is

critical for CD8+ effector function. (DeBenedette, Wen et al. 1999; Tan, Whitmire et
1999; Tan, Whitmire et al. 2000). Negative regulators, such as CTLA-4, BTLA, and PD-

1 also play a role in attenuating clonal expansion (Greenwald, Latchman et al. 2002;

Watanabe, Gavrieli et al. 2003). Thus, modulation of co-stimulatory pathway can effec
CD8+ memory cell generation indirectly via expansion of CD8+ effector cells.
A role for co-stimulatory ligands in regulating memory CD8+ cell generation also
has experimental support. Although CD4+ cells can be dispensable for CD8+ effector

cell generation, recent data suggest that CD4+ cells are crucial for CD8+ memory cel
formation. The first evidence of this phenomenon came from analysis of female HY
TCR transgenic mice exposed to male HY antigen. Although CD8+ effector generation
and expansion in response to HY occurred normally, CD8+ cells showed poor

proliferative capacity and effector function upon restimulation in vitro (Bourgeois,

et al. 2002). Upregulation of CD40 on CD8+ cells during activation led to the hypothe

that CD40-CD40L interactions between CD4+ and CD8+ cells is critical for memory cell

formation. Additional support for a role for CD4+ cells in CD8+ memory cell generati
came from a model involving cross-priming-induced CD8+ T cell activation. Depletion

of CD4+ cells as short as 3 days after the infection revealed that CD4+ cell help wa
required only during the initial antigen exposure (Janssen, Lemmens et al. 2003).
Finally, the importance of CD4+ cells in CD8+ memory cell generation has been

extended to include CD8+ memory cell generation after acute infections (Shedlock and
Shen 2003; Sun and Bevan 2003). Collectively, these data support the uncoupling of

38

C D 8 + memory cell formation from C D 8 + effector generation in the absence of C D 4 +

cells. Furthermore, robust secondary responses even in the absence of CD4+ helper ce

suggest that an instructive signal for CD8+ memory cell generation is provided by CD
cells during the initial CD8+ cell priming (Masopust, Kaech et al. 2004).

1 .C.6 Proliferation per se and CD8+ memory cell generation:
The process of proliferation is critical for memory cell development. Experiments
addressing the role of cell division in CD8+ memory cell generation used in vitro
proliferation of CD8+ cells labeled with CFSE (carboxyfluoroscein diacetate

succinimidyl ester) to allow for the isolation of activated CD8+ cells having underg

specific number of divisions. Seventy days after transfer, cytotoxic T lymphocyte (C

precursor frequencies from mice adoptively transferred with activated CD8+ cells tha

had undergone less than five cell divisions were similar to those of mice transferre

naive cells. In contrast, transfer of activated CD8+ cells that had undergone more t

nine divisions lead to a significant increase in CTL precursor frequency in the tran

mice, suggesting that memory cells had been transferred (Opferman, Ober et al. 1999).
Proliferation is more important than even cognate antigen stimulation, as
memory-like cells also develop after homeostatic proliferation in a lymphopenic

environment (Cho, Rao et al. 2000; Goldrath, Bogatzki et al. 2000; Murali-Krishna and

Ahmed 2000; Goldrath, Sivakumar et al. 2002). Homeostatically proliferating cells not

only express memory cell-surface markers but also have cytolytic activity and secret

IFNy faster in response to antigen (Cho, Rao et al. 2000; Goldrath, Bogatzki et al. 2
These memory-like cells do not behave exactly as memory cells, however. In contrast

true memory cells, memory-like cells revert to a naive phenotype upon removal from a
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lymphopenic environment (Cho, Rao et al. 2000).

Furthermore naive C D 8 + cells

undergoing homeostatic expansion do not survive in MHC I deficient hosts (Murali-

Krishna Jl 2000), in direct contrast to memory CD8+ cells (Murali-Krishna, Lau et al.
1999).

1.C.7 Cell Survival Factors and CD8+ Memory Cell Development:
After antigen encounter, the proliferative phase of the immune response is
followed by a contraction phase, where 90-95% of the CD8+ effector cells undergo
programmed cell death (Ahmed and Gray 1996). This contraction phase is programmed
during the initial antigen encounter. Treatment of mice infected with Listeria
monocytogenes with antibiotics 24 hours after infection reduces the magnitude of

expansion and the course of infection, but has no effects on the kinetics and extent

contraction (Badovinac, Porter et al. 2002). Conversely, treatment with a higher dose

Listeria prolongs the infection but does not change the magnitude or kinetics of the

contraction phase, even when there is a persistent infection at the beginning of the
contraction phase (Badovinac, Porter et al. 2002). This contraction in the face of
persisting antigen may be important for preventing lethal autoimmune pathologies.
The factors that determine the kinetics of the contraction phase as well as which

cells will survive to become memory cells are currently being elucidated. IFNy has b

implicated in the timing of the contraction phase, as the delayed kinetics of contra
seen in a secondary immune response are also seen in the primary immune response of
IFNy deficient mice (Badovinac, Tvinnereim et al. 2000). Furthermore, inhibiting
inflammation and IFNy production by giving antibiotics prior to an infection limits

extent of contraction but does not effect memory cell formation (Badovinac, Porter e
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2004). These data suggest that memory cells do not form by a default pathway after
surviving the contraction phase.

l.C.7.1 IL-7:
M e m o r y cell precursors exist in the effector cell population at the peak of the

immune response, but at this time they do not show the functional hallmarks of memor

T cells (Kaech, Hemby et al. 2002; Wherry, Teichgraber et al. 2003). These properties

are gained over the course of several weeks, but the signals that drive this differe

are unknown. What is clear is that survival is a prerequisite for memory cell genera

but the mechanisms that lead to the selective survival of precursor memory cells are
under investigation.
The clearest case for a survival factor being involved in memory cell generation is
IL-7. IL-7 is required for the survival of naive T cells (Tan, Dudl et al. 2001). In

addition, it is required for naive CD8+ cell proliferation in a lymphopenic environm
(Goldrath, Sivakumar et al. 2002). Recently, it has been shown that CD8+ memory cell
precursors can be identified by their expression of IL-7Ra (CD127) during the peak

effector response after antigen encounter (Kaech, Tan et al. 2003). IL-7Rahi cells ar

identified as memory cell precursors by several lines of evidence. Experiments invol

transfer of IL-7Rahi or IL-7Ralo cells into naive mice and challenge three weeks lat
show that IL-7Rahi cells but not IL-7Ralo provided immunological protection.

Although IL-7Rahi memory precursor cells express granzyme B like other effector cell

they differ in their expression of tumor necrosis factor receptor superfamily member
(CD27) and killer cell-lectin like receptor Gl (KLRG-1), which have been linked to

senescent effector cells (Hamann, Baars et al. 1997; Voehringer, Blaser et al. 2001).
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Furthermore, IL-7Rahi cells undergo homeostatic proliferation in vivo, an important
characteristic for potential memory cells.
Since IL-7 is a survival factor for T cells, it is thought that expression of IL-7Ra

leads to the selective survival of the 10-15% of effector cells that express it. Ind
memory precursor survival depends on the presence of IL-7. How IL-7 increases

survival is presently unclear. Signals that modify a cells ability to survive do not
necessarily effect CD8+ memory cell formation. For example, p53 deficiency does not
lead to an increase in the generation of memory cells (Grayson, Lanier et al. 2001).
Although Bcl-2 is upregulated in response to IL-7 signaling and in memory cells,
transgenic Bcl-2 and Bcl-XL mice also show no decrease in the contraction phase or
increase the size of the memory cell pool after infection (Razvi and Welsh 1993;

Petschner, Zimmerman et al. 1998). Thus the mechanisms that allow a minority of cells
expressing IL-7Ra to survive and become long-lived memory cells remain to be
elucidated.
Recently, a role for CD8aa expression in defining memory precursor cells and

causing IL-7Ra upregulation has been demonstrated (Madakamutil, Christen et al. 2004)
CD8aa binds the nonclassical MHC I molecule Thymus Leukemia antigen (TL) and is
thought to modulate TCR signaling (Leishman, Naidenko et al. 2001). Expression of

CD8aa has been linked to thymocyte survival (Barnden, Heath et al. 1997; Chidgey and
Boyd 1997). Why CD8aa is upregulated on a subset of effector cells, or how its
upregulation regulates IL7Ra upregulation and survival remain unclear.
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l.C.7.2 Bcl-6:
Data exist that implicate the survival factor Bcl-6 in C D 8 + memory cell

generation. Bcl-6 deficient and Bcl-6 transgenic mice have a decrease and an increas

memory phenotype CD8+ cells, respectively (Ichii, Sakamoto et al. 2002). Surprisingly
there is no change in the rate of apoptosis of CD8+ cells in Bel 6-1- mice; rather,
seems to be involved in maintaining cells in a CD44hi Ly6C+ state and in generating

central memory cells (Ichii, Sakamoto et al. 2004). Bcl6 may play a similar role in C

T cells as it does in B cells, where it is involved in inhibiting terminal different
maintaining stem-cell like proliferative qualities (Fearon, Manders et al. 2001).

1.C.8 Homeostatic proliferation of memory CD8+ cells:
One of the hallmarks of memory C D 8 + cells is their ability to undergo slow
homeostatic proliferation (Tough and Sprent 1994; Sprent 2003). The rate of
homeostatic proliferation can vary between CD8+ memory cells, as 40-50% of memory

cells remain in interphase and do not incorporate BrdU even after five weeks of labe
(Tough and Sprent 1994). Survival and homeostatic proliferation are both independent
TCR signaling, as memory-phenotype cells persist and proliferate in MHC I deficient
hosts (Murali-Krishna, Lau et al. 1999). Instead, cyotokines play a key role in
homeostatic maintenance.

l.C.8.1 The role of IL-15 in CD8+ memory cell homeostasis:
Interleukin 15 (IL-15) is synthesized by a wide variety of cells, especially
macrophages, but not by T cells (Kennedy and Park 1996). Memory CD8+ cells are

uniquely sensitive to IL-15, as demonstrated by several lines of evidence. Treatment
CD44hi CD8+ memory-like cells with low levels of IL-15 in vitro leads to their
proliferation, in direct contrast to CD441o naive CD8+ cells or CD44hi CD4+ cells
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(Zhang, Sun et al. 1998). Injection of IL-15 in vivo also causes a proliferative increase in
the CD44hi CD8+ population (Zhang, Sun et al. 1998). IL-15 transgenic mice have a
selective accumulation of memory phenotype CD8+ cells (Marks-Konczalik, Dubois et
al. 2000; Yajima, Nishimura et al. 2001). Conversely, studies in vivo using blocking

antibodies have revealed that CD8+ memory cell division requires IL-15 but is inhibi

by IL-2 (Dai, Konieczny et al. 2000; Ku, Murakami et al. 2000). Further evidence for t

critical role of IL-15 in vivo comes from the selective decrease in CD8+ memory cell
IL-15 deficient mice (Lodolce, Boone et al. 1998; Kennedy, Glaccum et al. 2000).

Transfer of memory CD8+ cells into IL-15 deficient hosts leads to the loss of memory

cells over time due to a lack of homeostatic proliferation (Goldrath, Sivakumar et a
2002). Surprisingly, transfer of IL-15Ra deficient CD8+ cells into normal hosts
followed by immunization revealed that IL-15Ra expression by CD8+ cells is not
required for memory cell generation (Burkett, Koka et al. 2003). This finding was
reconciled with existing data by showing that IL-15Ra can bind and present IL-15 in

trans to the common (3y chains. Finally, a role for IL-15 in the homeostatic prolife

of antigen induced bona-fide memory cells has also been demonstrated (Wherry, Becker

et al. 2002). The sensitivity of memory CD8+ cells to IL-15 may be due to the selecti

upregulation of the shared IL-2 and IL-15R(3 chain (Giri, Ahdieh et al. 1994) on mem
like CD8+ cells.

l.C.8.2 The role of IL-7 in CD8+ memory cell homeostasis:
The role of IL-7 in homeostatic maintenance of memory C D 8 + cells is less clear,

presumably because of the partially overlapping functions of IL-15 and IL-7. Transfe
of CD8+ memory cells into hosts given IL-7Ra blocking antibody decreases the extent
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homeostatic proliferation but does not completely block it (Goldrath, Sivakumar et al.
2002). Further evidence for the functional redundancy between IL-15 and IL-7 comes
from transfer experiments into lymphopenic hosts. Unlike CD8+ memory cells

transferred into complete hosts, which are completely dependent on IL-15 for their b
homeostatic proliferation, CD8+ memory cells transferred into either IL-15 or IL-7
deficient lymphopenic hosts have only a slight impairment in acute homeostatic

proliferation. Acute homeostatic proliferation is blocked only in the absence of bot

these cytokines (Schluns, Kieper et al. 2000; Goldrath, Sivakumar et al. 2002). Finall
overexpression of IL-7 in IL-7 transgenic animals leads to IL-15 independent

maintenance of memory CD8+ cells (Kieper, Tan et al. 2002). These data taken together

suggest that both IL-7 and IL-15 are involved in regulating homeostatic proliferatio

CD8+ memory cells, but that in a normal host, competition for IL-7 with other cell t
makes the role of IL-15 more critical in CD8+ memory cell maintenance.

1.C.9 Biochemical pathways involved in CD8+ memory cell
generation a n d m a i n t e n a n c e :
Although the requirements for C D 8 + memory cell generation and maintenance
have been defined at the cellular and even cytokine level, the biochemical pathways

governing a cell's decision to commit to the effector and memory lineage remain to b

determined. Insight into the potentially important signaling molecules has been prov

by analysis of expression levels of genes in naive, memory, and activated CD8+ cells

(Kaech, Wherry et al. 2002), but the definitive importance of these candidates awaits
confirmation from in vivo analysis.
Genetic proof exists for the role of SOCS1 in CD8+ memory cell generation.
SOCS1 fl/fl Lck-Cre mice, which under go SOCS1 deletion specifically in the thymus
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and T cell compartments, shows an increase in the memory-like compartment of C D 8 +
cells in the periphery (Chong, Cornish et al. 2003). Thymocytes from these mice are

hypersensitive to IL-7 induced Stat5 phosphorylation. SOCS1-/- IFNy-/- mice, which do
not die from the lethal IFNy induced inflammation seen in SOCS1 -/- mice, also
accumulate memory phenotype CD8+ cells because of an increased sensitivity to IL-15
induced Stat5 phosphorylation (Ilangumaran, Ramanathan et al. 2003).
Stat5 has independently been linked to memory CD8+ cell generation and
maintenance. Stat5a-/- and Stat5b-/- mice have decreased CD8+ memory cells, whereas
Stat5 transgenic mice have markedly increased CD8+ memory cell numbers (Kelly,

Spolski et al. 2003). Stat5 overexpression also rescues the CD8+ memory cell deficien
seen in common gamma chain deficient mice (Kelly, Spolski et al. 2003). The precise
role that Stat5 plays either in the generation or maintenance of memory CD8+ cells
remains unclear at this time.

1.D. Ubiquitination:
Ubiquitination of a protein refers to the covalent attachment of the 76 amino acid,
ubiquitously expressed globular protein ubiquitin by the stepwise action of three
enzymes. It is a commonly occurring phenomenon in eukaryotes, second only to

phosphorylation as a means of post-translational modification. The universality of t
form of regulation is highlighted by the fact that there is only a three amino acid
difference in the ubiquitin sequence between yeast and humans (Weissman 2001).
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1.D.1 T y p e s of ubiquitination:
The ubiquitination of proteins is not a homogenous modification. Proteins can be

ubiquitinated on either internal lysine residues or on the ct-NH2 at their N-termini

(Breitschopf, Bengal et al. 1998). Some proteins are ubiquitinated on only specific l

(K) residues (Chau, Tobias et al. 1989; Baldi, Brown et al. 1996), while other protei

show little specificity regarding which lysine residue is ubquitinated (Hou, Cenciar
al. 1994; Treier, Staszewski et al. 1994). The importance of which residues are
ubiquitinated is unclear at present.
In addition to the location of the ubiquitin moiety, the length of the ubiquitin
chain can also vary. Proteins can be mono- or poly- ubquitinated on a given lysine

residue, and different lysine residues within the same protein may be targeted for m
or poly- ubiquitination. Mono-ubiquitination serves as a signal for chromatin
modification and regulates various trafficking events (Hochstrasser 2004).
Polyubiquitination is important for regulating a protein's abundance, as a chain of

more ubiquitin tags is required to target a protein for proteosomal degradation (Thr
Hoffman et al. 2000).
The branching of the ubiquitin chain is also important. Ubiquitin contains seven

conserved lysine residues, all of which could potentially be used for iso-peptide li

Thus far, chain linkage sites at ubiquitin KI 1, K29, K48, and K63 have been describ
vivo. K48 linked polyubiquitin chains historically have been defined as signals for
proteosomal degradation (Chau, Tobias et al. 1989; Thrower, Hoffman et al. 2000);

however, emerging data suggests that they may also inhibit a protein's activity with

leading to its degradation (Elsasser, Gali et al. 2002; Bai, Yang et al. 2004; Flick,

al. 2004). In contrast, polyubquitin chains formed by attachment at K63 have been lin
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to protein activation (Deng, W a n g et al. 2000) and endocytosis (Bonifacino and
Weissman 1998).

1.D.2 The roles of ubiquitination:
Ubiquitination has been linked to myriads of cellular processes, including bulk-

protein degradation, cell-cycle control, DNA repair, stress response, vesicular traff
transcriptional regulation, as well as signal transduction (Hershko and Ciechanover

1998). Protein ubiquitination regulates the participation of a protein in a particula
biological process by changing its abundance, activity, or subcellular localization

(Mueller 2004). The way in which a ubiquitin moiety can regulate a protein's activity
so many diverse ways is only beginning to be understood, and there remain many
unanswered questions.

1.D.3 The enzymatic reactions of ubiquitination:
Ubiquitination consists of three steps (Figure 1-6). First, the ubiquitin-activating
enzyme El activates ubiquitin by forming a thioester bond between the c-terminus

glycine residue of ubiquitin and the active cysteine residue in El. The universality
step is underscored by the fact that there is a single El gene in humans that gives

two isoforms of El (Grenfell, Trausch-Azar et al. 1994). The activated ubiquitin is t

transferred via trans-acylation to the active cysteine residue of one of at least 25

ubiquitin conjugating enzymes (E2). Ubiquitin is then transferred to target proteins
the help of E3 ligases, which confer substrate specificity of ubiquitination. There

four families of E3 ligases, namely U box (Ufd2 related), RING (Really Interesting Ne
Gene), SOCS (suppressor of cytokine signaling), and HECT (homologous to E6-AP Cterminus) ligases. The distinction between these families is based on structural as
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functional features (Davis and Ben-Neriah 2004). Finally, an additional factor (E4) can
be necessary for some ubiquitin chain-assembly reactions (Koegl, Hoppe et al. 1999)
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1.D.4 U b o x E 3 ligases:
The U box domain was initially identified in the yeast protein Ufd2, which

possesses E4 activity. Homologs of this protein contain U box domains and comprise t

U box family of E3 ligases (Figure 1-7). These proteins function as E3 ligases in an

dependent fashion, because they cannot directly ubiquitinate target proteins. None o
murine or human family members has been shown to have E4 activity (Hatakeyama and
Nakayama 2003).
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1.D.5 R I N G finger E 3 ligases:
The R I N Gfingerdomain contains an octet of cysteine and histidine residues that

constitute a zinc-binding domain (Fig 1-7). Most RING-finger domain proteins functio

as E3 ligases by binding both target substrates and E2 ligases. RING-finger E3 ligas

not directly ubiquitinate target proteins but rather function to specify the targets
ligases. Members of the RING-finger E3 ligase family are further divided into four
subfamilies based on structural and functional differences. These subgroups are the
multi-protein subunit families SCF(SKPl,Cull, F-Box), CBC (Cul 2-Elongin, B Elongin,
C), APC/C (Anaphase Promoting Complex/cyclosome), and the single polypeptide
RING-finger E3 ligase subfamily.

1.D.6 SOCS E3 ligases:
The eight S O C S proteins contain a central src-homology 2 (SH2) domain and a
C-terminal 40 amino acid SOCS box domain (Figure 1-7). SOCS proteins are negative
regulators of cytokine signaling cascades, but they use a variety of mechanisms to

achieve this end. One mechanism is through protein ubiquitination, in which the SOCS
box domain binds elongins B and C and forms part of an E3 ligase ubiquitin complex
(Alexander 2002).

1.D.7 The HECT family of E3 ligases:
The H E C T (homology to E6-AP C terminus) family members are defined by their

conserved catalytic C-terminal domain, first identified in the E6- associated protei

AP) (Figure 1-7). This protein, together with the papillomavirus oncoprotein E6, lea
to the ubiquitination and degradation of p53 (Scheffner, Huibregtse et al. 1993). The
conserved C-terminal in the HECT E3 ligases forms a covalent bond with ubiquitin,

allowing these E3 ligases to directly ubiquitinate substrates. This is contrast to o
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ligases, which bind both E 2 ligases and target substrates, bringing the E 2 ligase in close
enough proximity to ubiquitinate the substrate. The N-termini of HECT E3 ligases are
less conserved and contain protein-protein interaction domains or intracellular
localization domains. Several HECT E3 ligases contain WW domains in groups of two
or four in the N-termini. These WW domains form hydrophobic pockets for binding
proline rich sequences. Most HECT E3 ligases that contain WW domains also contain a
C2 domain that mediates translocation to the membrane in response to increases in
intracellular calcium.
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Figure 1-7. The structural
domains of HECT, RING, Ubox
and S O C S family E3 ligases.
Figures
taken
from
Hatakeyama et al., Biochem
Biophys Res C o m , 2003 and
Alexander, Nature Reviews
Immunology 2002.

l.D.7.1 T h e H E C T E 3 ligase Itch
Itch belongs to the H E C T class of E3 ligases. It contains an N-terminal C 2
domain, 4 WW protein interaction domains, and a C-terminal HECT ubiquitin ligase
domain. It is a highly conserved protein, with homologs in yeast (Rsp5p) (Hicke and
Dunn 2003), C. elegans (CelWWPl) (Courbard, Fiore et al. 2002), and Drosophila
(Su(dx)) (Cornell, Evans et al. 1999). Biochemically, several substrates have been

identified for Itch. Studies exist implicating Itch in ubiquitinating Notch (Qiu, Jo

al. 2000), Bel-10 (Scharschmidt, Wegener et al. 2004), CXCR4 (Marchese, Raiborg et al.
2003), human enhancer of filamintin (Feng, Guedes et al. 2004), endophilin (Angers,

Ramjaun et al. 2004), Smad 2 (Bai, Yang et al. 2004), Cbl (Magnifico, Ettenberg et al.
2003), LMP2A (Ikeda, Caldwell et al. 2003), occludin (Traweger, Fang et al. 2002), NF-

E2 (Chen, Frank et al. 2001), phospholipase C gamma (PLOy) (Heissmeyer, Macian et al.

2004), and Jun-B (Fang, Elly et al. 2002). The physiological relevance of these findin
especially with regard to the immune system, is still unclear in many cases.

1.D.8 Roles for Ubiquitin in the Immune System:
Since ubquitination is such a universal and fundamental cellular process, it is not

surprising that cells of the immune system utilize it as well; however, understandin

ubiquitination-regulated processes in the immune system is still in its infancy. One

best-described examples is the activation of NF-kB. NF-kB translocation to the nucle
requires the IKK-regulated, ubiquitin-mediated degradation of IkB (Karin and BenNeriah 2000). The RING domain containing multimeric structure SCFp"TrCP is
responsible for this ubiquitination.
The Cbl-RTNG and SOCS family E3 ligases are implicated in the termination of

activation signals. c-Cbl downregulates receptor tyrosine kinases via targeting to t
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endocytic pathway (Levkowitz, Waterman et al. 1998; Joazeiro, Wing et al. 1999; Thien
and Langdon 2001). In T cells, c-Cbl ubiquitinates the TCR^ chain in a Zap-70
dependent fashion, leading to TCR downmodulation upon antigen stimulation (Wang,

Altman et al. 2001; Naramura, Jang et al. 2002). Ubiquitin also regulates immune cell
signaling cascades in a degradation-independent manner. For example,TRAF6

uibiquitination in response to IL-1(3 leads to its activation (Deng, Wang et al. 200

Wang, Deng et al. 2001). In addition, Cbl-b ubiquitinates the phosphotidyl inositol 3

kinase (PI3K) subunit p85, preventing its association with CD28 and TCR^ (Fang, Wang

et al. 2001). This ubiquitination is critical for inhibiting a cell's response in the

of co-stimulation. The importance of Cbl-b mediated regulation is underscored by the

occurrence of spontaneous autoimmune disease in Cbl-b deficient mice and the inabili

of Cbl-b deficient T cells to be anergized (Bachmair, Finley et al. 1986; Jeon, Atfi
al. 2004).

1.D.9 The role of Itch in the immune system:
The relevance of Itch to the immune system was initially discovered with the
1 PiH
cloning o f the inversion breakpoints in the m u r i n e agouti m u t a n t strain a

, w h i c h along

with a darker coat color displayed an inflammatory disease consisting of interstitial

inflammation of the lungs, splenomegaly, lymphadenopathy, and dermatitis in the mice.

The inversion resulted not only in a break in the agouti locus, but also disrupted t

for the E3 ligase Itch (Perry, Hustad et al. 1998). Subsequent analysis of the natura

occurring Itch deficient mice revealed increased serum IgGl and IgE titres, promptin

analysis of Th differentiation in Itch deficient mice (Fang, Elly et al. 2002). It wa

that CD4+ T cells from Itch deficient mice display a bias towards Th2 differentitati
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vitro, and further biochemical analysis demonstrated that this bias w a s due to increased
JunB levels (Fang, Elly et al. 2002).
Although the inversion clearly affected the Itch protein, it was possible that the
regulation of other genes within the inverted region was affected. Furthermore, although
the inflammatory disease in Itch deficient mice was consistent with a bias in Th2
differentiation, the experiments performed could not address whether the changes in
CD4+ T cell differentiation were secondary to the inflammatory pathology in these mice

or a cause for it. Since all cells were deficient for Itch, it was difficult to ascertain whi
lymphocyte subpopulation was responsible for initiating the disease.

1.D.10 Generation of mice with cell specific inactivation of Itch:
T h e limitations inherent in the analysis of Itch deficient mice led Kristina Jonsson
to generate mice in which it would be possible to inactivate Itch in a cell specific manner
(Jonsson 2002) (Figure 1-8). These mice were generated by flanking the last exon of
Itch containing the catalytic cysteine of the HECT domain with loxP sites (Itch fl/fl
mice). Breeding of Itch fl/fl mice to transgenic mice expressing Cre in specific cell types
allowed for the analysis of Itch inactivation in a cell specific manner. Because Cre
mediated deletion leads to the loss of only the last 32 amino acids of the 864 amino acid
protein, a truncated Itch protein may still be present in cells in which Cre is expressed.
The E3 ligase activity of this protein is abolished, however, because of the absence of the
catalytic cysteine in the mutant protein. Itch fl/fl Deleter Cre mice, in which Itch is
deleted in all cells, have the same inflammatory disease as the Itch deficient mice
resulting from an inversion in the
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Figure 1-8. Generation of conditional Itch deficient mice: a. Strategy for Itch g e n e targeting.
D o m a i n structure of the Itch protein, partial structure of the Itch g e n o m i c locus, m a p s of the
targeting vector a n d the targeted Itch locus before a n d after C r e mediated recombinations are
delineated. Filled rectangles represent exons. Triangles represent loxP sites. T h e partially filled
rectangles represents the selection marker genes. Restriction sites are E: E c o R V . Probes d a n d
e used in Southern blots are depicted by filled rectangles in the m a p a n d the length of respective
restriction fragments detected by these probes is depicted numerically a b o v e d a s h e d lines
representing the restriction fragments, b. Deletion efficiency in Itch fl/fl C D 4 Cre mice. Southern
blot analysis of g e n o m i c D N A from splenocytes or thymocytes digested with E c o R V a n d
visualized with probe d. T cells w e r e purified by depletion a n d the bound fraction consisting of
non-T cells w a s used to determine C D 4 C r e specificity. G e n o m i c D N A w a s digested using
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restriction fragments are indicated, c. Western blot anlaysis of the wild-type Itch protein in C D 4 +
cells purified from the spleen a n d lymph n o d e s of Itch fl/fl C D 4 C r e mice a n d littermate controls.
Expression of tubulin w a s m e a s u r e d to control for the accuracy of protein loading.
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agouti locus. This data supports the role of Itch in the pathology described in the a18H
inversion mutant.

1.E Overall aims of this study:
T h e experiments described in this thesis present an attempt to define which Itch
deficient lymphocyte population is sufficient for generating the previously described Itch
pathology, which regulatory networks of the immune system are disrupted as a
consequence of Itch deficiency, and which signaling pathways are affected due to Itch
deficiency. The findings are discussed in three chapters, based on the immune responses
analyzed.
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C h a p t e r 2: Materials a n d m e t h o d s :
2.A Reagents
2.A.1 Antibodies used for flow cytometric analysis and coating:
All antibodies were purchased from BD Pharmingen unless otherwise noted.
anti-mouse CDllb (clone M/170) biotin 1:100
anti-mouse CD 122 (clone TM-B1) biotin 1:100
anti-mouse CD127 (clone SB/199) PE 1:50
anti-mouse CD 19 (clone ID3) biotin 1:100
anti-mouse CD 19 (clone 1D3) biotin 1:100
anti-mouse CD24 (clone Ml/69) biotin 1:400
anti-mouse CD25 (clone 7D4) PE 1:100 (Southern biotech)
anti-mouse CD25 (clone 7D4) biotin 1:100
anti-mouse CD28 (clone 37.51) purified 1:100
anti-mouse CD3e (clone 145-2C11) purified 1:400
anti-mouse CD4 (clone GK1.5) PE 1:200
anti-mouse CD4 APC 1:100
anti-mouse CD44 (clone IM7) FITC, PE, and biotin 1:100
anti-mouse CD45R/B220 (clone RA3-6B2) cychrome 1:75
anti-mouse CD5 (clone 53-7.3) biotin 1:100
anti-mouse CD62L (clone MEL-14) 1:100
anti-mouse CD69 (clone H1.2F3) 1:100
anti-mouse CD86(B7.2) (clone GL1) biotin 1:100
anti-mouse CD8 (clone 53-6.7) FITC 1:100
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anti-mouse CD90.2 (clone 53-2.1) P E 1:400
anti-mouse gamma delta TCR (clone GL3) biotin 1:100
anti-mouse LY-6G (GR-1) (clone RB6-8C5) FITC and biotin 1:100
anti mouse CD49b (clone DX5) biotin 1:100
anti-mouse TCR beta chain (H57-597) biotin 1:100
anti-mouse TER-119 biotin 1:100
anti-mouse NK1.1 (clone PK136) biotin and PE 1:100
streptavidin-cy7 PE 1:100
anti-mouse IFNy (clone XMG1.2) FITC 1:100
anti-mouse IL-4 (clone 11B11) PE 1: 75
anti-mouse TCRVa 11.1 biotin 1:100
anti-mouse TCRVpll biotin 1:100
anti-mouse TCRV(38 (clone F23.1) bitoin 1:100
anti-mouse TCRV(33 (clone KJ25) biotin and PE 1:100
anti-BrdU FITC 1:50

2.A.2 Antibodies used for Western blots:
Rabbit cc-Itch (1383, recognizing the C-terminus of Itch) 1:1000
Rabbit a -JunB (SantaCruz) 1:500
Mouse a -tubulin (Sigma) 1:1000
Mouse a -actin (Santa Cruz) 1:20,000
a -mouse IgGHRP (Amersham) 1:10,000
a -rabbit IgG HRP (Amersham) 1:10,000
a -mouse IgM HRP (Amersham) 1:20,000
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2.A.3 Cytokines u s e d for cell culture:
IL-2 (laboratory made; supernatant of X63-Ag8-653 plasmacytoma cell lines transfected

with IL-2 expression vector. 1:1000 dilution equivalent to 50 U/ml recombinant IL-2
based on ELISA)
IL-4 (R&D)
IL-12(R&D)
IL-15 (recombinant human IL-15, RDI)

2.A.4 Synthetic oligonucleotides:
Oligonucleotides for P C R and sequencing were purchased lyophilized from
Fisher and Invitrogen and reconstituted at a concentration of 200uM in water.

2.A.5. Primers and PCRs used for gentoyping:
Table 2.1 Primers
PCR
Primer sequences
for
5'-TCT ggA C g A A g A g C A T C A ggg-3'
(32M

Primer
names
Neo160
184WT
185 W T

5'-TAT C A g T C T C A g Tgg ggg Tg-3'
5'-CTg A g C T C T g T T T T C g T C Tg-3'
Itch

AND

OVA
Stat 6

Rag

5'-AC A AgA ggTAgg AgA CAA gCA TT-3'
5'-TgC AgC TTA TTT ATC ATT CCT TA-3'
5'-Tgg TTA CTT TAT TTg gCT TTg ACA A-3'
5'-gAC TTg gAg ATT gCC AAC CCA TAT CTA
AgT-3'
5'-TgA gC gAA ggT gTA gTC ggA gTT TgC
ATT
5'- CAg gAg ggA TCC AgT gCC AgC-3'
5'- Tgg CTC TAC AgT gAg TTT ggT-3'
5'-CTg gAC CTC ACC A A A CgC-3'
5'- CCC ggA TgA CgT gTG C-3'
5'-CTg AAT gAA CTg CAg gAC gA-3'
5'-ATA CTT TCT Cgg CAg gAg CA-3*

Itch A
ItchB
Itch C
TgNlOl
TgN 102

5'- AgA CAC ACC ggC TTg CAA CAC Ag -3'
5'- TgC CgA gAA AgT CCT TCT gCC Ag-3'
5'- gTg gAA TgA gTg CgA ggC CAg A-3'

Rag4

5'-TAA TCg CCA TCT TCC AgC Ag-3'
5'-CAA TTT ACT gAC CgT ACA C-3'
5' CAA CCA ACA AgA gCT CAA gg-3'

Cre 1
Cre 2
CD4tgF

OVAF
OVAR
Stat6F
Stat6R
158NeoF
158NeoR

Expected
prouct sizes
+/+ 280 bp
+/- 280bp
400bp
-/- 400bp
Wt 237 bp
Fl 270 bp
Del 497 bp
400bp

PCR program
description

1

2 (C57B1/6)
3 (mixed)

2

300bp

2

+/+ 275 bp
+/- 275 bp
172 bp
-/- 172 bp

4

W T 450 bp
Mut 344 bp

2

1025 bp

2

390 bp

5

Rag5
Rag6

Cre
CD4
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Cre

5'-CgC A T A A C C AgT gAA A C A gCA T-3*
5'-gAA gAC A C C ggg A C C gAT C C A g-3'
5'-CgC A T A A C C AgT gAA A C A gCA T-3'
5'- CAg TgA A T g A C A gAT ggA C C T CC-3'
5'-gCA g A A gCC A C A A C C A T A C A T TC-3*
5'-CAC AgT A A C TCg TTC TTC TCT gC-3'

MxCreR
DelCreF
MxCreR
JHT1
JHT2
JHT3

5' CTC CTT CAT CCA CCA AgA CTA ACA
CA-3'
5'- CAT ggC ACA ACT CAg gCA ACT AgA-3'
5'- ggT ACC TgC AgT TCg CCT ATg A-3'
5'-Tgg ggC A A C CAg gCT Agt gTA TA-3'
5'- AgC ACT gTG gTT CCT TC-3'
5'- Agg TCC CCA TTA gAg AA-3'
5'-CAG CTG CCT ACA GTG CCC CTA G-3'
5'-CAT TTG CCA GCA GTG GGT AG-3'

Foxp3
hyb
oligo
HPRT

5'-ATC CTA CCC ACT GCT GGC A A A TGG
A G T C-3'

Foxp3hyb
oligo

5'-GCT G G T G A A A A G GAC CTC T-3'
5'-CAC A G G ACT A G A ACA CCT GC-3'

HPRT-1
HPRT-2

HPRT
hyb
oligo

5'-CAC A G G ACT A G A ACA CCT GC-3'

HPRT-2

Deleter
Cre

JHT

Haplot
yping

d2
probe
Foxp3

474 bp

2

W T 400 bp
JHT 650 bp

2

H-2DdlF
H-2DdlR
H-2Db8F
H-2Db8R

b 640 bp
d 444 bp

6

D2F
D2R
Foxp3F
Foxp3R

571 bp

1

384 bp

3

250 bp

1

Table 2.2 P C R p r o g r a m cycles

P C R program
number
1

2

Annealing
temperature
6 4 ° C , -0.5°C
per cycle
58°C

Annealing time

Extension time

cycles

30 seconds

35 seconds

1-12

30 seconds

35 seconds

13-37

62°C

45 seconds

90 seconds

35
35

3

58°C

45 seconds

90 seconds

4

54°C

30 seconds

30 seconds

35

5

62°C

45 seconds

90 seconds

25

6

68°C

30 seconds

45 seconds

30
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l.B Molecular Biology M e t h o d s :
2.B.1 Bacterial transformation:
Heat shock competent E. coli DH5ct were used for transformation. Bacteria were

thawed and incubated with plasmid DNA for 20 minutes on ice, heat-shocked at 42°C fo
45 seconds, and kept on ice for 2 minutes. Bacterial cells were incubated in 1 ml LB

medium at 37°C for 30 minutes prior to plating on LB agar plates containing appropri
selection antibiotics. Colonies were picked 12-16 hours after incubation at 37°C.

2.B.2 Purification of DNA:
Plasmid D N A was isolated by mini, midi, and maxi-prep kits from Qiagen
according to the manufacturer's protocol. DNA fragments were excised from agarose

gels using a scalpel and purified using Qiaquick gel extraction kit (Qiagen) accordi
the manufacturer's protocol

2.B.3 Restriction enzyme analysis:
Restriction enzymes (Boeringer, Gibco, Takara, N e w England Biolabs) were used
according the manufacturer's instructions.

2.B.4 DNA sequencing:
D N A sequencing was performed by the D N A sequencing core facility at the
Rockefeller University.

2.B.5. Generation of Itch expression vectors:
The murine Itch gene was P C R amplified from genomic D N A and subcloned into

the Bluescript plasmid. Itch was further subcloned into the EGFP_C1 expression vecto
The Itch gene with the N terminus C2 region deleted was also PCR amplified from
genomic DNA and cloned into the EGFP_C1 expression vector. In the Itch-EGFP_C1
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expression vector, the c-terminus cysteine required for the catalytic function of the H E C T
domain of Itch was mutated to an alanine using the ExSite PCR based site directed
mutagenesis kit (Stratagene) according to the manufacturer's protocol.

2.B.6 Amplification and purification of probes used for Southern blot
analysis:
The probe d and probe e were amplified from genomic D N A by P C R using
primers d2 forward and d2 reverse and e2 forward and e2 reverse, respectively. The
probes d and e fragments were subcloned into Bluescript BSKS II (+). Probes were
amplified from the subcloned DNA for Southern blot analysis.

2.B.7 Radioactive labeling of probes:
Probes were labled with radioactive dCTP ("ready to go D N A Labelling beads,
Amersham Pharmacia) according to the manufacturer's protocol.

2.B.8 Southern blot analysis:
Southern blot analysis was performed by standard procedures. Briefly, genomic
fragments or PCR products were resolved on 0.8% or 1.2% agarose gels, respectively.
Gels were stained in ethhidium bromide-containing running buffer (lx TAE) and

photographed with ultraviolet light to control for resolution of marker fragments. A
equilibrating the gel in transfer buffer (0.4M NaOH, 0.6M NaCl) for 20 minutes, DNA
was transferred onto a nitrocellulose membrane (Hybond N+, Amersham Biosciences) by
capillary blotting. Following overnight transfer, the membrane was rinsed in
neutralization solution (0.5 M Tris-HCl pH 7.0, IM NaCl) and DNA was permanently
fixed to the membrane by UV cross-linking in a photo-crosslinker (UV Stratalinker,
Stratagene). The membrane was blocked overnight at 65 C in hybridization buffer
(50mM Tris-HCl pH7.5, IM NaCl, 1% SDS, 10% dextran sulfate, 300 ng/ml sonicated
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salmon sperm D N A ) .

The labeled probe was added to the hybridization buffer and

incubated at 65°C overnight. Finally, the membrane was washed with 0.5-2x SSC
(150mM NaCl, 15mM tri-sodium citrate) and 0.1-1% SDS, and exposed for
autoradiography.

2.B.9 Polymerase chain reactions (PCRs):
Unless otherwise noted, PCRs were performed using Klentherm buffer (67 m M
Tris HCI, pH 9.2, 16mM (NH3)2S04, 0.15 mg/ml BSA, and 3.5 mM MgCl2), 25uM

dNTPs, and 4pmol primers, and 1 ul Taq polymerase (Invitrogen) in a 20-25 u,l reacti
volume.

2.B.10 Semiquantitative RT-PCR:
Semiquantitative reverse transcription-polymerase chain reaction (RT-PCR) was
performed to assess mRNA levels of target genes. Total RNA was isolated from 5xl051x10 cells using Trizol (GibcoBRL) and the concentration was measured by
spectophotometry. Equal concentrations of RNA were reverse transcribed into cDNA
using oligo(dT) primers and the Superscript reverse transcription kit (Invitrogen)

according to the manufacturer's protocol. A control reaction was performed without t

addition of reverse transcriptase to control for DNA contamination. Three fold seria
dilutions of cDNA were used for PCR reactions. Foxp3 PCR reactions were performed
with 1.5 mM MgCl2.The PCR reactions were visualized by Southern blotting with HPRT
and Foxp3 specific probes.
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2.B.11 Isolation of g e n o m i c D N A :
Genomic D N A was isolated from 1/4 inch mouse tail clips following a standard

protocol (Laird, Zijderveld et al. 1991) Briefly, tails were digested in 500 uJ tail
buffer (10 mM Tris-HCl pH8.5, 5mM EDTA, 0.2% sodium dodecyl sulfate (SDS), 200
mM NaCl, 100 u.g/ml proteinase K) at 55°C over night. Cell debris was pelleted at

15000 x g for 8 minutes and the supernatant was transferred to a fresh epindorf tube

DNA was precipitated with the addition of 1 ml 100% ethanol and vigorous shaking. Th

precipitate was pelleted at 15000 x g for 2 minutes, washed in 70% ethanol, air drie
5 minutes, and resuspended in 200-400 ul TE (10 mM Tris-HCl pH 8.0, ImM EDTA).
DNA was resolved at 55°C for 30 minutes. 1 ul of the resolved DNA solution was used
per PCR reaction.

2.B.12 Preparation of cell lysates:
Cells were washed one time in plain R P M I medium prior to lysis. If the cell
number was less than 5xl06 cells, the tubes into which the cells were placed were
precoated with fetal calf serum for 5 minutes at room temperature. Cells were lysed
octylglucoside (ODG) lysis buffer (50 mM Tris, pH 7.4, 150 mM NaCl, 20 mM NaF,
ImM EDTA, ImM EGTA, 2% ODG, 10% Glycerol) with fresh protease inhibitors
(Sigma) and 2mM Na orthovanadate added prior to lysing. Cells were lysed on ice for

minutes and nuclei were pelleted by centrifugation at 15000 x g for 10 minutes at 4°

not used immediately, the supernatants containing cellular protein extracts were fro
-80°C.
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2.B.13 W e s t e r n blots:
The total protein concentration of lysates was determined by a B C A assay
(Pierce) against a bovine serum albumin standard according to the manufacturers
protocol. Lysates were resolved by 8%-15% SDS polyacrilamide gel electropheresis
(SDS-PAGE) and transferred to polyvinylidenediflouride (PVDF) membrane (Immobilon

P, Millipore) by semi-dry blotting according to the manufacturer's protocol. Unspeci
binding to membranes was blocked by one hour incubation with 5%BSA TBST (100 mM
Tris-HCl pH 7.6, 140 mM NaCl, 0.2% Tween). Primary antibodies were incubated

overnight in TBST at dilutions indicated elsewhere. Membranes were washed 5 times fo
5 minutes in TBST and incubated with secondary HRP-coupled anti-species antibodies
(Amersham) for 30-60 minutes at room temperature. Membranes were washed again five
times for five minutes and proteins were detected by chemiluminescence (ECL,
Amersham) according to the manufacturer's protocol.

l.C Cellular Methods:
2.C.1 Preparation of murine lymphocyte suspensions:
Mice were killed using dry ice (CO2) and blood was removed from the heart by a
1 ml syringe with a 26 gauge needle. Thymus, spleen, and lymph nodes (superficial

cervical, mandibular, axillary, lateral axillary, pancreatic, superficial inguinal, i

hypogastric, and mesenteric) were isolated and placed in 5 ml ice cold Hanks Balance
Salt Solution (BSS). Single cell suspensions were obtained by either gentle shearing

organs placed in meshes using a blunt forcep or by incubation or organs in a collage

enzyme mixture (Blendzyme II, Roche). For preparation of single cell suspension using
Blendzyme, a PBS solution containing 130 fxg/ml blendzyme and 100 \ig/ml DNAase
was prepared fresh. A spleen (cut into four pieces) or pooled lymph nodes from one
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mouse were placed into one well of a 48 well plate containing 350 ul of solution
Blendzyme solution. Cells were incubated at 37 C for 15 minutes and single cell
suspensions were made by gentle mechanical disruption using a 1 ml syringe (with no

needle). Cells were placed in 5 ml BSS to dilute the suspension, and the cell suspens

was filtered through an 0.7 u.m mesh and washed one time in BSS. Splenic erythrocyte
were lysed by incubating cells for 1 minute at room temperature in 1 ml ACK buffer
(0.15M NH4C1, 10 mM KHC03, 0.1 mM EDTA). The reaction was stopped by adding 9
ml BSS. Cells were washed once with BSS and the single cell suspension was filtered
through an 0.7 um mesh. Cells were counted using a hemacytometer. Dead cells were
excluded by staining with trypan blue (Gibco) prior to counting.

2.C.2 T cell purification from spleen and lymph node:
Unless otherwise mentioned, T cells were purified by depletion using M A C S LS

columns. For purification of CD4+ T cells, cells were incubated at 2xl08 cells/ml in

Hanks Balanced Salt Solution (BSS) with a mixture of biotinylated antibodies against
CD8, CD 19, CD24, CD lib, GR-1, CD49b, NK1.1, TCR-yS, and TER-119 followed by
incubation with Streptavidin beads. Naive CD44 low cells were further purified from

purified T cells by incubation in BSS at a concentration of lxlO7 cells/ml with a mi
biotinylated and FITC coupled CD44 antibodies at 1: 300 dilution. The FITC coupled

CD44 antibodies were added for flow cytometric analysis of the purification procedur

CD8 T cells were purified by the same protocol, except that CD4 antibodies were adde

rather than CD8 antibodies and GR-l(Ly-6C) antibodies were omitted from the depletio

antibody cocktail. Cell purity after purification was consistently > 95% as assessed
flow cytometry.
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2.C.3 T cell purification f r o m t h y m u s :
Cells were purified by depletion using M A C S LS columns. Cells were incubated
Q
at 4x10 cells/ml in B S S with a mixture of biotinylated antibodies against CD19, C D 1 lb,
GR-1, CD49b, NK1.1, TCR-y6, TER-119. For CD4 single positive cell purification,

CD8 antibodies were added at 1:50 dilution. For CD8 single positive cell purificatio

CD4 antibodies were added at 1:50 dilution. After washing, cells were incubated with

strepavidin beads prior to running on an LS column. Purified cells consisted of doub
negative (DN) thymocytes and the single positive thymocytes that were purified.

2.C.4 T cell culture:
Unless otherwise noted, T cells were cultured in T cell medium that consisted of
RPMI (Gibco), 10% fetal calf serum, 2mM Glutamine (Gibco), lOOU/ml
penicillin/streptomycin (Gibco), and 55uM 2-mercaptoethanol (Gibco).

2.C.5 Coating of plates for stimulation of purified T cells:
96 well round bottom plates were coated with indicated concentrations of

antibodies in 30 \xl volume for 1-2 hours at 37°C. 24 well plates were incubated wit
\xl of antibody solution. a-CD3e (clone 145-2C-11) used for coating was made in the

laboratory and a-CD28 (clone 37.51) was bought from Pharmingen. After the incubation
time period, the antibody mixture was aspirated, and the wells were washed one time
with PBS prior to addition of cells.

2.C.6 Standard flow cytometric analysis:
2xl05-lxl06 cells were placed per well of a 96 well round bottom plate and
washed in PBS/l%BSA/0.01%azide (PBA). Cells were incubated with indicated

dilutions of antibody (listed elsewhere) in 15 ul PBA for 10 minute at 4°C, washed i
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\xl P B A , and, if necessary, incubated with secondary antibodies in 15 u.1. After a
secondary wash, cells were resuspended in 50-100 ul PBA containing 2nM TO-PRO-3
(Molecular Probes) to exclude dead cells.

2.C.7 Intracellular stainings for flow cytometric analysis:
Brefeldin A was added at a concentration of 10 iug/ml four-six hour prior to cell
staining. Intracellular stainings were performed using the BD Pharmingen
Cytofix/Cytoperm kit according to the manufacturer's protocol, with the following

variations. Cells were fixed for 20 minutes at RT in 30 \xl Cytofix, cytoperm soluti

Antibody stainings were performed in 15 ul volume for 15 minutes at room temperature
Antibody dilutions are listed elsewhere.

2.C.8 Assessment of cell proliferation by [3H]-thymidine
incorporation:
Eight hours prior to harvest, 1 uCi [3H]-thymidine was added in 50 u.1 volume to

each triplicate well of a 96 well plate. For analysis of [3H]-thymidine incorporatio

were harvested onto glass fibre filter paper (Printed Filtermat A, Wallac) using a c

harvester. The filter paper was dried using a microwave prior to being immersed in (
scintillation fluid. Scintillation counts were measured by a (3-counter.

2.C.9 Th1/Th2 differentiation of CD4+ T cells in vitro.
lxlO6 purified naive CD441o C D 4 cells were incubated in a 24 well plate with
plate bound 10 u.g/ml cc-CD3 and 5 ng/ml a-CD28 antibodies in T cell medium. Thl or

Th2 differentiation of cells was stimulated using a mix of cytokines and antibodies.

Thl differentiation, cells were placed in T cell medium containing 2 u.g/ml anti-IL4
antibody, 3.5 ng/ml IL-12 and 25 U/ml IL-2. For Th2 differentiation, cells were
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maintained in medium containing 2 [xg/ml anti-IFNy antibody, lOOOU/ml IL-4 and 25
U/ml IL-2. Cells maintained in non-biased differentiation conditions were maintined
25 U/ml IL-2. In some experiments laboratory made IL-2 supernatant was added at

equivalent concentrations. Cells maintained in blocking conditions were stimulated i
presence of 10 u.g/ml a-IFNy and oc-IL-4. Cells were stimulated for 2 days in the

appropriate differentiation medium in antibody coated wells, split 1:4, and rested f

days in differentiation medium in uncoated wells. On the sixth day, cells were washe
two times in T cell medium to remove antibodies and cytokines, and 2xl05 cells were
restimulated in 96 well round bottom plates with plate-bound a-CD3 and a-CD28

antibodies. Brefeldin A was added at a concentration of 10 u,g/ml 1 hour afterwards,

four hours later cells were stained for intracellular IL-4 and IFNy production using
standard intracellular staining protocol. Flow cytometric analysis of intracellular
stainings was performed thereafter.

2.C.10 TGF-p sensitivity assay:
lxlO5 purified C D 4 + or CD441o C D 4 + T cells were cultured per triplicate well in
96 well round bottom plates coated with 10 u.g/ml cc-CD3e and 5 ji,g/ml a-CD28

antibodies. Cells were cultured in medium alone or in medium containing 1, 2.5, 5, 1
or 25 ng/ml recombinant human TGF(3 (R&D). Cells were cultured for 72 hours at 37C,

and lu.Ci/well of [3H] thymidine was added for the final 8 hours of culture. Incorpo
[3H] thymidine levels were measured using a scintillation counter.

2.C.11 CFSE proliferation analysis:
Purified cells were washed in R P M I and then lx 107 cells/ml were incubated with
2.5u.M carboxyfluoroscein diacetate succinimidyl ester (CFSE; Molecular Probes) in
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R P M I at 37 C for 10 minutes. One volume primary T cell medium was added to stop the
labeling reaction. After the indicated days in culture, flow cytometric analysis of

proliferation as measured by CFSE dilution was performed. Cells were surface stained

for CD4 or CD8 prior to flow cytometric analysis. For all data plots, only live even
displayed.

2.C.12 Proliferation of CD8+ memory cells:
lxlO5 purified CD441o and CD44hi C D 8 + cells were cultured in the presence of

different amounts of recombinant human IL-15 for three days. 8 hours prior to harves
|j,Ci [ H]-thymidine was added to the cultures. Proliferation was measured by [ H]thymidine incorporation of flow cytometric analysis of CFSE dilution.

2.C.13 In vitro regulatory T cell suppressor assay:
C D 4 + T cells were purified by the standard depletion protocol. The cells in the

bound fraction were retained for use as antigen presenting cells (APCs) in the suppr
assay. CD25- vs. CD25+ CD4+ cells were further sorted by incubating 1 x 108 cells/ml
with a 1:8 dilution of a-CD25 (7D4) PE antibody. Cells were incubated for 15-20
o
minutes at 4 C with occasional agitation. Cells were washed, resuspended at 1 x 10
cells/ml and incubated with anti-PE microbeads at 1:8 dilution for 15-20 minutes at
CD25- responder cells were collected as the flow through fraction from the MACS

column. CD25 + suppressor cells were collected as the retained fraction after two ro

of column purification. Suppressor assays were set up using 5xl04 irradiated (3000ra
APCs, 5xl04 CD25- responder cells, 10 u.g/ml soluble anti-CD3 antibody, and titrated

numbers of suppressor cells (5xl04, 2.5xl04, 1.25xl04, 6xl03, and 3xl03) per triplica

well of a 96 well round bottom plate. Control wells included wells with medium alone
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wells with A P C s and anti-CD3e antibody only, wells with responder/suppressor co-

culture without anti-CD3 antibody, and wells with APCs, anti-CD3 antibody, and CD25+

suppressor cells only. Cells were cultured for 72 hours at 37C and liuCi/well of [3H

thymidine was added for the final 8 hours of culture. Incorporated 3H thymidine leve
were measured using a scintillation counter.

2.C.14 In vitro deletion of Itch using TAT-Cre:
2x10 purified C D 4 + T cells from fl/fl orfl/+mice were washed four times in
plain RPMI medium in epindorf tubes. Cells were incubated with 100|xg/ml TAT-Cre
(made in the lab) at a concentration of 1 x 108 cells/ml for one hour at 37°C in an

incubator. Cells were washed two times with T cell culture medium and then set up fo
culture.

l.D In vivo assays:
2.D.1 Mice:
C57B1/6 and Balb/c mice were maintained at the Labarotory Animal Research
Center (LARC) at the Rockefeller University in a pathogen free environment.

Conditional Itch mice were generated by Kristina Jonsson in the University of Cologn
and maintained on a pure C57B1/6 background (backcrossed more than 10 generations).
C57B1/6 JHT (Jackson Laboratory), C57B1/6 (32M -/-(Jackson Laboratory), C57B1/6
CDld -/- (Nussenzweig laboratory), C57B1/6 MHC II -/- (Taconic Farms), C57B1/6 Rag -

/- (Jackson Laboratory), C57B1/6 AND transgenic (Jackson Laboratory), Balb/c Stat 6 -

(Jackson Laboratory), and mixed background DO 11.10 rag -/-mice were crossed to Itch

fl/fl CD4 Cre mice to obtain genotypes discussed in the results section. Genotypes w

assessed using PCR as described elsewhere. Unless otherwise noted, littermate contro
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were used for all experiments. The genotype of these controls was Itchfl/+,Itch fl/+CD4

Cre, or Itch fl/fl. No phenotypic difference was ever noted between control genotype
Whenever possible, results were confirmed with mice from independent crosses.

2.D.2 Adoptive transfer of CD8 SP thymocytes:
1 x 107 thymocytes enriched for C D 8 SP and D N cells by M A C S depletion of

CD4+ cells were CFSE labeled and retroorbitally injected into unirradiated wild-type

recipients in 200 ul PBS. Two Itch fl/fl CD4 Cre or wild-type littermate controls we
used per transfer. Recipient mice were sacrificed four weeks later, and lxlO7
splenocytes or pooled lymph node lymphocytes were stained for CD8 and CD44. Flow
cytometric analysis of CD44 expression was performed on gated CD8+ CFSE labeled
cells.

2.D.3 Adoptive transfer of peripheral T cells:
1 x 107 purified C D 4 + , C D 8 + , or C D 3 + T cells were injected retroorbitally into

6-8 week old Rag deficient mice in 200 ul PBS. Mice were sacrificied and histologica

analysis of organ sections was performed one month after transfer. Successful transf

lymphocytes was confirmed by staining of peripheral blood for transferred lymphocyte
at the time of killing.

2.D.4 In vivo BrdU labeling:
6-8 week old mice given tap water containing 0.8 mg/ ml Bromodeoxyuridine
(Sigma) and 1% sucrose. A stock of 500 ml of BrdU containing water was made and

kept at 4C, and the drinking water of mice was changed every two days. After ten days

mice were sacrificed and flow cytometric analysis of BrdU incorporation was performe
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Intracellular staining for BrdU was performed using the instructions provided by the
manufacturer (BD Pharmingen).

2.D.5 Oral tolerization:
C57B1/6 x Balb/c mixed genetic background D O 11.10 dxd or Itch fl/fl C D 4 Cre
D011.10 dxd mice were given drinking water containing 20 mg/ml Ovalbumin (Sigma)

for five days. Mice were then sacrificed and CD4+ T cells were purified separately f
spleen and mesenteric lymph nodes. 5 x IO4 CD4+ cells were cultured with 5 x 105

irradiated syngeneic APCs and either 0, 15nM, 150 nM, or 1.5mM ovalbumin peptide per

triplicate well in a 96 well round bottom plate. Cells were cultured for 72 hours at

and luCi/well of [ H] thymidine was added for the final 8 hours of culture. Incorpor
[ H] thymidine was measured using a scintillation counter.

2.D.6 Histology:
Haematoxilin and eosin stainings of organ sections were performed by the

Genetically Engineered Mouse Phenotype Core at the Rockefeller University. Dr. Krist
La Perle provided descriptions of the pathology with representative pictures.
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C h a p t e r 3: T h e role o f Itch in peripheral t o l e r a n c e
3.A Introduction:
3.A.1 Tolerance:
Tolerance refers to the ability of the immune system to recognize and accept both

self-antigens and nonpathogenic foreign antigens to which it is exposed. Problems wi
tolerance can lead to a wide spectrum of pathologies, ranging from allergies to
autoimmune diseases. Key mechanisms in maintaining tolerance include T cell anergy,
regulatory T cells, and immunomodulatory cytokines such as IL-10 and TGF-(3.

3.A.2 E3 ligases in T cell anergy:
Recently, experimental data from several groups has suggested a critical role for

E3 ligases in both clonal and in vivo anergy. Several lines of evidence support a ro

the RING finger E3 ligase Cbl-b in T cell anergy. Cbl-b deficient mice spontaneously
develop systemic autoimmunity (Bachmaier, Krawczyk et al. 2000). This spontaneous

autoimmune disease was initially linked to the ability of Cbl-b deficient T cells to

the requirement for CD28 co-stimulatory signals for their activation (Chiang, Kole e

2000). The function of Cbl-b was defined as abrogating signals from the TCR, such tha

only stimulation with co-stimulatory ligands allows for full signal strength and act

Since anergy has been linked to stimulation in the absence of co-stimulatory signals

b became a natural target to consider in anergy induction. Further support for a rol
Cbl-b in the anergy phenotype came from studies demonstrating that Cbl-b mRNA and

protein levels were upregulated in T cells upon anergy induction (Heissmeyer and Rao
2004). The most convincing data has come from recent experiments using Cbl-b
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deficient mice, which demonstrate that Cbl-b deficient T cells are incapable of being
anergized both in vitro and in vivo (Jeon, Atfield et al. 2004).
Another E3 ligase which is selectively upregulated in anergic cells and thus may
regulate T cell anergy is GRAIL (Gene Related to Anergy in Lymphocytes)
(Anandasabapathy, Ford et al. 2003; Seroogy, Soares et al. 2004). T hybridoma cells

overexpressing GRAIL show a defect in both IL-2 and IL-4 production, similar to aner
cells (Anandasabapathy, Ford et al. 2003). Furthermore downregulation of GRAIL in

primary T cells transduced with ouabain 1 (a GRAIL-binding protein that increases it

rate of turnover) demonstrate enhanced IL-2 production, while T cells transduced wit
otubain 1 ARF-1 (an isoform that inhibits GRAIL degradation) show reduced IL-2

inducibility (Soares, Seroogy et al. 2004). While these data are suggestive for a rol
GRAIL in anergy, definitive proof awaits the analysis of GRAIL deficient mice.
Several indirect lines of evidence also implicate Itch in anergy induction.

Induction of clonal anergy in vitro using ionomycin leads to an upregulation of Itch

mRNA and protein levels (Heissmeyer, Macian et al. 2004). Furthermore, stimulation of

anergic but not activated T cells causes Itch to translocate to the detergent insolu

fraction of the plasma membrane (rafts) (Heissmeyer, Macian et al. 2004). The reporte

higher levels of Jun B in the nucleus of Itch deficient T cells (Fang, Elly et al. 2

also effect anergy induction. In addition to its role in Th2 differentiation, JunB i

responsible for AP-1 dependent IL-2 production, and JunB levels are specifically red
after clonal anergy induction (Mondino, Whaley et al. 1996). The increased levels of
JunB in Itch deficient T cells could therefore affect anergy induction as well.
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The most direct evidence for the involvement of Itch in the anergic state is that

Itch deficient T cells fail to become anergic after treatment with ionomycin (Heissm

Macian et al. 2004). The caveat in this experimental protocol is that ionomycin induc

of anergy requires stimulation of T cells under Thl polarizing conditions. Since Itc

deficient T cells display a bias towards Th2 differentiation, it is possible that th

differences in anergy reflect the Th differentiation bias more than a problem with a
induction per se.

3.A.3 The E3 ligase Cbl-b and suppressor cell function:
The molecular mechanisms by which C D 4 + C D 2 5 + regulatory T cells exert their
suppressive effects on CD4+CD25- effector cells remains unclear. Proteins that

negatively regulate signaling in effector cells are excellent candidates to consider

targets that are required for suppressor cells to function. Recently, it has been sh
CD4+CD25- effector T cells deficient in the RING-finger E3 ligase Cbl-b have an
impaired ability to be suppressed by CD4+CD25+ regulatory T cells. Thus, although
Cbl-b deficient mice have functional suppressor cells, suppression fails due to the
inability of effector cells to be suppressed (Wohlfert, Callahan et al. 2004).

3.A.4 E3 ligases and TGF-J3 signaling:
Upon ligation of TGF-(3RII with TGF-|3, TGF-p RLI heterodimenzes with TGF-|3
RI and phosphorylates it. Smad 2 and Smad 3 are recruited to this activated receptor
complex and are in turn phosphorylated by TGF-(3 RI. Phosphorylated Smad2 and

Smad3 then heterodimerize with Smad4 and translocate to the nucleus. Phosphorylation

of Smad proteins is critical for their nuclear import. In addition ubiquitin mediate
degradation of a repressor protein bound to Smads (SnON) is required for TGF-|3
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signaling. Once in the nucleus Smad proteins activate transcriptional complexes through

cis-regulatory Smad binding sequences (Bottner, Krieglstein et al. 2000; Wahl, Swishe

et al. 2004). TGF-(3 signaling is silenced by dephosphorylation and ubiquitin mediate
degradation of Smad proteins by Smad ubiquitin regulatory factors (Smurfs) (Zhu,
Kavsak et al. 1999; Lin, Liang et al. 2000).
T cells from mice deficient in the RING finger ligase Cbl-b show defects in
TGF-(3 mediated suppression of proliferation (Wohlfert, Callahan et al. 2004). The

biochemical pathway that leads to this insensitivity is presently unclear. The autho
analyzed both TGF-(3 receptor expression and proximal downstream signaling events
such as Smad phosphorylation, but found no difference between Cbl-b deficient and
wild-type T cells (Wohlfert, Callahan et al. 2004).
Recently, the murine E3 ligase Itch and its human homologue Atrophin-1

Interacting Protein 4 (AIP-4) have been implicated in regulating TGF-(3 signaling. I

Smad 3 dependent fashion, AIP-4 was found to bind and ubiquitinate human enhancer of
filamentation (HEF-1), a member of the multiple domain docking protein Cas family,

leading to its proteosome mediated degradation in vivo (Feng, Guedes et al. 2004). Si

HEF-1 degradation has been observed in response to TGF-(3 signling in both fibroblas

and a T cell line (Liu, Elia et al. 2000), this data suggests that AIP-4 may be respo
for TGF-(3 mediated HEF-1 degradation. Though this data is intriguing, it should be
considered with the caveat that no genetic proof was provided for the role of AIP-4
regulating HEF-1.
In a separate study, Itch was shown to directly regulate TGF-(3 signaling by
modulating Smad2 activation (Liu, Elia et al. 2000). Itch deficient mouse embryonic
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fibroblasts were found to have reduced susceptibility to TGF-(3 induced cell growth and
arrest. Interestingly, Itch ubiquitin-mediated modulation of signaling was in a

proteolysis-independent manner. Instead, TGF-.6 insensitivity was found to correlate

with decreased Smad 2 phosphorylation and association with the TGF-(3R. Further proo
that the activity of Smad2 was changed was provided by analysis of SnON levels. Upon
Smad2 phosphorylation and nuclear accumulation, SnON is degraded by Smurf2
mediated ubiquitination. SnON levels remained high in Itch deficient fibrolasts,
providing further evidence that Samd2 phosphorylation was decreased. Transfection

experiments revealed that Itch was capable of ubiquitinating Smad2 and that Smad2, It

and TGF-f3R form a complex in TGF-|3 stimulated fibroblasts. Surprisingly, the poly-

ubiquitination of Smad2 occurred on K48. Although K48 polyubiquitination is generall
associated with proteasomal degradation, Smad2 ubiquitination did not lead to its

degradation. Rather, Smad2 ubiquitination affected its ability to bind to the TGF-(3
receptor and consequently Smad2 phosphorylation. Whether this change in binding is

due to a conformational change due to ubiquitination or due to Itch localizing Smad2
the membrane via its C2 domain remains to be determined.

3.A.5 Aims of this study:
The inflammatory phenotype seen in the a18H naturally occurring Itch deficient

mice suggests that there is at some level inappropriate regulation of the immune res

To establish the role of T cells in the inflammatory pathology seen in naturally Itc
deficient mice, conditionally Itch deficient mice were generated. The aim of the
experiments described in this section of the thesis was to provide evidence for the

importance of CD4+ T cells in the inflammatory phenotype and to provide insight into
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which tolerance mechanisms may be affected in Itch fl/fl C D 4 Cre mice. In particular,
the role of CD4+CD25+ suppressor cells and the cytokine TGF-(3 in modulating Itch
deficient T cells was addressed. In addition, the ability of Itch deficient T cells
anergized by oral tolerance was assessed.

3.B Results:
3.B.1 C57BL/6 Itch fl/fl CD4 Cre mice develop a spontaneous
inflammatory disease
As reported previously for the naturally occurring Itch mutant mouse strain a18H

(Perry, Hustad et al. 1998), Itch fl/fl CD4 Cre mice developed a visible dermatitis b

weeks of age. In order to ascertain the type and extent of the inflammatory patholog

organ sections from two, five, and seven month old mice were stained with hematoxyli
and eosin (Figure 3-1). Analysis of sections from two-month old mice revealed

inflammatory lesions surrounding the epithelial lining of the respiratory tract, inc

the nasopharynx and alveoloi, the gastrointestinal tract, including the eosophagus an
stomach, and the urinary tract, including the ureters. The inflammatory lesions were

marked by hyalinosis of the epithelial lining. Neutrophil infiltrates and plasma cel

present in the lesions, along with eosinophilc crystalline granules. The lungs revea

most severe accumulation of eosinophilic granules as well as infiltrating macrophage

neutrophils, and plasma cells. No lesions were present in other internal organs, incl

the brain, heart, thyroid gland, parathyroid gland, pancreas, liver, small intestine,
intestine, adrenal gland and kidneys. The kidneys did show signs of hydronephrosis,

this may be secondary to the inflammation in the ureters, as no inflammatory lesions
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Figure 3-1. Inflammatory lesions along mucosal linings in Itch fl/fl C D 4 Cre mice. Left panel. Heaematoxilin
a n d eosin stainings of organ sections from 2 m o n t h old Itch fl/fl C D 4 C r e m i c e a n d littermate controls.
Analysis of lung sections reveals perivascular infiltrates a n d acidophilic m a c r o p h a g e p n e u m o n i a . Analysis
of sections of n a s o p h a r y n x , e s o p h a g u s , nonglandular sections of the s t o m a c h , a n d ureters reveals
acidophilic neutrophilic infiltrates, p l a s m a cell infiltrates, a n d hyalanosis. Kidney sections revealed
hydronephrosis but n o signs of inflammation. Right panel. Six m o n t h old mice develop further infiltrates
in the p a n c r e a s , skin, a n d t h y m u s .
Dermatitis b e c o m e s grossly visible at this time.
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were present in the kidneys themselves.
By 5 months of age, neutrophil, macrophage, and plasma cell infiltrates were

additionally seen in the pancreas, thymus, and skin (Figure 3-1). Dermatitis was gro
visible at this time. In addition, the corticomedullary boundary of the thymus was
obliterated.
Since Itch fl/fl CD4 Cre mice were housed in a pathogen free environment, and

since CD4 Cre leads to the deletion of Itch in only T cells and CD4+ NKT cells, it c
concluded that the inflammatory phenotype is due to either a cell autonomous,

spontaneous activation of T cells or the inappropriate activation of T cells by self
pathogenic environmental antigens.

3.B.2 Itch fl/fl CD4 Cre accumulate effector/memory CD4+ cells and B
cells in the spleen a n d l y m p h n o d e
By eight weeks of age, Itchfl/flC D 4 Cre mice had developed splenomegaly and
lymphadenopathy. In particular, the mandibular lymph nodes tended to be prominently

enlarged as compared to wild type mice upon gross inspection. Flow cytometric analys

of lymphocyte populations revealed that there was an increase in the percentage as w
as absolute number of B cells in both the spleen and lymph node (Figures 3-2a and 3-

3a). In contrast there was a decrease in the percentage of CD4+ T cells in the splee
lymph nodes, although the absolute numbers were similar or greater (Figure 3-2c). In

the spleen, and to a lesser extent in the lymph nodes, a greater percentage of CD4+ T
cells showed an effector/memory phenotype, as ascertained by CD44 and CD62L surface
marker levels (Figure 3-2a). Analysis of stainings from three independent
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Figure 3-2. Accumulation of B cells and activated T cells in secondary lymphoid organs of 8 w e e k
old Itch fl/fl C D 4 Cre mice. First panel. Spleen S e c o n d panel. L y m p h n o d e s a. Flow cytometric
analysis of lymphocyte populations. N u m b e r s indicate the percentage of cells in the gated
subpopulation. b. Cell surface expression of activation markers of C D 4 + cells, c. Increased
n u m b e r s of effector/memory C D 4 + cells in Itch fl/fl C D 4 C r e mice. Increase in absolute n u m b e r s
of total C D 4 + , a n d effector m e m o r y C D 4 + ( C D 4 4 h i C D 6 2 L l o ) cells. Absolute C D 4 + cell n u m b e r s
w e r e calculated using absolute splenic a n d l y m p h n o d e n u m b e r s a n d percentages of gated
subpopulations. E a c h data point represents the average of two Itch fl/fl C D 4 C r e a n d two littermate
controls analyzed o n the s a m e day. d. Increased percentage of actively dividng effector/memory
C D 4 + cells in Itch fl/fl C D 4 Cre mice. Proliferation rate of peripheral C D 4 + T cells in W T (open bars)
a n d Itch fl/fl C D 4 C r e (grey bars) m i c e in vivo. B r d U incorporation a m o n g total, effector/memory
( C D 4 4 h i C D 6 2 L l o ) , a n d naive ( C D 4 4 l o C D 6 2 L h i ) C D 4 + cells after mice w e r e given drinking water
containing 0.8 m g / m l B r d U for 10 d a y s is s h o w n . * T h e proliferation rate of splenic total C D 4 + a n d
effector/memory C D 4 + cells a s m e a s u r e d by B r d U incorporation is significantly higher in Itch fl/fl
C D 4 C r e mice (p<0.001 by student's t-test). Four mice w e r e used per experimental group. Flow
cytometric data is representative of three independent experiments.

groups of two Itchfl/flC D 4 Cre mice and two littermate controls revealed a statistically
significant increase in the percentage of CD44hi CD62L low effector/memory cells in

spleens of Itch fl/fl CD4 Cre mice (p<0.01 by student's t-test). In addition, an incr
percentage of splenic CD4+ cells showed recent activation markers such as CD25 and

CD69 (Figure 3-2c). No statistical difference was seen in the percentage of activated
CD4 cells in the lymph nodes.
Further confirmation that total CD4+ cells in the spleens of Itch fl/fl CD4 Cre

mice contained more activated CD4+ cells came from in vivo studies in which mice wer
given drinking-water containing 0.8 mg/ml of the DNA analog bromodeoxyuridine
(BrdU) for ten days. On the tenth day, mice were sacrificed and flow cytometric
analysis of the percentage of BrdU positive cells in naive and effector/memory

subpopulations of CD4+ cells was performed. Itch fl/fl CD4 Cre mice contained 1.5 fo
more proliferating CD4+ cells in the effector/memory compartment in the spleen

compared to littermate controls (Figure 3-2d). No difference in BrdU uptake was found

in the lymph nodes. These data are consistent with the hypothesis that there are mor
activated CD4+ T cells in the spleens of Itch fl/fl CD4 Cre mice.

3.B.3

T h e inflammation in Itch fl/fl C D 4 C r e m i c e d o e s not require B

cells
Although conditional deletion of Itch using C D 4 Cre insures that the disease

pathology is not initated by Itch deficiency in B cells, it remained possible that B
were critical for driving its progression. This hypothesis was consistent with data

showing increasing accumulation of B cells in the spleen and lymph nodes of Itch fl/
CD4 Cre mice with increasing age and pathology (Figure 3-2, data not shown). To

83

address the role of B cells in the Itch pathology, Itch fl/fl C D 4 Cre mice were crossed to

C57BL/6 JhT mice. JhT mice lack functional B cells due to a targeted disruption of t

heavy-chain joining region, which leads to developmental arrest of B cells at the pr

cell stage (Gu, Zou et al. 1993). Itch fl/fl CD4 Cre JhT mice developed dermatitis an

acidophilic macrophage pneumonia with similar severity and kinetics as Itch fl/fl CD
Cre mice (Figure 3-3). Haematoxilin and eosin stainings of organ sections revealed

similar levels of neutrophil infiltrates in the mucosal linings of the respiratory a

tract. There was a large decrease in the number of lymphocytes cuffing blood vessels
effected areas of the lung, consistent with previous data showing that the majority
lymphocytes in inflamed areas were CD 19+ B cells (Jonsson 2002). These data support

the view that the activation of B cells and the increase in serum IgGl and IgE titre
Itch fl/fl CD4 Cre mice are secondary events in the pathology and not essential for
inflammatory disease present in these mice.
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Figure 3-3. B cell accumulation is not essential for the Itch inflammatory pathology, a. Increased
numbers of B cells in spleen and lymph nodes of Itch fl/fl C D 4 Cre mice. Each point represents an
independent experiment of cell counts from the average of two wild-type and two Itch fl/fl C D 4 Cre
mice. Absolute B cell numbers were calculated from absolute splenic and lymph node numbers and
the percentage of C D 1 9 + B cells as assessed by flow cytometric analysis, b. B cell deficient Itch fl/fl
C D 4 Cre J H T mice develop an inflammatory pathology similar in extent and kinetics to Itch fl/fl C D 4
Cre mice. Haematoxilin and eosin stainings of lung sections and stomach sections are shown.
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3.B.4 Transfer of C D 4 + T cells transfers the Itch pathology.
Although C D 4 Cre is thought to delete specifically in the double positive stage of
thymocyte development, CD4 is also expressed at low levels in macrophages and

dendritic cells. In addition, CD4 Cre leads to Itch deletion in CD8+ cells as well a

CD4+ cells. In order to further substantiate the role of CD4+ cells in the Itch path
lx IO7 purified T cells or CD4+ T cells were transferred from 8-week old Itch fl/fl
Cre mice and littermate controls into Rag-/- recipients. Transfer of Itch deficient

cells and CD4+ T cells lead to a recapitulation of the Itch pathology one month afte

transfer into Rag deficient mice (Figure 3-4). Recipients of Itch deficient CD4+ T c

were visibly cachectic and had obvious dermatitis, whereas recipients of wild-type C
T cells showed no signs of pathology. Haematoxilin and eosin stainings of organ
sections from Rag deficient mice that received Itch deficient CD4+ T cells revealed
alveolar macrophages pneumonia in the lungs, as well as esophagitis, gastritis, and
nasopharyngitis. Notably, transfer of Itch deficient CD4+ T cells into unirradiated

type hosts lead to no visible pathology and no change in the percentage of activated

CD4+ cells or B cells in the spleen and lymph node of recipient mice (data not shown)
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F i g u r e 3-4. Itch deficient C D 4 + T cells are directly responsible for the Itch pathology. Haemotoxilin
a n d eosin staining of o r g a n sections f r o m R a g deficient m i c e that w e r e retroorbitally injected with
n o cells, 1 x 1 0 wild-type C D 4 + T cells, or 1 x 1 0
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Itch deficient C D 4 + T cells . M i c e w e r e sacrificied

3.B.5 T h e activation of Itch fl/fl C D 4 C r e T cells is not s p o n t a n e o u s
In order to address the role of antigen in the activation of C D 4 + T cells in Itch
fl/fl CD4 Cre mice, Itch fl/fl CD4 Cre mice were crossed to the AND TCR transgene on
C57BL/6 b haplotype background (Kaye, Hsu et al. 1989). The AND transgene encodes

a T cell receptor made from Va 11.1 alpha chain and V(33 beta chain which recognizes
peptide derived from pigeon cytochrome C on k haplotype MHC II molecules. T cells

expressing this receptor are expected to maintain a naive phenotype, as CD4+ T cells
have no access to pigeon cytochrome C in an otherwise unmodified mouse. Flow

cytometric analysis of Itch fl/fl CD4 Cre AND+ mice revealed that there was still an

accumulation of effector/memory phenotype T cells in Itch fl/fl CD4 Cre AND+ mice in
comparison to AND+ littermates; however, analysis of Vail.1+, V(33+ CD4+ T cells

revealed no difference in the percentage of naive cells between wild-type and Itch f
CD4 Cre mice (Figure 3-5). Overall, these data support the conclusion that Itch
deficiency in CD4+ T cells does not lead to spontaneous or antigen independent
activation, but rather modulates the signal from the TCR upon antigen engagement in
manner that leads to an inflammatory disease.
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3.B.6
Itch fl/fl C D 4
s u p p r e s s o r cells.

Cre mice develop and

maintain

CD4+CD25+

The pathology seen in Itchfl/flC D 4 Cre mice is clearly due to an unregulated
inflammatory response. Though this inflammatory response, which is predominantly

seen at mucosal sites and the skin, does not resemble the multi-organ autoimmune dis

described in mice deficient in CD4+CD25+ suppressor cells, it never-the-less remaine

formal possibility that the inflammatory pathology in Itch deficient mice was in som

way connected to an absence of suppressor T cells. In order to address this possibil
splenocytes and lymphocytes were co-stained for CD4 and CD25 cell surface markers
and the percentage of CD4+CD25+ cells was assessed by flow cytometry. 8-week old
Itch fl/fl CD4 Cre mice showed an increase in the percentage of CD4+CD25+ cells
compared to littermate controls (Figure 3-6a). Since CD25 is also upregulated on

activated CD4+ cells, it remained a possibility that the CD4+CD25+ cells seen in Itc
fl/fl CD4 Cre mice represented activated rather than suppressor T cells. A more
selective marker for suppressor T cells is Foxp3. Semi-quantitative RT-PCR from
purified CD4+ cells from Itch deficient mice and littermate controls revealed no
difference in the expression levels of Foxp3 (Figure 3-6b). Thus by two independent
means of assessment, Itch deficient mice contain CD4+CD25+ suppressor T cells. From

this data, one can conclude that the both the generation and maintenance of CD4+ CD2
suppressor T cells is not affected in Itch deficient mice.

90

3.B.7 C D 4 + C D 2 5 + s u p p r e s s o r cells f r o m Itch fl/fl C D 4 C r e m i c e are
functionally anergic a n d suppressive:
Although the previous data established that Itch deficient mice phenotypically

have suppressor T cells, it was possible that these suppressor cells were not functi

The ability of Itch deficient CD4+CD25+ cells to suppress effector CD4+ cells was te

using an in vitro suppressor assay. This assay is routinely used to measure suppress

function, and in the case of Cbl-b deficient cells, provided definitive proof of a f

suppression (Wohlfert, Callahan et al. 2004). To address the ability of Itch deficien
CD4+CD25+ to suppress, CD4+CD25+ were sorted from Itch fl/fl CD4 Cre mice and

wild-type littermate controls. The mice used for these experiments were 8-12 weeks o

with significant evidence of pathology both grossly and also by accumulation of acti
T cells and B cells in their secondary lymphoid organs. Older mice were used to

circumvent the argument that suppressor function ceases to work only later in the li

the mice, when disease is visibly present. CD4+CD25+ cells from Itch fl/fl CD4 Cre o
control mice were co-cultured with wild-type CD4+CD25- responder cells in the
presence of irradiated wild-type APCs and soluble a-CD3 antibody. To assess the
anergic phenotype of the suppressor cells, CD4+CD25+ cells were also cultured alone

with irradiated APCs and soluble a-CD3 antibody. Both wild-type and Itch fl/fl CD4 C
CD4+CD25+ cells failed to proliferate by themselves, providing evidence that Itch
deficient CD4+CD25+ cells are functionally anergic (Figure 3-6c, left panel).

Furthermore, co-culture of either wild-type or Itch fl/fl CD4 Cre CD4+CD25+ suppress
cells with wild-type CD4+CD25- effector cells lead to a titratable decrease in the
proliferation of CD4+CD25- effector cells (Figure 3-6c, left panel). Thus, one can

conclude that Itch deficient CD4+CD25+ cells are indeed functional suppressor cells.
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3.B.8
C D 4 + C D 2 5 - effector cells f r o m Itch fl/fl C D 4 C r e m i c e are
c a p a b l e of being s u p p r e s s e d b y C D 4 + C D 2 5 + regulatory T cells:
The ability of C D 4 + C D 2 5 + cells from Itchfl/flC D 4 Cre mice to suppress did not

rule out the converse possibility that effector cells from Itch fl/fl CD4 Cre mice w

incapable of being suppressed. To address this possibility, an in vitro suppressor a
was performed with wild-type CD4+CD25+ suppressor cells and CD4+CD25- effector

cells from either wild-type or Itch fl/fl CD4 Cre mice. Again, older mice with clear
of pathology (8-12 weeks old) were used for these experiments. CD4+CD25- effector

cells from both wild-type and Itch fl/fl CD4 Cre mice were capable of being suppress

to an equal degree (Figure 3-6c, right panel). Finally, to rule out the possibility t
suppression fails between mutant CD4+CD25+ suppressor and mutant CD4+CD25effector cells, the in-vitro suppressor assay was performed with Itch fl/fl CD4 Cre
CD4+CD25+ suppressor cells and Itch fl/fl CD4 Cre CD4+CD25- effector cells.

Suppression again was obvious in a titratable fashion (Figure 3-6c, right panel). Th
set of data combined with the previously mentioned data show that regulatory T cell

suppression as measured by an in vitro suppressor assay is not effected by Itch dele
T cells.
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Figure 3-6. C D 4 + C D 2 5 + regulatory T cell function is intact in Itch fl/fl C D 4 C r e mice. a. C D 4 + C D 2 5 +
cells are present in Itch fl/fl C D 4 C r e mice. F l o w cytometric analysis of the C D 4 + C D 2 5 + subpopulation
in the spleen. N u m b e r s indicate the percentage of cells in the gated C D 4 + subpopulation. Similar
results w e r e obtained for l y m p h n o d e s (data not s h o w n ) , b . A population of Itch deficient C D 4 +
cells e x p r e s s F o x p 3 . Semi-quantitative R T - P C R analysis of F o x p 3 expression in purified C D 4 + T
cells from wild-type a n d Itch deficient m i c e . Total R N A w a s reverse transcribed using oligo(dT)
primers a n d threefold serial dilutions of c D N A w e r e u s e d for P C R reactions. T h e P C R products
w e r e visualized b y southern blotting with F o x p 3 a n d H P R T specific p r o b e s . R T - P C R analysis of
H P R T expression w a s u s e d a s a loading control, c. Itch deficient C D 4 + cells display s u p p r e s s o r
cell function in vitro. In vitro suppressor assay. Left p a n e l . Wild-type C D 4 + C D 2 5 - responder cells
w e r e cultured with A P C s a n d soluble anti-CD3e alone a n d with wild-type ( W T ) or Itch fl/fl C D 4 C r e
( M T ) C D 4 + C D 2 5 + suppressor cells added at a ratio of 1:8, 1:4, 1:2, or 1:1. Right panel. Itch fl/fl
C D 4 Cre C D 4 + C D 2 5 - responder cells were cultured with A P C s +soluble anti-CD3e alone and with
wild-type ( W T ) or Itch fl/fl C D 4 Cre (MT) C D 4 + C D 2 5 + suppressor cells added at a ratio of 1:8, 1:4,
1:2,1:1. Anergy of C D 4 + C D 2 5 + suppressor cells w a s confirmed by co-culturing with A P C s + soluble
anti-CD3e (a). Culture of A P C s alone (b) and A P C s and responder cells without soluble anti-CD3
(c) provided negative controls for proliferation. Cells were cultured for 7 2 hours, and p H ] thymidine
w a s added 8 hours before cell harvesting. Proliferation w a s determined by the analysis of the p H ]
thymidine incorporation.
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3.B.9 C D 4 + T cells f r o m Itch fl/fl C D 4 C r e m i c e are insensitive to T G F c6 m e d i a t e d s u p p r e s s i o n of proliferation:
Peripheral tolerance is maintained by numerous mechanisms, only one of which is
CD4+CD25+ suppressor T cells. TGF-(3 is an immunomodulatory cytokine that has an

unclear role in suppressor T cell function in vivo, but has a clear role in regulati
activation and modulating inflammatory responses (Gorelik and Flavell 2000). The
recent demonstration that Itch and its human homolog AIP-4 are involved in TGF-(3
signaling in fibroblasts and cell lines (Bai, Yang et al. 2004; Feng, Guedes et al.

suggested that it may also play a role in modulating TGF-(3 signaling in T cells. In
to address this possibility, purified CD4+ T cells were isolated from either spleen

lymph nodes of wild-type and Itch fl/fl CD4 Cre mice and stimulated in vitro with pl
bound a-CD3 and a-CD28 antibodies in the presence of increasing concentrations of

TGF-(3. Wild-type CD4+ T cells showed a titratable decrease in proliferation in resp

to exogenous TGF-(3. In stark contrast, proliferation of CD4+ T cells from Itch fl/f

Cre mice was not inhibited by TGF-(3, even at ten fold higher concentrations than th

necessary to inhibit wild-type CD4+ T cells (Figure 3-7a). These data suggested that
CD4+ T cells from Itch fl/fl CD4 Cre mice may be insensitive to TGF-|3.
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F i g u r e 3-7: Itch regulates T G F - P sensitivity, a. Total C D 4 + T cells from Itch fl/fl C D 4 C r e m i c e
are insensitive to T G F - P m e d i a t e d suppression. Purified C D 4 + T cells from wild-type (squares) or
Itch fl/fl C D 4 C r e (triangles) w e r e cultured with 1 0 ug/ml oc-CD3 a n d 5 ng/ml c c - C D 2 8 platebound
antibodies in the p r e s e n c e or a b s e n c e of indicated concentrations of r e c o m b i n a n t h u m a n T G F p .
Proliferation w a s a s s e s s e d after 7 2 hours of culture b y the incorporation of [3H] thymidine a d d e d
eight hours prior to cell harvesting. Results are representative of t w o independent experiments with
three mice per experimental group. Left panel. Spleen. Right panel, lymph nodes, b. CD44lo
"naive" C D 4 + T cells are sensitive to T G F P mediated suppression. Wild-type (WT) or Itch fl/fl C D 4
Cre (MT) CD44lo C D 4 + T cells were purified to > 9 8 % purity from pooled spleen and lymph node
lymphocytes. Cells were cultured with 10 ng/ml anti-CD3 and 5 ng/ml anti-CD28 platebound
antibodies in the presence (grey bars) or absence (open bars) of 2.5 ng/ml recombinant human
TGF-p. Proliferation was assessed by pH] thymidine incorporation during the last eight hours of a
72 hour culture period. Data represent three wild-type and Itch fl/fl C D 4 Cre mice. Left panel.
CD44lo C D 4 + T cells. Right panel. Total C D 4 + T cells from the s a m e mice.
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3.B.10 N a i v e C D 4 4 l o C D 4 + T cells f r o m Itch fl/fl C D 4 C r e m i c e are
sensitive to T G F - p m e d i a t e d s u p p r e s s i o n of proliferation
Since TGF-p inhibition is dependent on the levels of IL-2 present (Kehrl,

Wakefield et al. 1986), it remained a possibility that the difference seen in vitro w
compounded by the increase in IL-2 secreting activated/effector cells in Itch fl/fl

Cre mice compared to wild type control mice. In order to address this concern, CD441

CD4+ cells were purified and stimulated in the presence of TGF-(3. CD441o CD4+ cells
from Itch fl/fl CD4 Cre mice proliferated five-fold more than their wild-type
counterparts, although proliferation levels of total CD4+ cells were similar. TGF-P

mediated suppression was more evident in Itch fl/fl CD4 Cre CD441oCD4+ cells than in
total CD4+ cells (Figure 3-7b). These data suggest that TGF-P insensitivity seen in
deficient CD4+ T cells may correlate with their activated phenotype.

3.B.11 Itch fl/fl CD4 Cre mice do not develop oral tolerance:
Itch m R N A and protein levels are increased in a model of clonal anergy induced

by incubation of differentiated Thl T cells with ionomycin (Heissmeyer, Macian et al

2004). Although this data suggests that Itch may be upregulated in clonally anergic c

it does not provide any evidence for the role of Itch in anergy induction in vivo. I

to directly address the role of Itch in peripheral tolerance in vivo, Itch fl/fl CD4
DO 11.10 TCR transgene mice were give soluble ovalbumin for 5 days to induce oral
tolerance. CD4+ cells from splenocytes were restimulated with ovalbumin peptide

presented by irradiated syngeneic splenocytes for three days, and proliferation rate

determined by [3H] thymidine incorporation. Preliminary results indicate that CD4+ T
cells from Itch fl/fl CD4 Cre mice fail to tolerize. There was no difference in the

of proliferation of mutant mice whether they were fed Ovalbumin or not (Figure 3-8a).
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It should be noted; however, that the proliferation rates of mutant cells were considerably
lower than wild-type cells, in striking contrast to what is seen in nontransgenic mice upon
antibody stimulation (Figure 3-8b).
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Figure 3-8. Itch deficient cells are not anergized upon oral tolerization. DO11.10 mice (WT) or
D011.10 Itch fl/fl C D 4 Cre (MT) were given water alone (water) or water containing 20 mg/ml ovalbumin
(OVA) for five days. Mice were sacrificed on the sixth day and purified C D 4 + splenocytes were cultured
with indicated concentrations of O V A peptide presented by irradiated syngeneic splenocytes. Proliferation
was measured three days later by addition of pH] thymidine to cultures eight hours prior to harvesting.
a. Proliferation in response to titrated concentrations of peptide in mice given water (squares) or
ovalbumin (triangles) in their drinking water. Left panel. DO11.10 mice. Right panel. D011.10 Itch
fl/fl C D 4 Cre mice b. Proliferation rates of DO11.10 mice (WT) and D011.10 Itch fl/fl C D 4 Cre mice
( M T ) mice in response to 0 m M (empty bars) or 1.5mM O V A peptide (filled bars).
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3.C Discussion:
3.C.1 C57BL/6 Itch fl/fl CD4 Cre mice develop a spontaneous
inflammatory disease
Histological analysis of 8-week old Itchfl/flC D 4 Cre mice revealed an
inflammatory phenotype identical to that described for the naturally occurring Itch
mutant strain a

1 QTT
. T h e inflammation w a s characterized by infiltrates consisting of

neutrophils, eosinophils, macrophages, and plasma cells along the respiratory tract,
gastrointestinal tract and urinary tract. The lungs showed the most striking level of
inflammation in the alveoli, where infiltrates of eosinophilic macrophages accumulated to
the point of alveolar acidophilic macrophage pneumonia. The inflammation was far from
systemic, however, as many internal organs, including the brain, liver, thyroid gland,
small and large intestine and kidneys, showed no inflammatory infiltrates in the mice
analyzed. Specifically, it seems that the infiltrates accumulated along mucosal linings
and eventually along the skin, all areas which are exposed to external antigens. The
location of these infiltrates is suggestive of a problem in regulating local inflammatory
responses in areas exposed to external antigens. This concept makes the study of Itch
deficient mice particularly intriguing from the standpoint of allergies, which are also
known to involve dysregulated immune responses to external antigens.
Analysis of lymphocyte populations in secondary organs revealed that while there
was visible splenomegaly and lymphadenopathy, there was no difference in the absolute
numbers of CD4+ cells. The percentages and absolute numbers of activated/memory
phenotype CD4+ T cells were increased in the spleen but not in the lymphnodes.
Furthermore, analysis of proliferation rates in vivo in Itch fl/fl CD4 Cre mice and
littermate controls suggests that the CD44hiCD62Llo cells are indeed activated cells
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undergoing proliferation. W h y then is there no accumulation of C D 4 + cells in the
spleen? One reason is that later timepoints need to be assessed in order to see the
accumulation. A second potential explanation is that the CD4+ cells emigrate to the
periphery upon activation. In situ stainings of organ sections for CD4+ cells could
address this hypothesis.

3.C.2 The Itch inflammatory phenotype is due to Itch deficient CD4+
T cells:
In addition to the fact that conditionally Itch deficient Itchfl/flC D 4 Cre mice
develop an inflammatory phenotype akin to Itch deficient mice, two pieces of data
described in this thesis provide compelling evidence that the Itch inflammatory
phenotype is due solely to Itch deficiency in CD4+ T cells. Firstly, although Itch
deficient mice show an accumulation of plasma cells in inflammatory lesions and
increased serum IgGl and IgE titres, Itch fl/fl CD4 Cre JHT mice developed an

inflammatory disease similar in kinetics and severity to that seen in Itch fl/fl CD4

miced. Thus, while B cells are activated in Itch mice, their role in the pathology i

secondary. Secondly, transfer of purified Itch deficient CD4+ T cells into Rag defic

mice led to a recapitulation of the inflammatory phenotype within one month of trans

These data not only provide evidence for a role of CD4+ T cells in the Itch patholog

also demonstrate that Itch deficient CD8+ T cells are not required for the pathology

Strikingly, the location of inflammatory lesions mirrored that seen in Itch fl/fl CD

mice, suggesting that the location of inflammation is not arbitrary and must provide
insights into the role of Itch in modulating immune responses.
Genetic proof that CD4+ cells are required for the Itch pathology can be obtained
from the analysis of Itch fl/fl CD4 Cre MHC II -/- mice. Breedings to generate these
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mice are currently underway. In addition, genetic evidence of the role of Itch defcient
CD8+ T cells in the Itch pathology can be obtained from the analysis of Itch fl/fl CD4
Cre p2M -/- mice. Breedings of these mice have been hampered by the linkage between
P2M and Itch, but eventually will yield conclusive results.

The transfer of CD4+ T cells into unirradiated syngeneic hosts failed to cause any
visible pathology, in striking contrast to transfer into Rag deficient mice. There are
several potential explanations for this, none of which are addressed by the experiments
performed thus far. Firstly, the discrepancy between transfer into Rag deficient mice and
unirradatiated syngeneic hosts may simply be a matter of the number of CD4+ T cells
that survived the transfer. It is much easier for lymphocytes to survive in a lymphopenic
host than to compete with existing lymphocytes for niches. Secondly, transfer of CD4+
T cells into lymphopenic hosts leads to their homeostatic expansion. This expansion may
trigger activation of CD4+ T cells (King, Ilic et al. 2004). Although transfer of CD4+ T
cells from WT mice caused no obvious pathology in recipient mice, it may be that Itch
deficiency coupled with further activation of T cells is required for the Itch pathology to
occur. This scenario seems unlikely, as the transferred Itch deficient CD4+ T cells came
from mice with visible splenomegaly, lymphadenopathy, and inflammation, which speak
in favor of the T cells already being sufficiently activated to cause disease. The third and
most intriguing possibility is that the discrepancy between transfer into Rag deficient
hosts and unirradiated syngenic hosts is due to an underlying problem with regulatory T
cell suppressor function in Itch deficient mice. Transfer of mixed wild-type and Itch
deficient CD4+ T cells into Rag deficient mice should provide a way to tease apart some
of these potential explanations. If the transfer of mixed wild-type and Itch deficient
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C D 4 + T cell populations leads to disease, then one could argue that the absence of
disease in unirradiated syngeneic hosts is more likely due to the percentage of
survived transfer rather than absent suppressor functions in vivo.

3.C.3 The activation of Itch fl/fl CD4 Cre T cells is not cell
autonomous
While transfer of C D 4 + T cells from diseased Itch fl/fl C D 4 Cre mice transferred

the disease, it remained unclear whether the activation of Itch deficient CD4+ T

occurred cell autonomously or in an antigen-dependent manner. Analysis of Itch f
CD4 Cre AND transgenic mice revealed that AND TCR expressing CD4+ T cells

remained naive as judged by surface marker staining. Although AND Itch fl/fl CD4

mice became sick and accumulated activated CD4+ T cells, these CD4+ cells did not

express the AND transgene. These data support the notion that Itch deficiency in

T cells does not lead to spontaneous activation. Instead these data are consiste

hypoethesis that Itch deficiency modulates signaling such that TCR signaling lea

inappropriate activation and inflammatory responses in these mice. Itch may regu

TCR signaling itself or may regulate co-stimulatory ligand signaling such that u

antigen encounter, Itch deficient CD4+ T cells respond inappropriately. It is al

possible that Itch regulates CD4+ T cell effector function upon T cell activation
One potential caveat in this interpretation of the data is that surface markers

used to assess the naive phenotype of CD4+ T cells. Although cell surface marker

commonly used to identify a cell's activation status, it remains a formal possib

Itch deficient AND transgenic CD4+ T cells, while appearing naive, were none-the

activated and contributing to the disease phenotype. These concerns will be addr

with the generation of Itch fl/fl CD4 Cre mice on a Ragl deficient TCR transgenic
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background. Crosses are already underway for both the A N D and D O 11.10 transgenes.

If Itch deficient cells truly require cognate antigen stimulation to become inapprop

activated, then one would expect Itch fl/fl CD4 Cre Rag-/- AND+ and Itch fl/fl CD4 C

Ragl -/- DO 11.10 mice to remain free of pathology. Conversely, if Itch deficient CD

cells secrete cytokines even in the absence of antigenic stimulation, then one would
expect the Rag deficient TCR transgenic mice to also succumb to disease.

3.C.4 C D 4 + C D 2 5 +
C D 4 Cre mice:

in vitro s u p p r e s s o r function is intact in Itch fl/fl

The inflammatory pathology seen in Itchfl/flC D 4 Cre mice, which is restricted

primarily to mucosal areas and does not affect internal organs, is very different fr
multi-organ pathology described for mice deficient in CD4+CD25+ regulatory T cells.

None-the-less, it could be formally argued that the dysregulated inflammatory respon

seen in Itch deficient mice was due to either an absence or a problem in the functio
CD4+CD25+ suppressor T cells. Itch fl/fl CD4 Cre mice contain CD4+CD25+ cells, as

judged both by surface marker staining and expression of the regulatory T cell speci
transcription factor Foxp3. In addition, in vitro suppressor assays using wild-type
Itch deficient suppressor and responder cells revealed no qualitative difference in

ability of Itch deficient suppressor cells to suppress and Itch deficient responsder

be suppressed. It should be noted that there was a small but consistent difference i
suppressor assay curves between wild-type and Itch deficient cells. Assays in which

deficient cells were added had higher proliferation counts and required higher numbe

suppressor cells to bring the counts down. This difference can easily be explained b
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contaminating fraction of activated C D 2 5 + cells in the C D 4 + C D 2 5 + suppressor cell
population of Itch deficient mice.
Although Itch deficient CD4+ T cells show no obvious defect in suppressor

function as assessed by in vitro suppressor assays, it remains quite possible that t
problem with suppressor function in vivo. How CD4+CD25+ regulatory T cells function

in vivo remains a matter of controversy, but it is unlikely that direct contact-medi
suppression is the mechanism by which these cells globally suppress inflammatory
responses in an organism. Currently, the only in vivo assessment of CD4+CD25+
suppressor cell function comes from a SCID colitis model. Transfer of purified
CD45RBhi CD4+ cells into SCID mice causes colitis, which can be suppressed by cotransfer of CD45RBlo CD4+CD25+ cells (Mottet, Uhlig et al. 2003). It would be

interesting to see if transfer of Itch deficient CD45RBhi and either wild-type or It
deficient CD45RBlo CD4+CD25+ cells leads to colitis, as this data would indicate a

problem with suppression of Itch deficient responder cells in vivo. Conversely trans
wild-type CD45RBhi and either wild-type or Itch deficient CD45RBlo CD4+ CD25+

suppressor cells could address the suppressive potential of Itch deficient suppresso

These experiments will require backcrossing the Itch conditional deletion onto a Bal

background first, but will eventually provide definitive data regarding suppressor T
function in vivo in the absence of Itch.
It is also increasingly clear that the naturally occurring CD4+CD25+ regulatory T

cells are not the only T cells with suppressor function in vivo. Tr-1 and Th3 suppre
cells, which are both induced upon exposure to antigen under tolerizing conditions,

play key roles in modulating immune responses. The suppressive capabilities of these

104

cells m a y be affected by Itch deficiency.

The generation of Tr-1 cells and their IL-10

dependent suppressive capabilities in vitro have been described for DO 11.10 mice

(Groux, O'Garra et al. 1997). It would be interesting to repeat these experiments wit

CD4+ T cells from Itch fl/fl CD4 Cre DO 11.10 mice. Problems with either the generat
of Tr-1 cells or their suppressive functions in vitro could provide an interesting
explanation for the Itch inflammatory phenotype.

3.C.5 T G F - p sensitivity m a y b e affected in Itch deficient C D 4 + T cells:
Recently, Itch has been implicated in regulating TGF-P signaling. Analysis of

purified CD4+ T cells from Itch fl/fl CD4 Cre mice initially seemed to support a rol
Itch in TGF-P signaling in CD4+ T cells; however, analysis of CD441o CD4+ cells

provided data inconsistent with the initial findings. Although there was a great dea

variation between the purified Itch deficient CD441o CD4+ T cells from different Itc

fl/fl CD4 Cre mice, they showed a greater sensitivity to TGF-P than total Itch defic
CD4+ T cells. These data may be interpreted to suggest that the TGF-P insensitivity

in total CD4+ T cells reflects their activated status more than direct TGF-P insensi

TGF-P inibits in vitro T cell proliferation in an IL-2 dependent manner (Kehrl, Wake

et al. 1986), and the enhanced proliferation seen in Itch deficient CD4+ T cells sugg
that there may be an increase in IL-2 production, either due to an intrinsic change
production in response to Itch deficiency, or due to the activated status of CD4+ T
purified from Itch fl/fl CD4 Cre mice. Definitive answers can only be provided by

purification of naive CD4+ T cells from Itch fl/fl CD4 Cre Rag deficient TCR transge

mice, once it is established that these mice do not develop an inflammatory patholog
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One puzzling feature of the comparison of total C D 4 + T cells from wild-type and

Itch deficient mice with regards to sensitivity to TGF-P is that the difference in T

sensitivity is far more striking than the difference in activated CD4+ cells as asse
surface marker staining. One explanation, which has already been discussed, is that

surface marker analysis underestimates the number of activated CD4+ T cells. Another

possibility is that the cells that are insensitive to TGF-P suppression not only pro

but also cause bystander activation of other CD4+ T cells through their secretion of

It is known that TGF-P mediates its suppression in an IL-2 dependent manner. But why

don't the activated CD4+ T cells from wild-type mice also cause this bystander activ

of naive CD4+ T cells? One possible reason is that only Itch deficient activated CD4

cells are insensitive to TGF-P mediated suppression. One possible way to address thi

issue would be to activate CD4+ T cells for 24-48 hours prior to the addition of TGF

3.C.6 The role of Itch in T cell anergy:
Recent experimental evidence supports a role for E3 ligases, including Itch in

regulating T cell anergy (Heissmeyer, Macian et al. 2004). Tolerization of Itch fl/fl

Cre DO 11.10 transgenic mice supports this hypothesis, as Itch deficient CD4+ T cell
failed to tolerize. These data are preliminary, however, and much more definitive

experiments are needed before a compelling case for the role of Itch in anergy induc
in vivo can be made. Itch deficient CD4+ DO11.10 T cells proliferated to the same

extent, whether or not the mice were tolerized to OVA using an oral tolerization pro

Although these data are consistent with a role for Itch in anergy induction, it shou
noted that the proliferation rates of Itch deficient CD4+ T cells were low, whether

the mice from which they were derived were tolerized. These data are in striking con
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to what is seen upon polyclonal stimulation of Itch deficient T cells in vitro. It is

presently unclear whether this discrepancy is due to the stimulation of Itch deficie
cells with more physiologically relevant APCs and peptide or is related to the TCR
transgene.
Analysis of Itch fl/fl CD4 Cre DO 11.10 Rag -/- mice should provide a cleaner

sytem for anlayis, as all CD4+ cells should be OVA sensitive and naive. Comparison o

proliferation rates between DO 11.10 Rag -/- and Itch fl/fl CD4 Cre DO 11.10 Rag -/either upon polyclonal antibody stimulation or APC and peptide stimulation should
provide important control data regarding the effects of the type of stimulus on

proliferation rates. Furthermore, analysis of oral tolerance in Rag deficient mice s
also remove the confounding variable that T cells in Itch fl/fl CD4 Cre mice do not
anergize because of the inflammatory environment they are in rather than because of
problems with anergy induction per se in the absence of Itch.

Experimental evidence also exists for a role of suppressor cells in oral tolerizatio
protocols (Thorstenson and Khoruts 2001). Many of the existing oral tolerization
protocols may lead to tolerance through both suppressor cells as well as anergy.

Definitive experiments regarding anergy induction will therefore require transfer of
CD4+ T cells into transgenic mice expressing soluble OVA, where the only mechanism
for tolerance is anergy (Abul Abbas, personal communication). Unfortunately, these
transfers require Itch fl/fl CD4 Cre DO 11.10 mice on a Balb/c background. As such,

will require 10 generations of backcrossing to DO11.10 Balb/c mice before these assa
can be performed.
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3.D S u m m a r y :
Collectively, the results presented in this chapter of the thesis demonstrate that

Itch deficient CD4+ cells are sufficient to phenocopy the pathology of Itch deficien
mice. Activation of Itch deficient CD4+ T cells requires antigen. CD4+CD25+
regulatory T cell suppressor function is intact, at least by in vitro assays. TGF-P
sensitivity may be reduced in Itch deficient CD4+ T cells but this may be secondary

the inflammatory pathology. Finally, peripheral tolerance mechanisms may be affected
in Itch fl/fl CD4 Cre mice in vivo.
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C h a p t e r 4:

T h e role o f T h 2 cells in t h e p a t h o l o g y o f Itch

mice
4.A Introduction:
4.A.1 Th1 versus Th2 immune responses:
C D 4 + helper T cells can differentiate into two well define subsets called T helper
type 1 (Thl) and T helper type 2 (Th2) T cells during an immune response. Thl cells
preferentially produce inflammatory cytokines such as interferon gamma (IFNy) and
lymphotoxin alpha (LTa) and are generally mediators of cellular immunity. Th2 cells

produce cytokines such as interleukins 4,5,9,10, and 13 (IL-4,IL-5,IL-9,IL-10,IL-13)

are critical for humoral responses as well as immune responses against extracellular

parasites such as helminthes (Heinzel, Sadick et al. 1989; Finkelman, Pearce et al. 1

During dysregulated immune responses, the dominance of either helper cell type shape
the outcome of immunologically mediated disease conditions, including autoimmune
diseases and allergic responses (Abbas, Murphy et al. 1996).

4.A.2 Evidence for a role of Itch in regulating Th2 differentiation:
The inflammatory pathology and increased serum IgGl and IgE titres in Itch

deficient mice prompted investigators to look at Th2 differentiation in Itch deficie

CD4+ T cells. Analysis of CD4+ T cells from Itch deficient mice revealed a bias towa

Th2 differentiation in vitro (Fang, Elly et al. 2002). Biochemical analysis suggested
this bias was due to increased JunB levels in Itch deficient CD4+ T cells. Recent
experimental data has provided further mechanistic details regarding the regulation
JunB by Itch. Gao and colleagues have found that Itch is phosphorylated upon TCR
engagement in a Janusk Kinase (JNK) dependent manner (Gao, Labuda et al. 2004). This
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phosphorylation leads to increased E3 ligase activity of Itch, leading to increased JunB

turnover in recently stimulated T cells. The models the authors propose is that in t

absence of either JNK signaling or Itch, JunB accumulates in activated T cells, favo

Th2 differentiation. This model is consistent with the similar Th2 bias and the mode

Jun B accumulation seen in both Itch deficient and JNK1 deficient mice (Dong, Yang e

al. 1998; Fang, Elly et al. 2002). What remains unclear from these findings is how It

autoubiquitination, which is also increased upon JNK mediated phosphorylation of Itc

and which leads to Itch degradation, relates to the overall Itch activity in stimula
cells. Furthermore, it should be noted that JNK1 deficient cells, while displaying
moderate accumulation of nuclear JunB, show a far more drastic increase in nuclear
NFATc. This drastic increase could also increase the Th2 bias observed in JNK1
deficient mice. Finally, the Th2 bias seen in Itch deficient and JNK deficient mice

be secondary to other changes in the mice due to complete ablation of the respective
genes in all cell types.

4.A.3 Aims of this study:
Previous work has shown that Itch deficient C D 4 + T cells have an increased

propensity to differentiate into Th2 cells in vitro. While these data were consisten

the increased IgGl and IgE serum titres in older mice, it was unclear whether the bi
observed was secondary to existing pathology in the mice or the actual cause of the
pathology. The experiments described in this chapter provided a causal link between
deficiency in CD4+ T cells and the Th2 bias observed in Itch deficient mice.
Furthermore, the importance of this Th2 bias in the inflammatory pathology was
addressed using genetic techniques. Overall the experiments were designed to
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definitively determine the link between Itch deficiency, dysregulated Th2 immune
responses, and the pathology seen in Itch deficient mice.

4.B Results:
4.B.1 Increased Th2 differentiation of Itch deficient naive CD4+ T
cells:
In order to determine whether Itch deficient C D 4 + T cells have an inherent bias
towards Th2 differentiation, CD441o naive CD4+ T cells were purified from wild-type

and Itch fl/fl CD4 Cre mice at 4 weeks of age. At this age, no dermatitis is visible

FACS analysis reveals minimal changes in lymphocyte populations or activation status
CD4+ cells as compared to wild type littermate controls. Purified naive CD441o CD4+
cells were stimulated in vitro with plate bound a-CD3e (10 u.g/m.1) and a-CD28 (5

[xg/ml) antibodies in the presence of 25 U/ml IL-2 for two days, rested for three day
restimulated with plate bound a-CD3e and a-CD28 antibodies in the presence of

Brefeldin A for four to six hours. Cytokine production by the cells was then assesse

intracellular staining. Analysis of these experiments revealed that naive Itch defic

CD4+ T cells had the same propensity towards Th2 differentiation as published for to
CD4+ populations of naive and activated cells (Figure 4-la,b).

4.B.2 Itch deletion does not effect Th1 differentiation:
Thl and Th2 differentiation are reciprocally regulated pathways, such that

differentiation towards Thl inhibits Th2 differentiation, and vice versa. It thus se

possible that the increased Th2 differentiation in Itch deficient CD4+ cells was due
inability to differentiate towards the Thl lineage. In order to address this issue,

wild type and Itch deficient CD4+ cells were stimulated under Thl polarizing conditi

Ill

N o difference was seen in the ability of Itch deficient cells to become Thl cells (Figure
4-la).

4.B.3 Itch deletion in vitro leads to a bias towards Th2 differentiation:
Although purification of naive cells from Itchfl/flC D 4 Cre mice suggested that
Itch deficiency in CD4+ T cells was directly responsible for the Th2 skewing bias

observed, it remained possible that the naive T cell as judged by surface marker sta
had received non-TCR mediated signals in vivo that influenced their differentiation

vitro. To further substantiate the claim that Itch can directly modulate CD4+ Thl ve

Th2 lineage commitment decisions, CD4+ T cells from Itch fl/+ and Itch fl/fl mice we

treated with cell permeable Cre (TAT-Cre) in vitro. Cells were allowed to proliferat
7 days in medium in the presence of anti-IFNy and anti-IL-4 antibodies to inhibit
differentiation. At this time, cells that had deleted Itch at the genomic level had
reduced Itch protein levels as measured by Western (Figure 4-lc). Cells were then

subjected to a second round of stimulation under Thl, Th2, or unpolarizing condition

Intracellular cytokine analysis for IFNy and IL-4 after a-CD3e and a-CD28 stimulati

revealed that TAT-Cre treated Itch fl/fl CD4+ cells showed an increased frequency of
Th2 cells compared to TAT-Cre treated Itch fl/+ CD4+ cells (Figure 4-lc).

4.B.4 Itch modulation of Th2 differentiation is Stat 6 dependent:
Stat6 is a transcription factor critical for signaling downstream of the IL-4

receptor, and its presence is critical for TH2 differentiation of wild-type CD4+ cel

112

WT

TAT-Cre
fl/+ fl/fl

Itch fl/fl C D 4 Cre

13

6

unpol

19

unpol

^
38

B r 10
0

0.7

5

Th1

54

9

5

10

Th2

Th2
&&•'•

22'

Th1

f.^fe'.
ffl$p39

PJP&

22

^ r ;

X*^.^ 51

20

i„

:£?- 31

| f e 15
IFNy

IFNy
18
W+

16

fl/fl

14

oc-ltch

A

12

a-tubulin
3? 8
6

1

0.25

4
2
0
DWT

AUch fl/fl CD4 Cre

F i g u r e 4-1. Itch regulates T h 1 / T h 2 differentiation, a. In vitro differentiation of Itch deficient C D 4 4 l o
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bound anti-CD3e and anti-CD28 antibodies in m e d i u m containing IL-2 alone (nonpolarizing medium),
IL-2, IFNy, and anti-IL-4 antibodies (Th1 polarizing m e d i u m ) or IL-2, IL-4, and anti-IFNy antibodies
(Th2 polarizing m e d i u m ) . Cells were stimulated for 2 days, rested for four days, w a s h e d , and
restimulated for four hours in the presence of Brefeldin A. Cytokine production w a s assessed by
intracellular staining for IFNy and IL-4. N u m b e r s indicate the percentage of cells in the gated
subpopulation. b. S u m m a r y of the percentage of IL-4+ cells from purified wild-type (open sqaures)
and Itch fl/fl C D 4 C r e (closed tringles) C D 4 + cells cultured under nonpolarizing conditions as described
in a. Each dot represents an individual m o u s e . T h e percentage of IL-4+ cells w a s significantly
increased in Itch fl/fl C D 4 Cre mice compared to littermate controls (p=0.001 by student's t-test).
c. In vitro deletion of Itch leads to T h 2 bias in differentiation. Purified C D 4 + cells from fl/+ or fl/fl
mice were incubated with cell permeable Cre (TAT-Cre) for one hour. Cells were stimulated for 3
days with plate bound anti-CD3e and anti-CD28 antibodies under T helper differentiation blocking
conditions (10ng/ml anti-IFNy and anti-IL-4 antibodies). After resting cells for four days, Itch protein
levels in T A T - C r e treated cells were assessed by Western blot of half the cells (lower panel).
N u m b e r s indicate relative Itch protein levels normalized to tubulin and quantified using NIH Imager.
Remaining cells were stimulated and cyotkine production w a s assessed one w e e k later as described
in a.
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The requirement for Stat6 can be overcome when C D 4 + cells are stimulated through the
Notch pathway and also upon certain genetic modifications. For example, CTLA-4

deficient CD4+ cells are capable of generating Th2 effector cells even in the absenc

Stat 6, as demonstrated by in vitro assays of CD4+ T cells from double deficient mic
To determine if Itch modulation of Th2 differentiation was Stat6 dependent, C57B1/6
fl/fl CD4 Cre mice were crossed to Balb/c Stat 6 deficient mice. Itch fl/fl CD4 Cre

6 -/- mice were born at normal mendelian ratios. Strikingly, Itch fl/fl CD4 Cre Stat

cells were incapable of differentiating into Th2 cells in vitro, even under Th2 pola
conditions (Figure 4-2).

4.B.5 Itch pathology in vivo is Stat6 dependent
The pathology of Itch deficient mice has been ascribed to an overwhelming Th2
immune response in these mice. As Stat6 is critical for Th2 cell differentiation in

and in vitro, and as Stat6 deficiency inhibited Th2 differentiation of Itch deficien
T cells in vitro, Itch fl/fl CD4 Cre Stat 6-1- mice were compared to Itch fl/fl CD4
Stat6 +/+ mice for the extent of their pathology. C57B1/6 x Balb/c mixed genetic

background Itch fl/fl CD4 Cre mice developed a similar inflammatory pathology as the
C57B1/6 counterparts. Itch fl/fl CD4 Cre Stat6 -/- mice, however, showed no grossly

visibly signs of pathology. Analysis of organs sections from Itch fl/fl CD4 Cre Stat
mice further revealed that the Itch pathology was absent in Itch fl/fl CD4 Cre Stat

mice (Figure 4-3). All mucosal linings were free of inflammatory infiltrates, though

only lung and esophageal sections are shown. The occasional focal infiltrates seen i
fl/fl CD4Cre Stat 6 -/- mice were consistent with the age (6 month old) of the mice
did not indicate pathology. Surprisingly, the inflammatory infiltrates were also
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Figure 4-2.
Stat6 is required for Itch dependent Th2 differentiation in vitro, a. C D 4 + T cells were
purified from Itch fl/fl C D 4 Cre Stat 6 +/-, Itch fl/+ Stat 6 -/-, and Itch fl/fl C D 4 Cre Stat 6 -/- mice. Cells
were stimulated with plate bound anti-CD3e and anti-CD28 antibodies in medium containing IL-2,
IL-4, and anti-IFNy antibodies (Th2 polarizing medium) for 2 days, rested for four days, washed, and
restimulated for four hours in the presence of 10ng/ml Brefeldin A. Cytokine production was assessed
by intracellular staining for IFNy and IL-4. Numbers indicate the percentage of cells in the gated
subpopulation. b. Graph summarizing 3 independent experiments carried out as described in a. for
Th2 polarizing conditions. Each dot represents C D 4 + T cells purified from an Itch fl/fl C D 4 Cre Stat
6 +/- (triangle), Itch fl/fl C D 4 Cre Stat 6 -/- (square) or Stat 6 -/- (diamond) mouse.

115

Itch fl/fl C D 4 Cre
Stat 6 +/+

Itch fl/fl C D 4 Cre
Stat 6 -/-

lung
2x

lung
40x

eosophagus
40x
•

.

Figure 4-3. Stat6 is required for the pathology s e e n in Itch fl/fl C D 4 Cre mice. Haematoxilin and
eosin stainings of organ sections from mixed C57BI/6 x Balb/c genetic background 3-month old Itch
fl/fl C D 4 C r e Stat 6 +/+ mice a n d 6-month old Itch fl/fl C D 4 Cre Stat 6 -/- mice. L u n g sections (2x
and 40x) reveal acidophilic m a c r o p h a g e p n e u m o n i a in Itch fl/fl C D 4 C r e stat 6 +/+ but not Itch fl/fl
C D 4 C r e Stat 6 -/- mice. E s o p h a g u s sections reveal hyalinosis a n d eosinophilic infiltrates in Itch
fl/fl C D 4 C r e Stat 6 +/+ mice but not Itch fl/fl C D 4 C r e Stat 6 -/- mice. Three Itch fl/fl C D 4 Cre Stat
6 +/+ a n d six Itch fl/fl C D 4 C r e Stat 6 -/- mice w e r e analyzed. Sections depicted are representative
for e a c h experimental group.
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moderately decreased in Itchfl/flC D 4 Cre Stat 6 +/- mice as well

4.B.6 Increased antigen sensivity in Itch deficient CD4+ T cells:
The decision to differentiate into a Thl or Th2 helper cell is in part determined by

the strength of the signal from the TCR. To address the role of Itch in modulating t

strength of the TCR signal, naive CD4+ T cells were purified from wild-type and Itch

fl/fl CD4 Cre mice and cultured with titrated doses of plate bound a-CD3 or a-CD3 a

a-CD28 antibodies. Sensitivity to antigen was measured by the proliferation of cells
response to different amounts of antigen (Figure 4-4, Table 4-1). CD441oCD4+ Itch

deficient cells showed increased sensitivity to antigenic stimulation as assessed by
proliferation.
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Figure 4-4. Itch deficiency leads to an increased proliferative responses in response to antigenic
stimulation in vitro. Purified C D 4 4 l o C D 4 + cells were labeled with C F S E and cultured with indicated
concentrations of plate bound anti-CD3e (left panel) or plate bound anti-CD3s and anti-CD28
antibodies (right panel). T h e extent of proliferation w a s measured after three days by flow cytometric
analysis of C F S E dilution.

Table 4-1: Increased proliferative responses in purified CD44lo C D 4 + cells from Itch fl/fl C D 4 Cre
mice s h o w s variation between mice. T h e percentage of cells that divided and the proliferation
index (the n u m b e r of divisions a cell that had begun dividing m a d e ) in the experiment described
a b o v e were calculated using flow cytometric software (Flow Jo). Data from six mice is s h o w n .

ng/ml a-CD3e

10

5
2

Percent division
wt
Itch fl/fl C D 4 Cre
61.5
91.4
57.1
73.1
47
87.9
28.9
75.6
24.9
30.5
18.6
66.4
14.3
30
19.5
6.65
18.7
38.1
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Proliferation Index
wt
Itch fl/fl C D 4 Cre
1.98
2.54
1.87
2.9
1.58
2.26
2.57
1.39
1.41
2.13
1.33
2.3
1
2.01
1
1
1
2.28

4.C Discussion:
4.C.1 Itch regulates Th2 differentiation in CD4+ T cells:
Previous work has shown that C D 4 + T cells from Itch deficient mice show a bias
towards Th2 differentiation in vivo. Because of the inherent limitations of working
Itch deficient mice, it was unclear whether this bias was the cause of the Itch

inflammatory pathology or a consequence of it. The data provided in this chapter pro
the first definitive evidence that Itch deficiency directly leads to a bias towards

differentiation. Firstly, purified CD441o CD4+ cells from four-week old Itch fl/fl C

Cre mice, which displayed no visible signs of inflammation, showed a bias towards Th

differentiation. Secondly, in vitro deletion of Itch using cell permeable TAT-Cre al

to a bias towards Th2 differentiation. Combined, these data strongly argue that Itch

directly involved in modulating signals that regulate Thl versus Th2 differentiation

decisions. Furthermore, the data generated using TAT-Cre argue that the bias towards
Th2 differentiation is not secondary to differences that may occur in the selection
deficient thymocytes.

4.C.2 Itch modulation of Th2 differentiation is along the IL-4-Stat6
pathway:
There are numerous pathways that regulate Th2 differentiation.

Broadly

speaking, these include signals downstream of cytokine receptors, signals from the T

signals from co-stimulatory ligands, and signals involving the Notch pathway. The ro
of Stat6 in Th2 differentiation is well established for in vitro differentiation of

cells; however, it is also clear that Notch signaling, constitutive Stat5 signaling,
absence of CTLA-4 regulation of TCR signaling all lead to Stat6 independent Th2
differentiation in vitro. Itch deficiency does not modulate signaling along these
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pathways, as Th2 differentiation in the absence of Itch is Stat6 dependent.

This

observation is particularly relevant for the Notch pathway, where data exists to sup

role for Itch in negatively regulating Notch signaling (Qiu JBC 2000) and recently a

for the Notch pathway in regulating Th differentiation has been established (Maekawa
Tsukumo et al. 2003; Amsen, Blander et al. 2004). There is no data that speaks

definitively on the connection between JunB and Stat6 in Th2 differentiation. Thus i
difficult to ascertain whether the increased JunB levels reported in Itch deficient
indeed the mechanism by which the bias towards Th2 differentiation occurs.

4.C.3 Stat6 dependence of inflammatory pathology seen in Itch
deficient m i c e :
Although a bias towards Th2 differentiation was consistent with the Itch

pathology, it remained unclear whether this bias was sufficient to cause the inflamm
phenotype seen in these mice. Indeed, recent data using an in vitro model system has
suggested that Itch deficient T cells may have a more general problem with anergy

induction (Heissmeyer, Macian et al. 2004). Analysis of Itch fl/fl CD4 Cre Stat6-/- m
provides data in support of a dysregulated Th2 immune response and speaks less
favorably towards a general problem in tolerance. Itch fl/fl CD4 Cre Stat 6-1- mice

shown no visible signs of inflammation at the latest time points that have been asse

thus far (8 months). Histological analysis of six-month old mice revealed no acidophi
macrophage pneumonia in the lungs and no significant accumulation of lymphocytes in
any organs. The lack of changes are not due to the mixed genetic background of these
mice, as Itch fl/fl CD4 Cre Stat 6 +/+ from the same mixed genetic background show

similar inflammation as C57B1/6 Itch fl/fl CD4 Cre mice. Surprisingly, Itch fl/fl CD4
Stat 6 +/- mice also showed reduced inflammation compared to
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Itchfl/flC D 4 Cre Stat 6 +/+ controls. These data suggest that there m a y be a dosage
effect for Stat 6 in Th2 differentiation
It is important to note that no novel inflammatory lesions or novel

immunopathologies were seen in Itch fl/fl CD4 Cre Stat 6 -/- mice. If Itch deficiency

caused a general problem with inappropriate activation of T cells, then crossing Itch
fl/flCD4 Cre mice to Stat 6 -/- mice might have been expected to cause a severe

autoimmune pathology, as activated T cells would have been forced to differentiate a

a Thl pathway. Examples exist of Thl mediated pathologies that are exacerbated in St
6 deficient mice (Chitnis, Najafian et al. 2001; Wang, Ostlie et al. 2004). The fact
Itch fl/fl CD4 Cre Stat 6-1- mice seem healthy argues against a problem with general
tolerance mechanisms.
So, is the inflammatory response in Itch deficient mice entirely due to the Th2

bias? While the data speak clearly in favor of a Th2 mediated pathology, it is prese

unclear why these cells become activated Th2 effector cells. Although JNK1 deficient,
MEKK7 deficient, and DR6 deficient CD4+ T cells all display a bias towards Th2
differentiation similar to or greater than the bias mediated by Itch deficiency, no
accompanying pathology has been reported in these mice. Thus tolerance mechanisms
specific to regulation of Th2 cells must be addressed.

4.C.4 Itch deficient CD4+ cells display increased antigen sensitivity:
At lower doses of titrated antigen, there was a clear increase in the sensitivity of

Itch deficient purified CD441oCD4+ cells as compared to wild-type cells. These result

can be interpreted in two different ways. If one takes the cell surface activation ma

phenotype as a true reflection of the naive status of these cells, then one would hav
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conclude that Itch deficient cells are m o r e sensitive to antigen. A s T h 2 differentiation
occurs at the extremes of antigenic stimulation, this data could suggest that more CD4+
cells from Itch fl/fl CD4 Cre mice are stimulated sufficiently to favor Th2 differentiation.
These data are also consistent with the data described above with Itch fl/fl CD4 Cre
Stat 6 -/- mice, as signals from the TCR and IL-4 receptor need to be integrated for Th2
differentiation to occur.
The caveat that must be considered with this model of increased antigen
sensitivity in Itch deficient CD4+ T cells is that cell surface marker expression may not
necessarily reflect the activation status of a cell. The wide variation in the antigen
sensitivity of CD441oCD4+ cells purified from Itch fl/fl CD4 Cre mice suggests that the
populations that are being purified are not homogenous. This data could be interpreted to
suggest that the variations in antigen sensitivity noted are reflective of the purity of the
naive Itch deficient CD4+ cells used for the assay. Conclusive data regarding changes in
antigen threshold will come from Rag deficient TCR transgenic Itch fl/fl CD4 Cre mice,
assuming that these mice do not develop spontaneous inflammation. CD4+ cells purified
from Rag deficient TCR transgenic mice can be functionally defined as antigen
inexperienced. Furthermore, the cells will be homogenous with regards to the TCR that
is expressed on their surface. Therefore, proliferation analysis of CD4+ T cells from
these mice will provide more decisive answers regarding the role of Itch in antigen
sensitivity.

4.D Summary:
T h e results presented in this chapter of the thesis provide definitive evidence that
Itch directly modulates Thl versus Th2 differentiation decisions in naive CD4+ T cells.

122

In addition, evidence is provided that this modulation occurs upstream of the Stat6

pathway in Th2 differentiation. Finally, genetic proof is provided for the importanc

Th2 differentiation in the pathology of Itch mice. Combined, these data argue strong
that the pathology of Itch deficient mice is driven by a dysregulated Th2 immune
response.
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5.A Introduction:
5.A.1 CD8+ memory cells:
A critical difference between the adaptive and the innate immune systems is the
generation of immunological memory during an immune response. Because of the

importance of CD8+ cells in the generation of immune responses against intracellular
pathogens, the generation of CD8+ memory cells is of key interest in the field of

vaccination. Although the cellular events and cytokines involved in CD8+ memory cell

formation have been elucidated, the molecular pathways that regulate CD8+ memory cel
generation and maintenance remain poorly understood.

5.A.2. Factors regulating CD8+ memory cell generation
M a n y factors influence the generation of C D 8 + memory cells. The amount of
antigen encountered initially is important. CD8+ cells undergo a programmed
proliferative response after antigen encounter, and the extent of proliferation is
determined in part by the antigen dose (Ludewig, Ehl et al. 1998; Wherry, Puorro et
1999; Kedl, Rees et al. 2000; Kaech and Ahmed 2001). The number of memory CD8+
cells is reflective of the initial expansion (Hou, Hyland et al. 1994; Busch, Pilip

1998). Part of the signal for generating memory cells comes from CD4+ cells, as in th

absence CD8+ cells generate effector cells but not memory cells (Janssen, Lemmens et
al. 2003; Shedlock and Shen 2003; Sun and Bevan 2003). Survival of memory precursors

during the contraction phase following the proliferative phase is also important. Af

surviving the contraction phase, memory precursor cells continue to differentiate in

memory cells. They become able to proliferate slowly. This proliferation is importan
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for homeostatic maintenance of memory C D 8 + cells for the lifetime of the organism.

Proliferation occurs in response to the cytokines IL-7 and IL-15 (Goldrath, Sivakuma
al. 2002; Kieper, Tan et al. 2002).

5.A.3 Aims of this study:
Conditional deletion of Itch using CD4-Cre leads to deletion of Itch at the double

positive stage of thymocyte development. Therefore both CD4+ and CD8+ cells are Itch

deficient in Itch fl/fl CD4 Cre mice. During the course of analysis of Itch fl/fl CD
mice, it was serendipitously noted that there was a dramatic increase in CD44hiCD8+
cells in Itch fl/fl CD4 Cre mice. Since the role of Itch in CD8+ cells has not been

previously addressed, the aim of experiments described in this section was to provid
evidence for a direct role for Itch in regulating CD8+ T cells.

5.B. R e s u l t s :
5.B.1 Accumulation of memory-like CD8 cells in secondary lymphoid
o r g a n s of 8 - w e e k old Itch fl/fl C D 4 C r e mice.
Cell surface marker stainings of C D 8 + cells from the spleen and lymph node of
Itch fl/fl CD4 Cre mice showed a dramatic increase in the percentage of CD44hi CD8+

cells. Although CD44 upregulation can be a marker for activated cells, these cells w
neither larger by forward scatter nor positive for other activation markers such as
CD69, or CD62L (Figure 5-1 a,b). These preliminary surface stainings suggested that

there was an increase in memory-like CD8+ cells in Itch fl/fl CD4 Cre mice. Along wi

CD44 upregulation, CD 122 (the p subunit of the IL-15 receptor) and Ly6C upregulatio
also occurs selectively on memory CD8+ cells. Surface staining of CD8+ cells with

CD 122 and Ly6C showed similar increases in their surface expression (Figure 5-la,b).
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Figure 5-1. E x p a n s i o n of C D 8 + m e m o r y cell population in 8 w e e k old Itch fl/fl C D 4 C r e mice. a.
spleen b. l y m p h n o d e s . Left panel. F l o w cytometric analysis of lymphocyte populations. All
stainings are gated o n live C D 8 + cells. N u m b e r s indicate the percentage of cells falling within the
gated subpopulation. M i d d l e panel. Cell surface expression of activation m a r k e r s in C D 8 + cells.
R i g h t p a n e l . Increase in absolute n u m b e r s of m e m o r y C D 8 + cells in Itch fl/fl C D 4 C r e m i c e .
Absolute C D 8 + cell n u m b e r s w e r e calculated using absolute splenic a n d lymph n o d e n u m b e r s a n d
percentages of C D 8 + lymphocytes in the spleen a n d l y m p h n o d e . E a c h data point represents a n
independent experiment consisting of a v e r a g e cell counts of t w o Itch fl/fl C D 4 C r e m i c e a n d t w o
littermate controls.
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Calculation and comparison of absolute numbers of memory-like C D 8 + cells in
spleenand lymph nodes of Itch fl/fl CD4 Cre mice and littermate controls reveals an
average 1.6 fold increase in CD8+ cell numbers in both the spleen and lymph node of

Itch fl/fl CD4 Cre mice, and a 4 fold increase in the absolute number of memory like-

cells in both spleen and lymph nodes. Collectively, these data demonstrate a signifi

(p < 0.001 by student's t-test) accumulation of memory-like CD8+ cells in Itch fl/fl
Cre mice as judged by surface marker staining.

5.B.2 Increased frequency of CD44hi CD8 SP cells in the thymi of Itch
fl/fl C D 4 C r e mice.
Normally, memory cells are generated in response to antigen in the periphery. In

the absence of Itch, it was possible that the activation of CD8+ cells could occur p
the cell encountering its cognate antigen in the periphery. Preliminary analysis of
thymocyte development based on thymocyte population analysis and cell surface
expression of CD3, CD5, CD69, and CD24 revealed no significant differences between

wild-type and Itch fl/fl CD4 Cre mice (Figure 5-2a,b). To determine if Itch deficien

sufficient to cause an increase in CD44 expression in the absence of cognate antigen

stimulation, recently positively selected CD41o CD81o double positive thymocytes, CD
SP thymocytes and CD8+ SP thymocytes were stained for CD44. These stainings reveal

that Itch fl/fl CD4 Cre have a small but significant increase in the percentage of C
cells amongst recently positively selected
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Figure 5-2. N o r m a l T cell d e v e l o p m e n t but early C D 8 + cell activation in Itch fl/fl C D 4 C r e mice.
F l o w cytometric analysis of t h y m o c y t e populations, a. P e r c e n t a g e s of D o u b l e Negative ( D N ) ,
D o u b l e Positive ( D P ) , C D 4 l o C D 8 l o positively-selected D o u b l e Positive ( C D 4 l o C D 8 l o D P ) , C D 4
Single Positive ( C D 4 S P ) , a n d C D 8 Single Positive ( C D 8 S P ) populations are equivalent in wildtype a n d Itch fl/fl C D 4 C r e mice. b. Upregulation of cell surface expression of C D 3 , C D 5 , a n d
C D 6 9 a n d downregulation of C D 2 4 during transition from D P to S P stages of d e v e l o p m e n t is
equivalent b e t w e e n wild-type a n d Itch fl/fl C D 4 C r e mice. c. Significant increase in frequency
of CD44hi C D 8 S P thymocytes in Itch fl/fl C D 4 Cre mice. C D 4 4 expression in C D 8 S P (top
panel) and C D 4 S P (bottom panel). * denotes p<0.01 by student's t-test. The percentages of
CD44hi C D 4 S P cells is not significantly increased in Itch fl/fl C D 4 Cre mice (p=0.3 by students
t-test). d. C D 4 4 expression in recently positively selected CD4loCD8lo D P thymocytes is
increased in Itch fl/fl C D 4 Cre mice. Positive selection of CD4loCD8lo D P thymocytes was
judged by C D 6 9 upregulation and C D 2 4 downregulation. Itchfl/fl C D 4 Cre mice have a significant
increase in the percentage of CD44hi CD4loCD8lo D P thymocytes (* p<0.01 by student's ttest). Stainings are representative of two independent experiments of three 6-8 week old mice.
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CD41o CD8I0 double positive thymocytes and C D 8 + SP thymocytes, but not among C D 4
SP thymocytes (Figure 5-2c,d). These data are consistent with the hypothesis Itch

deficiency modulates signaling such that CD8+ cells are activated in the thymus, pri
encountering their cognate antigen in the periphery.

5.B.3 The increased frequency of memory like CD8+ cells is
i n d e p e n d e n t of the inflammatory pathology in Itch fl/fl C D 4 C r e m i c e
The cytokine milieu can play a role in the proliferation rate of memory like C D 8 +
cells. Naive cells placed into a lymphopenic environment acquire a memory-like
phenotype and proliferate. Furthermore, naive cells from adult mice placed into a

neonate also develop a memory phenotype and undergo proliferation as if they were in
lymphopenic environment (Ichii, Sakamoto et al. 2002), suggesting that the cytokine
environment in neonates leads to expansion of memory like cells through a process
potentially similar to a lymphopenic expansion. In particular, IL-15 has been shown
play a critical role in CD8+ memory cell proliferation (Zhang, Sun et al. 1998), and
of the main producers of IL-15 are macrophages (Kennedy and Park 1996). The
accumulation of macrophages in Itch fl/fl CD4 Cre mice (Jonsson 2002) made it

important to consider the possibility that the accumulation of memory phenotype CD8+
cells is secondary to the inflammatory disease in these mice.
Three pieces of evidence speak against this argument. Firstly, CD8+ memory

cell accumulation is seen in two-week old Itch fl/fl CD4 Cre mice, prior to any visb

activation of CD4+ T cells as judged by surface marker stainings (Figure 5-3a). Trans

studies have made it clear that CD4+ T cells initiate the inflammation in Itch fl/fl
Cre mice. Secondly, Itch fl/fl CD4 Cre mice do not show an increase in NK
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Figure 5-3. C D 8 + memory-like cell accumulation in Itch deficient mice is independent of the
Itch inflammatory pathology, a. Increased frequency of memory-like C D 8 + cells is the first
population change in Itch fl/fl C D 4 Cre mice. Flow cytometric anlaysis of two week old Itch fl/fl
C D 4 Cre mice. B cell accumulation and C D 4 + T cell activation is not evident (left panel)
whereas memory-like C D 8 + cell accumulation is evident (right panel) b. N K and N K T cell
accumulation is unaffected in Itch fl/fl C D 4 Cre mice c. Maintenance of Itch deficient CD44hi
C D 8 + cells in the periphery of wild-type mice. C F S E labeled Itch deficient (MT) or wild-type
(WT) C D 8 + S P cells were transferred into wild-type mice. Recipient mice were sacrificed four
weeks after transfer and splenocytes were stained for surface expression of C D 8 and CD44.
The percentage of CD44hi C F S E labeled C D 8 + cells is shown.
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and N K T cells (Figure 5-3b), whose homeostatic proliferation is also controlled by IL-15
(Ranson, Vosshenrich et al. 2003); nor do they develop fatal leukemias like IL-15

transgenic mice (Fehniger, Suzuki et al. 2001). Finally, transferred CD8+ SP thymocyt
from Itch fl/fl CD4 Cre mice accumulate as CD44hi transferred cells in wild-type
recipients (Figure 5-3c).

5.B.4 Itch deficient memory-like cells CD8+ cells function like
m e m o r y cells in r e s p o n s e to IL-15 stimulation in vitro.
Although cell surface marker stainings suggested an accumulation of memory-

like CD8+ cells in Itch fl/fl CD4 Cre mice, it remained a possibility that these cel

only "masquerading" as memory cells but had no functional properties of memory cells

In the absence of MHC I restricted TCR transgenic mice lacking Itch, it was impossib
to track in vivo CD8+ memory cell generation in response to an antigen or measure
memory cell function in secondary responses to an antigen. Therefore, proliferation
response to IL-15 was used as a functional readout of the memory like cells seen in
fl/fl CD4 Cre mice. CD441o and CD44hi CD8+ cells were purified and stimulated with

titrated concentrations of IL-15. As is the case for wild-type CD8+ cells, Itch defic
CD441o CD8+ cells proliferated minimally in response to IL-15, whereas CD44hi cells
proliferated vigorously (Figure 5-4a). Comparison of CD441o and CD44hi proliferation

rates from Itch fl/fl CD4 Cre mice to wild-type mice revealed a slight increase in t

sensitivity of Itch deficient CD8+ cells to IL-15 in vitro (Figure 5-4b); however, th
was confounded by the fact that the purification procedure left more contaminating

CD441o cells in the CD44hi population of wild-type cells. Thus no conclusive argumen
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Figure 5-4. T h e memory-like C D 8 + cells accumulating in Itch fl/fl C D 4 Cre mice have functional
properties of m e m o r y C D 8 cells, a. Proliferation of CD44hi but not CD44lo C D 8 + cells in response
to IL-15. Purified CD44lo (traingle) and C D 4 4 hi (square) C D 8 + cells from Itch fl/fl C D 4 Cre mice
were incubated with indicated concentrations of recombinant IL-15 for three days. Proliferation w a s
measured by [3H] thymidine incorporation during the last eight hours of culture. Standard error of
the m e a n of triplicates is provided, b. Equivalent proliferation of wild-type and Itch fl/fl C D 4 Cre
CD44hi C D 8 + cells in response to titrated concentrations of IL-15. Purified and C F S E labeled cells
were cultured for three days prior to flow cytometric analysis of proliferation. Results are representative
of two independent experiments.

132

can be made about the sensitivity of Itch deficient C D 8 + cells to IL-15 in vitro.

5.B.5 Itch deficient memory-like CD8+ cells have the same basal
homeostatic proliferation rate a s wild-type cells
To determine if the increased proliferation in response to IL-15 seen in vitro had
any correlate in vivo, Itch fl/fl CD4 Cre mice and littermate controls were fed 0.8
of the DNA precursor analog bromodeoxyuridine (BrdU) in their water for 10 days.
Mice were then sacrificed and the percentage of BrdU positive cells was ascertained

intracellular staining. Concomittant staining of surface markers allowed for the ana

of proliferation rates of naive and memory cells separately. Although Itch fl/fl CD4

mice had an increase in the proliferation rate of CD8+ cells in total, no difference
seen between the memory and naive compartments when compared to wild-type controls

(Figure 5-5). The overall difference reflects simply the increased percentage of mem

cells, which have a higher proliferative rate than naive cells. These data show that

is no increase in the homeostatic proliferation rate of memory-like CD8+ cells in It
CD4 Cre mice.
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Figure 5-5. T h e rate of homeostatic proliferation of m e m o r y C D 8 + cells is unaffected in Itch fl/fl C D 4
Cre mice. a. Spleen b. L y m p h nodes. Mice w e r e given 0.8 mg/ml of the D N A analog bromodeoxyuridine
(BrdU) in their drinking water for ten days. T h e percentage of cells that proliferated in this time period
w a s assessed by flow cytometric analysis of B r d U incorporation. T o p panel. Flow cytometric analysis
of naive ( C D 4 4 l o C D 1 2 2 l o ) and m e m o r y ( C D 4 4 h i C D 1 2 2 h i ) C D 8 + subpopulations in wild-type a n d Itch
fl/fl C D 4 Cre mice given BrdU. N u m b e r s indicate the percentage of cells falling in the gated subpopulations.
B o t t o m panel. B r d U incorporation in total C D 8 + , naive C D 8 + , and m e m o r y C D 8 + of wild-type (open
bars) a n d Itch fl/fl C D 4 C r e (closed bars) mice is s h o w n . Four mice w e r e used per experimental group.
Error bars denote the standard deviation of the m e a n of groups. T h e percentage of proliferating C D 8 +
cells is significantly increased in both the spleen a n d lymph n o d e s of Itch fl/fl C D 4 C r e mice (p<0.01
by student's student's t-test). N o difference w a s observed in the proliferation rate of m e m o r y C D 8 cells.
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5.B.7 Itch d o e s not regulate antigen sensitivity in C D 8 + cells
The generation of memory cells is dependent on the initial proliferation of naive

cells. If more naive cells were triggered in Itch fl/fl CD4 Cre mice, then presumabl
number of memory CD8+ cells would also be increased. To address the role of antigen

sensitivity in the extent of proliferation and hence memory cell formation in Itch f
CD4 Cre mice, CD441o naive CD8+ cells were purified from Itch fl/fl CD4 Cre mice and

littermate controls and stimulated with titrated doses of plate bound a-CD3 antibody
plate bound a -CD3 and a -CD28 antibodies. Antigen sensitivity was assessed by

proliferation (Figure 5-6). No difference was seen between naive WT and Itch deficie

CD8+ cells. These data are consistent with the hypothesis that Itch does not modulat
antigen sensitivity in CD8+ cells.
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Figure 5-6. Proliferative capacity in response to antigenic stimulation is unaffected in Itch deficient
C D 8 + cells. Purified C D 4 4 l o naive C D 8 + were labeled with C F S E and incubated with indicated
concentrations of plate-bound anti-CD3e (left panel) or plate-bound anti-CD3e and anti-CD28 (right
panel) antibodies. Flow cytometric analysis of C F S E dilution upon proliferation w a s performed after
three d a y s of culture. T h e results are representative of two independent experiments.
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S.C

Discussion:

5.C.1 Accumulation of memory-like CD8+ cells in the secondary
l y m p h o i d o r g a n s of Itch fl/fl C D 4 C r e m i c e :
Accumulation of CD25"CD62LhiCD69"CD44hiCD122hiLy6C+ memory-like

CD8+ cells occurred in both the spleen and lymph nodes of Itch fl/fl CD4 Cre mice. I

is expressed at similar levels between CD4+ and CD8+ cells and Itch conditional dele

using CD4 Cre leads to its deletion in both T cell subpopulations. Thus, it was poss

that Itch played an as yet unidentified role in regulating CD8+ memory cell generati

The expression of CD62L and the accumulation of these memory-like cells in the lymph

nodes as well as in the spleen suggest that these are central memory cells. Although
these memory-like cells phenotypically resemble CD8+ memory cells and even have

functional attributes of CD8+ memory cells, their definitive description as memory C

cells will require crossing Itch fl/fl CD4 Cre mice to an MHC I restricted TCR trans
background and infection of these mice so that memory responses can be traced. An
ideal TCR transgene to cross these mice to is PI4, which encodes a MHC I restricted
TCR specific for an epitope of the LCMV virus (Pircher, Burki et al. 1989). Numerous
CD8+ memory studies have been performed using this system, making it an ideal model
system for defining the function of Itch.
One can invisage two potential outcomes from this cross. In one scenario, TCR

transgenic mice will have no CD8+ memory cells, which will suggest that Itch regulat
memory cell formation through an antigen-dependent manner. Infection of mice will

provide insight into which aspect of CD8+ memory cell generation is affected in Itch
deficient mice.
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A second scenario is that Itchfl/flC D 4 Cre mice will continue to accumulate

CD8+ memory like cells even in the absence of cognate antigen stimulation. This resu
will imply that Itch regulates CD8+ memory cell generation in a TCR independent
manner, perhaps through cytokine signaling. The role of Itch in regulating memory

responses can still be studied by adoptively transferring CD441o naive TCR transgeni
CD8+ cells into recipient hosts before viral infection. Of more interest will be
determining which cytokine is responsible for the TCR independent memory cell

accumulation in the absence of Itch. The two cytokines that are critically important
memory CD8+ cell generation are IL-7 and IL-15. Both may play a role in homeostatic

proliferation, but IL-7 is also critical for the survival of memory-precursor cells.
Itch has been implicated in regulating the protein levels of the IL-7 receptor in B
(Liu 2004), it is an important target to test in Itch deficient CD8+ cells.
Recently, a role for CD4 cells in CD8+ memory cell generation has been
described. The requirement for CD4 cells in the accumulation of CD8+ memory like

cells in Itch fl/fl CD4 Cre mice could be addressed by the analysis of Itch fl/fl CD
MHC II-/- mice. Breedings to generate these mice are currently underway.

5.C.2 Itch deficiency leads to upregulation of CD44 on CD8 SP cells
in the t h y m u s :
Stainings of thymi from Itchfl/flC D 4 Cre mice reveal a small but significant

increase in the number of CD44hi CD8+ single positive (SP) cells in the thymus. Thes
data suggest that CD8+ cells are being activated inappropriately soon after their

generation. Further multi-color stainings are required to deterimine if these CD44hi
have also upregulated other memory cell markers such as CD 122 and Ly6C or other

activation markers such as CD25. Already, this data is consistent with Itch modulati
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C D 8 + cell development prior to the cells encountering antigen in the periphery.
Experiments to determine which cytokine is responsible for this activation will be
difficult to design. One possible approach would be to look at signaling events
downstream of the IL-15 or IL-7 receptor. Changes in signaling thresholds for these

cytokines would lead to memory cell accumulation, and perhaps biochemical analysis o

signaling pathways downstream of the cytokine receptors could shed light on the role

Itch in CD8+ memory cell generation In particular, Stat5 signaling should be conside

as it is involved in both CD4+ Th2 differerntiation and CD8+ memory cell generation.

5.C.3 Accumulation of Itch deficient memory-like CD8+ cells is
i n d e p e n d e n t of the inflammatory pathology in Itch fl/fl C D 4 C r e m i c e :
Although B cells accumulate in Itchfl/flC D 4 Cre mice, it is clear that this
accumulation is secondary to the inflammatory pathology initiated in these mice by
CD4+ T cells. The accumulation of memory-like CD8+ T cells could also have been
secondary to the Itch pathology. Two pieces of data argue against this hypothesis.

Firstly, the accumulation of memory-like CD8+ cells is seen in two week old mice, wh

neither splenomegaly not CD4+ T cell activation as assessed by surface marker staini

is evident. Secondly, transfer of Itch deficient CD8+ single positive cells into wil

mice leads to an accumulation of CD44hi CD8+ cells even in the periphery of wild-typ
mice. Thus, it seems that the accumulation of memory-like Itch deficient CD8+ cells
independent of the Itch pathology. Ofcourse, the cytokine environment in the thymus
Itch fl/fl CD4 Cre mice may be altered such that it leads to CD8+ cell activation.

Definitive proof that Itch has a direct role in regulating CD8+ memory cells indepen

of its function in CD4+ T cells requires crossing of Itch deficient mice to a CD8+ T
specific Cre. Unfortunately, such a Cre transgene does not yet exist.
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5.C.4
Itch deficient m e m o r y - l i k e C D 8 +
C D 8 + cells

cells b e h a v e like m e m o r y

Although Itchfl/flC D 4 Cre mice accumulated C D 8 + cells that looked like
memory cells by surface phenotype, proof that they behaved like memory CD8+ cells
was missing. In the absence of an in vivo model system to study CD8+ memory cell

generation, in vitro proliferation in response to IL-15 was chosen as a functional r
It has been shown that memory CD8+ cells are unique in their ability to proliferate

response to IL-15 (Zhang, Sun et al. 1998). Purification of Itch deficient CD441o and

CD44hi CD8+ cells and culture in the presence of IL-15 demonstrated that Itch defici
CD44hi CD8+ cells proliferated in response to IL-15, whereas CD441o cells did not.
Furthermore, comparison of proliferation rates between wild-type and Itch deficient

CD44hi cells revealed that Itch deficient cells were as sensitive if not more sensit
vitro. Thus the memory-like CD8+ cells accumulating in Itch fl/fl CD4 Cre mice have
memory CD8+ cell functional characteristics as well as phenotypic similarities.

5.C.5 CD8+ memory cell homeostatic proliferation is unaffected in
Itch fl/fl C D 4 C r e m i c e :
One potential mechanism by which C D 8 + memory cells might accumulate in Itch
fl/fl CD4 Cre mice is through an increased rate of homoestatic proliferation. This

hypothesis was consistent with the increased proliferation rate of Itch deficient CD

CD8+ cells in response to IL-15 in vitro. A potential caveat in the interpretation o

vitro data was the consistent contamination of a higher percentage of CD441o cells i

CD44 hi population of wild-type cells. To determine if there was an increased rate o

homeostatic proliferation of memory CD8+ cells in Itch fl/fl CD4 Cre mice in vivo, m
were given drinking water containing the DNA analog Bromodeoxyuridine (BrdU) for

ten days, and incorporation of this analog in proliferating cells was assessed. As h
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previously published, approximately 1 5 % of memory C D 8 + cells undergo proliferation in
this time period. There was no difference between Itch fl/fl CD4 Cre and wild-type

memory CD8+ cells in the percentage of BrdU+ cells, suggesting that the proliferatio

rate is equivalent. Since all existing evidence suggests that the homeostatic prolif

rate is controlled predominantly by IL-15, these data argue that there is neither an

increase in the levels of IL-15 in Itch fl/fl CD4 Cre mice nor an increase in the se
to IL-15 of Itch deficient CD8+ cells.

5.C.6 Antigen sensitivity is unaffected by Itch deficiency in CD8+
cells:
Since the number of memory cells generated is dependent on the initial

proliferation burst, it seemed plausible that the accumulation of memory-like CD8+ c
in Itch fl/fl CD4 Cre mice was due to an increase in the antigen sensitivity of Itch

deficient CD8+ cells. In order to address this hypothesis naive CD441o CD8+ cells we

purified from wild-type and Itch fl/fl CD4 Cre mice and proliferation in response to

titrated concentrations of plate-bound antibodies was assessed. No difference was se

antigen sensitivity, suggesting that the accumulation of memory-like CD8+ cells is n

due to an increase in antigen sensitivity. One potential caveat of this experiment i
purification of CD441o cells from Itch fl/fl CD4 Cre mice may select for only those
whose antigen sensitivity was not affected such that they did not proliferate and
eventually give rise to memory CD8+ cells. One way to circument this problem would

be to delete Itch in vitro using cell permeable TAT-Cre and then assess proliferatio
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5.D

Summary:
The data provided in this chapter of the thesis provide preliminary evidence in

favor of a role for the E3 ligase Itch in regulating CD8+ memory cell generation.
Collectively these data show that Itch fl/fl CD4 Cre mice have an accumulation of
memory-like CD8+ cells, both by phenotype and by function. Furthermore, this
accumulation is shown to be independent of the Itch inflammatory pathology. Antigen
sensitivity of naive CD8+ cells and homeostatic proliferation of memory CD8+ cells
were found to be equivalent to wild-type in Itch fl/fl CD4 Cre mice. However,

accumulation was found to begin in the thymi of Itch fl/fl CD4 Cre mice, shortly aft

positive selection. These data can be interpreted to suggest two different mechanism
the accumulation of memory like CD8+ cells. The first is that this accumulation is

cytokine driven, perhaps through increased IL-7 sensitivity. The second is that anti

sensitivity may be modified such that upon positive selection CD8+ T cells are becom
activated and acquiring memory like phenotypes.
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C h a p t e r 6: D i s c u s s i o n
6.A Itch fl/fl CD4 Cre mice develop a spontaneous inflammatory
disorder:
The study of spontaneously occurring inflammatory disorders in mice is
considered of particular clinical significance because they resemble idiopathic

inflammatory diseases seen in humans (at least in their idiopathic nature). In the ca
the E3 ligase Itch, this approach is made all the more appealing based on the highly
polymorphic nature of the Itch gene (Jonsson 2002). It would be of great interest to
Itch polymorphisms within the human population correlate with atopic diseases.
The spontaneous inflammatory disease seen in Itch fl/fl CD4 Cre mice could be
explained by a number of models. The least exciting of these is that Itch regulates

activation in the most general way possible, such that in the absence of Itch, CD4+ T

cells are spontaneously activated. This hypothesis is less appealing to immunologist

because it brings the regulation of CD4+ T cells to questions of cell biology rather

systems regulation. Fortunately, the role of Itch in immune response regulation is n

blunt. Analysis of TCR transgenic mice has revealed that TCR transgenic CD4+ T cells

are not spontaneously activated, at least as judged by cell surface activation marke

analysis. This suggests that Itch regulates immune responses in response to antigens

addition, the location of the inflammation seen in Itch deficient mice, which occurs

mucosal linings, suggests that Itch may be involved in regulating immune responses t

external antigens. Further analysis of Itch deficient mice could provide insight int
physiological mechanisms involved in regulating local inflammatory responses in the
absence of pathogens.
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The inflammatory phenotype in Itch deficient mice suggested that Itch could also
be involved in general processes such as CD4+CD25+ regulatory T cell function. The

experiments provided in this thesis also speak against such a role for Itch. At leas

vitro assays, no functional defect in CD4+CD25+ regulatory T cells was found. This i
consistent with the differences in phenotypes observed between mice deficient in
CD4+CD25+ regulatory T cells, which develop multi-organ autoimmune diseases, and

mice deficient in Itch, which display inflammatory infiltrates along their mucosal l
Itch deficient CD4+ T cells display problems with tolerance induced in response

to an antigen. Induction of tolerant CD4+ T cells in response oral tolerization with

ovalubmin failed in Itch fl/fl CD4 Cre DO 11.10 mice. In addition, Itch deficient CD4

cells show decreased sensitivity to TGF-P , a cytokine which has been linked to indu

tolerance. Surprisingly, the decrease in sensitivity to TGF-(3 seemed to be more due
changes in the sensitivity of activated Itch deficient CD4+ cells rather than naive

deficient CD4+ T cells. Combined these data may argue that Itch regulates the extent
immune responses once an antigen is encountered.

6.B Dysregulated Thl immune response in Itch fl/fl CD4 Cre
mice:
Are these problems with peripheral tolerance mechanisms general, or are they
more specific? Intriguingly, it seems that Itch fl/fl CD4 Cre mice have only a

dysregulated Th2 immune response. Analysis of CD4+ T cells in which Itch was deleted

in vitro confirmed that Itch deficiency does indeed affect Th2 differentiation. It s

be noted, though, that these data and data from naive Itch deficient CD4+T cells rev

significant but small increase in the total number of Th2 effector cells, at least in

Similar, if not greater, changes in Th2 bias have been reported for DR6 or JNK1 defi
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mice, but no inflammatory pathology has been published for these mice. Overall, these

data argue that Itch must regulate more than Th2 differentiation in order to lead to
spontaneous inflammatory pathology seen in Itch deficient mice.
Analysis of Itch fl/fl CD4 Cre Stat 6-1- mice revealed that in the absence of Stat6,

Itch deficient CD4+ T cells cannot differentiate into Th2 cells in vitro. Furthermor

analysis of Itch fl/fl CD4 Cre Stat 6 -/- mice revealed that the inflammatory phento

Itch fl/fl CD4 Cre mice disappeared in the absence of Stat6. Firstly, these data arg

strongly that the inflammatory pathology was Th2 driven. Secondly, they argue that I
deficient T cells are not generally activated. If the Th2 bias were a marginal side
Itch fl/fl CD4 Cre mice, and if the underlying reason for the inflammatory disorder

a universal problem in peripheral tolerance, then one might have expected manifestat

of auto-immune disease in Itch fl/fl CD4 Cre mice. Since Thl and Th2 differentiation

reciprocally regulated, an inability to generate Th2 effector cells would have led t
effector cells in these mice. It is widely accepted that dysregulated Thl immune
responses mediated auto-immune diseases while dysregulated Th2 responses lead to
inflammatory disorders of an atopic nature. Therefore, one might have expected that

fl/fl CD4 Cre Stat 6 -/- mice would develop a sever auto-immune disease. This was no
the case. Combined, these data argue that if there is a problem with tolerance
mechanisms in Itch fl/fl CD4 Cre mice, it is restricted to tolerance of Th2 effector
Definitive proof regarding the role of Itch in regulation of Th2 effector responses

requires the generation of TCR transgenic Rag deficient Itch fl/fl CD4 Cre mice. The

mice, which presumably will contain naive Itch deficient CD4+ T cells, can be analyze

for Thl and Th2 immune responses generated in vivo. It is the author's prediction th
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immunization with antigen favoring Thl differentiation m a y lead to normal immune

responses, assuming that Itch deficient mice don't generate Th2 effector cells under
favoring conditions. In contrast, immunization with antigen that favors Th2
differentiation will lead to an unregulated inflammatory response.
The study of peripheral tolerance mechanisms that are induced upon antigen

exposure and are specific to either Thl or Th2 effector cells is a relatively new co
immunology (Akbari, Stock et al. 2003). The ability to regulate specific effector

responses without affecting others would be of considerable clinical interest, as ma
diseases are due to dysregulation of either Thl or Th2 immune responses. Skewing
immune responses towards the opposite effector phenotype has been attempted in the
past, but brings with it the risk of causing different pathologies. The ability to
specifically regulate Thl or Th2 effector responses would provide a more controlled
regulation of the immune system.

6.C

T h e role of Itch in C D 8 + m e m o r y cell generation:
Serendipitously, it was noticed that Itch fl/fl C D 4 Cre mice have an increase in

the number of CD44hiCD122hiLy6C+ CD8+ memory-like cells in their secondary
lymphoid organs. Although Itch is expressed in CD8+ cells, its role in CD8+ cell

function has previously gone unstudied. The experiments described in this thesis att
to lay the groundwork for further studies about the role of Itch in CD8+ memory cell
generation. These data suggest that Itch deficient CD8+ memory cells accumulate not

because of the pathology in Itch fl/fl CD4 Cre mice but because of an inherent diffe

in Itch deficient CD8+ cells. The rate of homeostatic proliferation of Itch deficien
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memory-like cells in the periphery was found to be unaffected, suggesting that Itch does
not regulate CD8+ memory cell homeostasis once they are formed. Instead, Itch may

regulate the generation of memory-like CD8+ cells. Consistent with this hypothesis i

the finding that an increase in CD44hiCD8+ was observed as soon as positive selectio
occurs in the thymus. The exact mechanims by which Itch regulates the CD8+ memory
like formation requires analysis of MHC I TCR transgenic mice, in which antigen
dependence of this process will be tested, and MHC II deficient mice, in which the
requirement for CD4+ help will be tested. It is hoped that by discovering the

mechanisms by which Itch modulates CD8+ memory cell generation, further insight into
the general mechanisms whereby CD 8+ memory cells are formed will be provided.
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